
<html lang="en"     class="pb-page"  data-request-id="3b4fcf95-1dff-4f0d-aef4-2b345a4aa6af"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.7b00947;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2017.60.issue-18;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Fragment-Derived Small Molecules for in Vivo Inhibition of Ketohexokinase (KHK)" /></meta><meta name="dc.Creator" content="Kim  Huard" /></meta><meta name="dc.Creator" content="Kay  Ahn" /></meta><meta name="dc.Creator" content="Paul  Amor" /></meta><meta name="dc.Creator" content="David A.  Beebe" /></meta><meta name="dc.Creator" content="Kris A.  Borzilleri" /></meta><meta name="dc.Creator" content="Boris A.  Chrunyk" /></meta><meta name="dc.Creator" content="Steven B.  Coffey" /></meta><meta name="dc.Creator" content="Yang  Cong" /></meta><meta name="dc.Creator" content="Edward L.  Conn" /></meta><meta name="dc.Creator" content="Jeffrey S.  Culp" /></meta><meta name="dc.Creator" content="Matthew S.  Dowling" /></meta><meta name="dc.Creator" content="Matthew F.  Gorgoglione" /></meta><meta name="dc.Creator" content="Jemy A.  Gutierrez" /></meta><meta name="dc.Creator" content="John D.  Knafels" /></meta><meta name="dc.Creator" content="Erik A.  Lachapelle" /></meta><meta name="dc.Creator" content="Jayvardhan  Pandit" /></meta><meta name="dc.Creator" content="Kevin D.  Parris" /></meta><meta name="dc.Creator" content="Sylvie  Perez" /></meta><meta name="dc.Creator" content="Jeffrey A.  Pfefferkorn" /></meta><meta name="dc.Creator" content="David A.  Price" /></meta><meta name="dc.Creator" content="Brian  Raymer" /></meta><meta name="dc.Creator" content="Trenton T.  Ross" /></meta><meta name="dc.Creator" content="Andre  Shavnya" /></meta><meta name="dc.Creator" content="Aaron C.  Smith" /></meta><meta name="dc.Creator" content="Timothy A.  Subashi" /></meta><meta name="dc.Creator" content="Gregory J.  Tesz" /></meta><meta name="dc.Creator" content="Benjamin A.  Thuma" /></meta><meta name="dc.Creator" content="Meihua  Tu" /></meta><meta name="dc.Creator" content="John D.  Weaver" /></meta><meta name="dc.Creator" content="Yan  Weng" /></meta><meta name="dc.Creator" content="Jane M.  Withka" /></meta><meta name="dc.Creator" content="Gang  Xing" /></meta><meta name="dc.Creator" content="Thomas V.  Magee" /></meta><meta name="dc.Description" content="Increased fructose consumption and its subsequent metabolism have been implicated in hepatic steatosis, dyslipidemia, obesity, and insulin resistance in humans. Since ketohexokinase (KHK) is the pr..." /></meta><meta name="Description" content="Increased fructose consumption and its subsequent metabolism have been implicated in hepatic steatosis, dyslipidemia, obesity, and insulin resistance in humans. Since ketohexokinase (KHK) is the pr..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 11, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00947" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00947" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00947" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00947" /></link>
        
    
    

<title>Discovery of Fragment-Derived Small Molecules for in Vivo Inhibition of Ketohexokinase (KHK) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00947" /></meta><meta property="og:title" content="Discovery of Fragment-Derived Small Molecules for in Vivo Inhibition of Ketohexokinase (KHK)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0016.jpeg" /></meta><meta property="og:description" content="Increased fructose consumption and its subsequent metabolism have been implicated in hepatic steatosis, dyslipidemia, obesity, and insulin resistance in humans. Since ketohexokinase (KHK) is the principal enzyme responsible for fructose metabolism, identification of a selective KHK inhibitor may help to further elucidate the effect of KHK inhibition on these metabolic disorders. Until now, studies on KHK inhibition with small molecules have been limited due to the lack of viable in vivo pharmacological tools. Herein we report the discovery of 12, a selective KHK inhibitor with potency and properties suitable for evaluating KHK inhibition in rat models. Key structural features interacting with KHK were discovered through fragment-based screening and subsequent optimization using structure-based drug design, and parallel medicinal chemistry led to the identification of pyridine 12." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00947"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00947">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00947&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00947&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00947&amp;href=/doi/10.1021/acs.jmedchem.7b00947" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 7835-7849</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00952" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00990" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Fragment-Derived Small Molecules for in Vivo Inhibition of Ketohexokinase (KHK)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kim++Huard">Kim Huard</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-5902-968X" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kay++Ahn">Kay Ahn</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Amor">Paul Amor</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+A.++Beebe">David A. Beebe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kris+A.++Borzilleri">Kris A. Borzilleri</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Boris+A.++Chrunyk">Boris A. Chrunyk</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+B.++Coffey">Steven B. Coffey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yang++Cong">Yang Cong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edward+L.++Conn">Edward L. Conn</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey+S.++Culp">Jeffrey S. Culp</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+S.++Dowling">Matthew S. Dowling</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+F.++Gorgoglione">Matthew F. Gorgoglione</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jemy+A.++Gutierrez">Jemy A. Gutierrez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+D.++Knafels">John D. Knafels</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Erik+A.++Lachapelle">Erik A. Lachapelle</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jayvardhan++Pandit">Jayvardhan Pandit</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+D.++Parris">Kevin D. Parris</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sylvie++Perez">Sylvie Perez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey+A.++Pfefferkorn">Jeffrey A. Pfefferkorn</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+A.++Price">David A. Price</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian++Raymer">Brian Raymer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Trenton+T.++Ross">Trenton T. Ross</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andre++Shavnya">Andre Shavnya</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aaron+C.++Smith">Aaron C. Smith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Timothy+A.++Subashi">Timothy A. Subashi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gregory+J.++Tesz">Gregory J. Tesz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benjamin+A.++Thuma">Benjamin A. Thuma</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Meihua++Tu">Meihua Tu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+D.++Weaver">John D. Weaver</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yan++Weng">Yan Weng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jane+M.++Withka">Jane M. Withka</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gang++Xing">Gang Xing</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+V.++Magee">Thomas V. Magee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Medicine Design, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Internal Medicine, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Structural Biology and Biophysics, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Medicine Design, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#c982a0a4e781bca8bbad8999afa0b3acbbe7aaa6a4"><span class="__cf_email__" data-cfemail="43082a2e6d0b362231270313252a3926316d202c2e">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00947&amp;href=/doi/10.1021%2Facs.jmedchem.7b00947" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 7835–7849</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 30, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 July 2017</li><li><span class="item_label"><b>Published</b> online</span>11 September 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 September 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00947" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00947</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7835%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DKim%2BHuard%252C%2BKay%2BAhn%252C%2BPaul%2BAmor%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D18%26contentID%3Dacs.jmedchem.7b00947%26title%3DDiscovery%2Bof%2BFragment-Derived%2BSmall%2BMolecules%2Bfor%2Bin%2BVivo%2BInhibition%2Bof%2BKetohexokinase%2B%2528KHK%2529%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7849%26publicationDate%3DSeptember%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00947"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4547</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">21</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00947" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Fragment-Derived Small Molecules for in Vivo Inhibition of Ketohexokinase (KHK)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Kim&quot;,&quot;last_name&quot;:&quot;Huard&quot;},{&quot;first_name&quot;:&quot;Kay&quot;,&quot;last_name&quot;:&quot;Ahn&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Amor&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;A. Beebe&quot;},{&quot;first_name&quot;:&quot;Kris&quot;,&quot;last_name&quot;:&quot;A. Borzilleri&quot;},{&quot;first_name&quot;:&quot;Boris&quot;,&quot;last_name&quot;:&quot;A. Chrunyk&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;B. Coffey&quot;},{&quot;first_name&quot;:&quot;Yang&quot;,&quot;last_name&quot;:&quot;Cong&quot;},{&quot;first_name&quot;:&quot;Edward&quot;,&quot;last_name&quot;:&quot;L. Conn&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;S. Culp&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;S. Dowling&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;F. Gorgoglione&quot;},{&quot;first_name&quot;:&quot;Jemy&quot;,&quot;last_name&quot;:&quot;A. Gutierrez&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;D. Knafels&quot;},{&quot;first_name&quot;:&quot;Erik&quot;,&quot;last_name&quot;:&quot;A. Lachapelle&quot;},{&quot;first_name&quot;:&quot;Jayvardhan&quot;,&quot;last_name&quot;:&quot;Pandit&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;D. Parris&quot;},{&quot;first_name&quot;:&quot;Sylvie&quot;,&quot;last_name&quot;:&quot;Perez&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;A. Pfefferkorn&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;A. Price&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;Raymer&quot;},{&quot;first_name&quot;:&quot;Trenton&quot;,&quot;last_name&quot;:&quot;T. Ross&quot;},{&quot;first_name&quot;:&quot;Andre&quot;,&quot;last_name&quot;:&quot;Shavnya&quot;},{&quot;first_name&quot;:&quot;Aaron&quot;,&quot;last_name&quot;:&quot;C. Smith&quot;},{&quot;first_name&quot;:&quot;Timothy&quot;,&quot;last_name&quot;:&quot;A. Subashi&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;J. Tesz&quot;},{&quot;first_name&quot;:&quot;Benjamin&quot;,&quot;last_name&quot;:&quot;A. Thuma&quot;},{&quot;first_name&quot;:&quot;Meihua&quot;,&quot;last_name&quot;:&quot;Tu&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;D. Weaver&quot;},{&quot;first_name&quot;:&quot;Yan&quot;,&quot;last_name&quot;:&quot;Weng&quot;},{&quot;first_name&quot;:&quot;Jane&quot;,&quot;last_name&quot;:&quot;M. Withka&quot;},{&quot;first_name&quot;:&quot;Gang&quot;,&quot;last_name&quot;:&quot;Xing&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;V. Magee&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;11&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;7835-7849&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00947&quot;},&quot;abstract&quot;:&quot;Increased fructose consumption and its subsequent metabolism have been implicated in hepatic steatosis, dyslipidemia, obesity, and insulin resistance in humans. Since ketohexokinase (KHK) is the principal enzyme responsible for fructose metabolism, identification of a selective KHK inhibitor may help to further elucidate the effect of KHK inhibition on these metabolic disorders. Until now, studies on KHK inhibition with small molecules have been limited due to the lack of viable in vivo pharmacological tools. Herein we report the discovery of 12, a selective KHK inhibitor with potency and properties suitable for evaluating KHK inhibition in rat models. Key structural features interacting with KHK were discovered through fragment-based screening and subsequent optimization using structure-based drug design, and parallel medicinal chemistry led to the identification of pyridine 12.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00947&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00947" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00947&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00947" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00947&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00947" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00947&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00947&amp;href=/doi/10.1021/acs.jmedchem.7b00947" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00947" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00947" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00947%26sid%3Dliteratum%253Aachs%26pmid%3D28853885%26genre%3Darticle%26aulast%3DHuard%26date%3D2017%26atitle%3DDiscovery%2Bof%2BFragment-Derived%2BSmall%2BMolecules%2Bfor%2Bin%2BVivo%2BInhibition%2Bof%2BKetohexokinase%2B%2528KHK%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D18%26spage%3D7835%26epage%3D7849%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290925" title="Carbohydrates">Carbohydrates</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/jmcmar.2017.60.issue-18/20170928/jmcmar.2017.60.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Increased fructose consumption and its subsequent metabolism have been implicated in hepatic steatosis, dyslipidemia, obesity, and insulin resistance in humans. Since ketohexokinase (KHK) is the principal enzyme responsible for fructose metabolism, identification of a selective KHK inhibitor may help to further elucidate the effect of KHK inhibition on these metabolic disorders. Until now, studies on KHK inhibition with small molecules have been limited due to the lack of viable in vivo pharmacological tools. Herein we report the discovery of <b>12</b>, a selective KHK inhibitor with potency and properties suitable for evaluating KHK inhibition in rat models. Key structural features interacting with KHK were discovered through fragment-based screening and subsequent optimization using structure-based drug design, and parallel medicinal chemistry led to the identification of pyridine <b>12</b>.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74403" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74403" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Ketohexokinase (KHK) is the rate-limiting enzyme involved in fructose metabolism and catalyzes the phosphorylation of fructose to fructose 1-phosphate (F1P).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Human KHK (hKHK) is expressed from two alternative mRNA splice variants, encoding the two distinct enzyme isoforms KHK-A and KHK-C. The affinity and capacity of KHK-C for fructose phosphorylation is much greater than KHK-A as evidenced by a much lower <i>K</i><sub>m</sub> (0.73 mM for KHK-C vs 28.6 mM for KHK-A), greater <i>k</i><sub>cat</sub> (3.14 × 10<sup>3</sup> s<sup>–1</sup> for KHK-C vs 3.04 × 10<sup>2</sup> s<sup>–1</sup> for KHK-A), and a 405-fold greater overall catalytic efficiency (4.30 × 10<sup>6</sup> M<sup>–1</sup> s<sup>–1</sup> for KHK-C vs 1.06 × 10<sup>4</sup> M<sup>–1</sup> s<sup>–1</sup> for KHK-A).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> While KHK-A is ubiquitously expressed, the expression of KHK-C is limited to the liver, kidney, and intestine, the primary sites of fructose metabolism in the body.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">Fructose consumption, which has increased dramatically over the past century, may be a dietary factor contributing to nonalcoholic fatty liver disease (NAFLD), dyslipidemia, obesity, and insulin resistance in humans.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> In contrast to glucose, metabolism of fructose is not regulated by feedback inhibition. As a consequence, fructose is preferentially metabolized relative to other carbohydrates, and its metabolism generates various reactive and signaling metabolites that contribute to metabolic disease progression.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> As an example, glycolytic metabolites generated from fructose, such as glucose 6-phosphate, activate the carbohydrate response element binding protein (ChREBP), a highly lipogenic transcription factor that can promote both steatosis and insulin resistance with carbohydrate overfeeding.<a onclick="showRef(event, 'cit5c ref6'); return false;" href="javascript:void(0);" class="ref cit5c ref6">(5c, 6)</a> Consequently, postprandial hypertriglyceridemia occurs in both rodents and humans following fructose feeding due to decreased very low density lipoprotein (VLDL) clearance and enhanced de novo lipogenesis.<a onclick="showRef(event, 'ref3 ref7'); return false;" href="javascript:void(0);" class="ref ref3 ref7">(3, 7)</a> In clinical studies, high fructose consumption also increased insulin resistance and hepatic steatosis.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Additionally, correlation studies have revealed that consumption of fructose-containing carbonated beverages is associated with NAFLD in patients who lack other features of the metabolic syndrome, indicating that fructose intake independent of metabolic disease can increase liver fat.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Taken together, these data suggest that increased fructose consumption promotes features of the metabolic syndrome, such as hepatic steatosis, insulin resistance, and obesity.</div><div class="NLM_p">Studies in KHK-null mice (i.e., lacking both KHK-A and -C) have previously demonstrated that KHK is required for the adverse metabolic effects of fructose. Mice lacking KHK were protected from fructose-induced hypertriglyceridemia, insulin resistance, hepatic lipid accumulation, weight gain, and adiposity compared to the wild type littermate controls.<a onclick="showRef(event, 'ref3 ref10'); return false;" href="javascript:void(0);" class="ref ref3 ref10">(3, 10)</a> Interestingly, KHK-null mice are also protected from the deleterious effects of endogenously produced fructose, as they display reduced weight gain, insulin resistance, and hepatic steatosis when fed a high glucose, fructose-free diet that promotes endogenous fructose synthesis, features of insulin resistance and the metabolic syndrome.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> KHK loss of function mutations have been reported in humans and result in a benign and asymptomatic syndrome known as essential fructosuria, in which fructose from the diet results in fructose wasting in the urine.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> On the basis of the overall data from human genetics and nonclinical studies, KHK inhibition was proposed as a potentially safe mechanism to treat metabolic diseases.</div><div class="NLM_p">At the molecular level, KHK-C (KHK hereafter) exists as a dimer in solution<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and has been observed to form a dimer in all published crystal structures.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The main structural features of the protein as well as its interactions with fructose and AMP-PNP, a nonhydrolyzable imidophosphate analogue of ATP, have been described in detail elsewhere.<a onclick="showRef(event, 'cit14a cit14d'); return false;" href="javascript:void(0);" class="ref cit14a cit14d">(14a, 14d)</a> Key interactions are illustrated in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>, which shows two orthogonal views of AMP-PNP bound to KHK. Three noteworthy features of this binding site, indicated in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>, are exploited in subsequent inhibitor designs: (1) hydrogen bond between the ribose 3′-OH and the backbone carbonyl oxygen of Gly229, part of a loop (A224–A230) that forms the “roof” of the binding pocket in this representation; (2) water molecule that makes two hydrogen bonds with AMP-PNP and with protein backbone atoms (backbone amide of Phe245 and backbone carbonyl of Cys282); (3) section of the binding site made up of three consecutive proline residues (246–248) that we termed the “proline wall” forms the “southwest” corner of the binding pocket. Three crystal structures with bound fragments that separately interact with each of these elements are shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) hKHK-C complexed with AMP-PNP (PBD code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NBV">3NBV</a>), showing the two molecules in the crystallographic asymmetric unit. Molecule A (colored by secondary structure) is in a closed conformation, and molecule B (yellow) is in an open conformation. Each molecule is bound to AMP-PNP, and the binding site in the closed conformation is shown in a close-up view in (B). (B) A close-up view of the AMP-PNP binding site is shown in two approximately orthogonal views. Three key interactions described in the text are identified with numbers. A semitransparent surface is drawn around the atoms constituting the binding site, colored according to the hydrophobicity of the underlying atoms, with brown being more hydrophobic than green. Hydrogen bonds are indicated with dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Relative to protein kinases, the flipped orientation of the purine ring of AMP-PNP in the binding pocket is noteworthy as it offers the possibility of finding nonhinge binding inhibitors, which could avoid broad kinome activity. An unusual feature of the hKHK-C dimeric assembly is the formation of a β-clasp at the interface, in which residues 19–33 from one subunit (designated A) form part of a β sheet with β-strands from the other subunit (B); hence it is a pseudohomodimer. As a result, Asp27 from monomer B (Asp27(B)) extends into the active site of monomer A within about 6 Å of the bound AMP-PNP (illustrated in <a href="/doi/suppl/10.1021/acs.jmedchem.7b00947/suppl_file/jm7b00947_si_001.pdf" class="ext-link">Figure S1 in Supporting Information</a>) and is a feature that was exploited in inhibitor design by others (vide infra).<a onclick="showRef(event, 'cit14b cit14c cit14d cit14e cit14f'); return false;" href="javascript:void(0);" class="ref cit14b cit14c cit14d cit14e cit14f">(14b-14f)</a></div><div class="NLM_p">Two chemical series of hKHK inhibitors have been reported in the literature (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). A pyrimidinopyrimidine series, represented by <b>1</b>, was identified from a high throughput screening (HTS) campaign. This chemical series was optimized to provide the most potent inhibitors of hKHK reported to date. However, only low exposure levels were achieved in rat pharmacokinetic (PK) studies due to high metabolic clearance.<a onclick="showRef(event, 'cit14b cit14c'); return false;" href="javascript:void(0);" class="ref cit14b cit14c">(14b, 14c)</a> A second series, based on an indazole core, was initially identified through X-ray crystallographic fragment screening and further developed into analogs such as indazole <b>2</b> with moderate inhibitory activity against hKHK and a good rat PK profile.<a onclick="showRef(event, 'cit14d cit14e cit14f'); return false;" href="javascript:void(0);" class="ref cit14d cit14e cit14f">(14d-14f)</a> The basic amine is a key functional group in both series that specifically interact with Asp27 of monomer B as a way to improve potency in the hKHK in vitro assay.<a onclick="showRef(event, 'cit14b cit14c cit14d cit14e cit14f'); return false;" href="javascript:void(0);" class="ref cit14b cit14c cit14d cit14e cit14f">(14b-14f)</a> To our knowledge, in vitro inhibition of rodent KHK was not reported for either the pyrimidinopyrimidine or indazole series and, until now, there were no reports of in vivo KHK inhibition. In our in vitro enzymatic assays, significantly decreased potency against the rat KHK (rKHK) vs hKHK enzyme was observed for basic analogues interacting directly with Asp27(B). Comparison of the human and rat KHK amino acid sequences revealed a difference at residue 107: asparagine in human and serine in rat (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00947/suppl_file/jm7b00947_si_001.pdf" class="ext-link">Figure S1</a>). On the basis of the X-ray structure, such a difference is hypothesized to create a different environment around Asp27 and cause potency shifts between species for basic compounds interacting directly with Asp27(B).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Representative structures of KHK inhibitors from the pyrimidinopyrimidine and indazole series reported in the literature.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Given the limitation of the currently available KHK inhibitor tools for biological studies, we sought to identify a novel series of inhibitors that are equipotent against the human and rat KHK enzyme, with good PK properties. Fragment-based drug discovery (FBDD) is now a well-established technology for generating new chemical leads and drugs.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Screening of a Pfizer proprietary fragment library<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> using NMR ligand-based methods has been useful in identification of unique fragment hits for many internal targets. KHK was considered an excellent candidate for FBDD due to relatively easy generation of high quality and large quantity of a biotin acceptor peptide (BAP) tagged stable protein for development of NMR and SPR binding assays, the precedent for robust protein crystallography, and suitable DMSO tolerance for high concentration screening. Due to prior success with our fragment library for kinases<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and the enabling biophysical characteristics of KHK, we initiated a FBDD approach to identify novel chemical matter. Herein we report the identification of new fragment hits from a primary ligand-based NMR screen, secondary confirmation by SPR and biochemical assays, followed by determination of key interactions observed by X-ray protein crystallography, which were then used to rapidly provide a nonbasic pharmacological tool compound for further study in rodent in vivo models.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07084" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07084" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">During our search for KHK inhibitors, hKHK was screened against our previously described fragment library containing 2592 fragments using a NMR saturation transfer difference (NMR-STD) ligand-based method.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The total hit rate was 17%, which is consistent with other in-house NMR kinase fragment screens. Of these 451 hits, 286 (11%) were considered of high confidence based on the intensity of the NMR-STD signal. Although novel hits are generally observed for each target screened, hKHK had a significant number of unique fragment hits (11 hits, 2.4%) which were not hits in any of our 31 prior NMR fragment screens. Prior experience has taught us that application of orthogonal biophysical and biochemical assays is critical for validating fragment hits, prioritizing for X-ray crystallography and building confidence for medicinal chemistry efforts. To this end, 448 available primary fragment hits were evaluated in an SPR binding assay using an 11-point dose–response curve with a top concentration of 300 μM and 2-fold dilution. Of these primary fragments hits, 114 had binding affinities (<i>K</i><sub>D</sub>) of <100 μM while 16 fragments had <i>K</i><sub>D</sub> values of <25 μM.</div><div class="NLM_p">The fragment hits were evaluated for their physicochemical properties, inhibitory activity in the KHK enzymatic assay, and chemical tractability. Of the 179 SPR-validated hits, 23 were found to be functionally active in the in vitro biochemical assay (IC<sub>50</sub> values ranging from 46 to 439 μM) and these 23 fragments were prioritized for X-ray crystallography. <a href="/doi/suppl/10.1021/acs.jmedchem.7b00947/suppl_file/jm7b00947_si_001.pdf" class="ext-link">Figure S2</a> shows that the distribution of log <i>D</i> and fraction Sp3 for the selected fragments is representative of the distribution for all SPR-confirmed hits. Additionally, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00947/suppl_file/jm7b00947_si_001.pdf" class="ext-link">Figure S2</a> highlights the fact that the selected fragments were neutral, which is aligned with our goal of avoiding basic amines. Finally, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00947/suppl_file/jm7b00947_si_001.pdf" class="ext-link">Figure S2</a> also illustrates the range of <i>K</i><sub>d</sub> covered by the selected 23 fragments, showing that not only tight binders were progressed to crystallization. All 23 fragments were found to bind in the ATP binding site with similar key interactions observed across multiple fragments. Consistent with the flipped orientation of the purine ring of ATP in this pocket relative to protein kinases, none of the hits contained a hinge-binding motif. <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> and <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a> summarize the profile and binding modes of representative hits. As mentioned previously, the hits from NMR screening were confirmed by SPR, with <i>K</i><sub>D</sub> values ranging from 20 μM to 103 μM for the selected examples. Compounds <b>3</b>, <b>4</b>, and <b>5</b> also showed measurable inhibitory activity in the hKHK enzymatic assay (IC<sub>50</sub> of 118 μM, 319 μM, and 100 μM, respectively).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Representative Hits from the NMR Fragment Screening<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0013.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last"><i>K</i><sub>D</sub> values were determined by SPR (<i>n</i> = 1).</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> values for hKHK are reported as the mean of three replicates with pIC<sub>50</sub> ± SD in parentheses.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">MW: molecular weight.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">FQ: fit quality is a scaled measure of ligand efficiency that centers optimal binders near 1.0.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">The functional groups identified in blue, purple, and pink respectively make key interactions with the ribose pocket, conserved water molecule, and proline wall as described in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>.</p></div></div><div></div></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding modes of fragment hits <b>3</b>–<b>5</b>, illustrating the three key interactions in the binding site highlighted in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>. (A) Compound <b>3</b> contains a saturated ring with a polar substitution in the ribose pocket, making a hydrogen bond with the backbone carbonyl oxygen of Gly229 (PBD code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBM">5WBM</a>). (B) The nitrile group of <b>4</b> interacts with a conserved molecule of water deep in the binding pocket (PBD code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBO">5WBO</a>). (C) The trifluoromethyl group of <b>5</b> makes favorable hydrophobic interactions with the proline wall (PBD code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBP">5WBP</a>). A sulfate ion (drawn as a ball-and-stick model) from the crystallization buffer is seen in all three structures to be bound at the site previously occupied by the γ phosphate group of AMP-PNP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Most of the confirmed hits contained a heteroaromatic core (observed in the narrow ATP binding pocket) with multiple aliphatic substituents. As exemplified by compounds <b>3</b> and <b>4</b>, saturated heterocyclic rings with polar functionalities such as an alcohol or an ether were deeply embedded in the ribose pocket (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A and <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). Interestingly, a high fraction of the fragment hits contained a nitrile group. In the examples selected for crystallization, the nitrile group was found to accept a hydrogen bond with a conserved water molecule deep in the binding site (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). Additionally, various lipophilic groups such as methyl or trifluoromethyl (in compounds <b>4</b> and <b>5</b>, respectively) made hydrophobic interactions with the proline wall (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B and <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C).</div><div class="NLM_p">Due to the identification of multiple fragment hits with similar binding modes, the Pfizer screening library was searched for compounds possessing an aryl core densely functionalized with substituents that could satisfy all three key interactions described above and illustrated in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>. This approach led to the identification of compounds <b>7</b> and <b>8</b> where an alcohol-substituted pyrrolidine or piperidine was positioned to fill the ribose pocket, a nitrile group forms a hydrogen bound with the conserved water molecule, and a trifluoromethyl group interacts with the proline wall (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>7</b> (blue in the crystal structure, PBD code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBQ">5WBQ</a>) and compound <b>8</b> (pink in the crystal structure, PBD code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBR">5WBR</a>) with improved potency against hKHK. The functional groups identified in blue, purple, and pink reproduce the key interactions described for the fragments hits in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> and <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>. In this figure, which shows the binding site in exactly the same view as the right-hand panel of <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, all protein atoms have been hidden for clarity. The nitrile group in both compounds interacts with a conserved water molecule, shown as a gold sphere. A second water molecule, shown as a red sphere, is seen in the crystal structure of <b>7</b>, which occupies the same space as that filled by the hydroxyl group in <b>8</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As described in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, pyrrolopyridine <b>7</b> is a hKHK inhibitor with moderate potency and low metabolic stability in human liver microsome (HLM) assays.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> As observed in the crystal structure (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>), the ethyl substitution at the C2 position does not make any important interactions and was therefore removed without loss of potency. This modification significantly decreased log <i>D</i> and resulted in much improved metabolic stability in the HLM assay (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The methylpyrrolidinol group was found to complement the ribose pocket with the <i>S</i> enantiomer <b>9</b> found to be more potent than the <i>R</i> enantiomer <b>10</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structure–Activity Relationship (SAR) with the Pyrrolopyridine Core</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0014.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0015.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values for hKHK are reported as the mean of three replicates with pIC<sub>50</sub> ± SD in parentheses.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">The log <i>D</i> values were determined using the shake-flask method with an octanol/water partition at pH 7.4.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Apparent clearance from human liver microsomes.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></p></div></div><div></div></div><div class="NLM_p">As depicted in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, pyrrolopyridine <b>9</b> was identified as a relatively potent and efficient human and rat KHK inhibitor with adequate microsomal stability, permeability (<i>P</i><sub>app</sub>),<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and thermodynamic solubility. When evaluated in rat PK studies, a mean free <i>C</i><sub>max</sub> of 1.3 μM with high interanimal variability was observed following oral administration at a high dose of 300 mg/kg. With an IC<sub>50</sub> of 0.64 μM against the rKHK, this exposure profile did not allow complete inhibition of KHK activity over a time frame suitable for studying metabolic end points in vivo; thus further improvement of the series was pursued.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) In vitro profile of pyrrolopyridine <b>9</b>. <sup><i>a</i></sup>IC<sub>50</sub> values for hKHK and rKHK are reported as the mean of three replicates (pIC<sub>50</sub> = 6.17 ± 0.08 and 6.19 ± 0.01, respectively). <sup><i>b</i></sup>Permeability (<i>P</i><sub>app</sub>) was assessed in Ralph Russ canine kidney cells.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a><sup><i>c</i></sup>Thermodynamic solubility was measured at pH 7.4. <sup><i>d</i></sup>Fu = fraction unbound in plasma as assessed by equilibrium dialysis.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (B) Free plasma level of <b>9</b> in rat PK studies. 300 mg/kg dose was administered orally using 0.25% HPC-SL/0.05% DOSS as vehicle. Data are presented as mean values (±standard deviation) with <i>n</i> = 3 per data point. Solid line = exposure. Dashed line = in vitro rKHK IC<sub>50</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Since the substituents of pyrrolopyridine <b>9</b> recapitulated all three important interactions observed with the fragment hits (<a class="ref internalNav" href="#fig3" aria-label="Figures 3">Figures 3</a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>), efforts to further improve the series were focused on the heteroaromatic core. When comparing the crystal structures of pyrrolopyridine <b>7</b> and pyridine <b>8</b>, the two scaffolds overlapped well and both displayed all three critical interactions with the ribose pocket, conserved water molecule, and hydrophobic pocket of KHK (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). Although pyridine <b>8</b> is a weaker KHK inhibitor, presumably due to suboptimal interaction of the functionalized piperidine ring in the ribose pocket, it offered an additional and synthetically enabled vector that was targeted for further optimization. As illustrated in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>, merging functionalities from compounds <b>9</b> and <b>8</b> provided compound <b>11</b>, which displayed moderate KHK inhibitory potency (hKHK IC<sub>50</sub> = 1.03 μM) and microsomal stability (HLM Cl<sub>app</sub> = 14 μL min<sup>–1</sup> mg<sup>–1</sup>) in a reasonable log <i>D</i> space (SFLogD = 2.2).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Merging pharmacophores led to the identification of pyridine <b>11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">By use of parallel chemistry, the piperazine vector of <b>11</b> was rapidly explored. In order to avoid discrepancies between potency against human and rat KHK (vide supra), neutral analogs were the key focus of optimization efforts. The optimal balance of potency, physical properties, and clearance was achieved with <i>trans</i>-dihydroxypyrrolidine analog <b>12</b> having a hKHK IC<sub>50</sub> value of 0.45 μM and no observable turnover in the HLM assay (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). The two hydroxyl groups form hydrogen bonds with solvent-exposed polar side chains Glu227 and Asn107, as well as with a bound water molecule. A complete map of interactions between compound <b>12</b> and hKHK is reported in <a href="/doi/suppl/10.1021/acs.jmedchem.7b00947/suppl_file/jm7b00947_si_001.pdf" class="ext-link">Figure S3</a>.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Structure and profile of pyridine <b>12</b> in in vitro assays. <sup><i>a</i></sup>IC<sub>50</sub> values for rat and human KHK-C inhibition are reported as the mean of 19 replicates (pIC<sub>50</sub> = 6.3 ± 0.2 and 6.5 ± 0.2 respectively). <sup><i>b</i></sup>IC<sub>50</sub> value for hKHK-A inhibition is reported as the mean of four replicates (pIC<sub>50</sub> = 6.41 ± 0.09). RLM = rat liver microsomes. (B) The binding mode of <b>12</b> in the crystal structure (PBD code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBZ">5WBZ</a>) is reported with a view of the binding site that is identical to the right panel of <a class="ref internalNav" href="#fig3" aria-label="Figures 3">Figures 3</a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. All protein atoms have been hidden for clarity. (C) Free plasma level of <b>12</b> in rat PK studies. A 150 mg/kg dose was administered orally using 1% polyvinylpyrrolidone/0.025% sodium lauryl sulfate/1% Pluronic (nanocrystal suspension) as vehicle. Data are presented as mean values (±standard deviation) with <i>n</i> = 4 per data point. Solid line = exposure. Dashed line = in vitro rKHK IC<sub>50</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Pyridine <b>12</b> does not interact directly with Asp27(B) and inhibited rKHK and both human isoforms with comparable potency in enzymatic assays. On the basis of its high metabolic stability in rat liver microsomes (RLMs), improved solubility, and acceptable permeability (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A), compound <b>12</b> progressed to PK studies in rats. As determined with a 1 mg/kg intravenous (iv) dose, <b>12</b> demonstrated moderate in vivo systemic clearance (25.9 mL min<sup>–1</sup> kg<sup>–1</sup>), moderate volume of distribution (1.38 L/kg), and short effective half-life (1.2 h) in rats. When orally dosed at 5 mg/kg using 0.5% methylcellulose as the vehicle, <b>12</b> exhibited an oral bioavailability of 45% (<i>C</i><sub>max</sub> = 2.94 μg/mL, AUC<sub>last</sub> = 14.5 μg·h/mL) in rats. Free plasma concentration equivalent to multiples over the in vitro IC<sub>50</sub> was achieved for an extended period of time (∼14 h) at an oral dose of 150 mg/kg (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>C).</div><div class="NLM_p">Compound <b>12</b> showed high selectivity for KHK with no significant activity detected against a broad panel of transporters, receptors, ion channels, and enzymes, including the hERG channel and major human CYP450s (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00947/suppl_file/jm7b00947_si_001.pdf" class="ext-link">Table S1</a>). Overall, <b>12</b> had a clean in vitro safety profile with no genetic toxicology risks identified in Ames mutagenicity and in vitro micronucleus assays, and no toxicity was observed in HepG2 cells at concentrations up to 300 μM with 72 h incubation. Supported by inhibitory potency against rKHK (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A), suitable exposure in rat PK studies (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B), and clean in vitro safety profile, compound <b>12</b> was resynthesized on larger scale to enable the evaluation of KHK inhibition in vivo.</div><div class="NLM_p">Sprague Dawley rats were utilized to demonstrate KHK inhibition in vivo, focusing on the liver and kidney which are primary sites of KHK-C expression and fructose metabolism. All procedures performed on these animals were in accordance with regulations and established guidelines and were reviewed and approved by the Pfizer Institutional Animal Care and Use Committee. Sprague Dawley rats were administered increasing oral doses of compound <b>12</b> followed by an iv bolus of fructose. Two minutes after fructose administration, animals were sacrificed and the liver and kidney tissues were removed and snap-frozen in liquid nitrogen. F1P was directly quantified in liver and kidney tissues by liquid chromatography/mass spectrometry (LC/MS). Direct F1P quantitation is challenging due to highly abundant sugar monophosphate isomers, such as glucose 6-phosphate (G6P), fructose 6-phosphate (F6P), and glucose 1-phosphate (G1P). Because the isomers have one common <i>m</i>/<i>z</i>, selectivity may not be achieved in the mass spectrometer; rather, they must be separated chromatographically. Widely adopted MS-compatible LC methods result in poor separation or coelution of hexose monophosphate isomers. Therefore, an in-house ion exchange liquid chromatography method, which maintains compatibility with MS, was developed to address this problem. By use of this method, dose-dependent decreases in both liver and kidney F1P concentrations were measured with ED<sub>50</sub> values of 30.0 mg/kg and 15.7 mg/kg, respectively (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). The decrease in both liver and kidney F1P levels indicates potent KHK inhibition in these tissues.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0008.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Concentrations of hepatic and renal fructose 1-phosphate (F1P) following an iv bolus of fructose and increasing doses of compound <b>12</b> in Sprague Dawley rats. A nonlinear dose–response curve was fitted to a variable slope (four parameter) using GraphPad Prism, and the calculated ED<sub>50</sub> values for kidney and liver F1P reduction are reported. Data are presented as mean values (±standard error) with <i>n</i> = 7–8 per data point.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To determine the effect of compound <b>12</b> on systemic fructose metabolism, plasma fructose levels were measured following an oral bolus of fructose. Sprague Dawley rats were treated with increasing doses of compound <b>12</b> and then administered a 2 g/kg oral bolus of fructose. Because KHK is the primary enzyme responsible for metabolic clearance of fructose, treatment with compound <b>12</b> was anticipated to increase plasma fructose levels. Indeed, a dose-dependent increase in plasma fructose levels was observed (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>), suggesting that compound <b>12</b> inhibited systemic fructose metabolism. Taken together, these data support that oral administration of compound <b>12</b> inhibits hepatic and renal fructose metabolism in rats, resulting in decreased formation of F1P in these organs and increased fructose concentration in plasma. Future studies will be informative as to the degree of KHK inhibition required for metabolic benefit since no clinical and nonclinical data have been reported with a KHK inhibitor.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0009.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Plasma fructose levels in Sprague Dawley rats following an oral fructose bolus and treatment with the indicated dose of compound <b>12</b>. Animals were administered compound <b>12</b> orally 1 h prior to an oral bolus of fructose (2 g/kg). Data are presented as mean values (±standard error) with <i>n</i> = 6–8 per data point.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Synthesis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86675" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86675" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of the pyrrolopyridine series began with construction of pyrrole <b>15</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Cyanogen bromide was first reacted with phenol, and subsequent S<sub>N</sub>2 displacement with 1-butyne led to nitrile <b>14</b>. Condensation with diethyl aminomalonate led to formation of pyrrole <b>15</b>. Pyrrole <b>16</b> was commercially available. Reaction of these aminopyrroles with tosylate <b>13</b> and subsequent DBU-mediated ring closure led to pyrrolopyridine cores <b>17</b> and <b>18</b>. Chlorination and subsequent S<sub>N</sub>Ar reactions led to the formation of <b>7</b>, <b>9</b>, and <b>10</b>.</div><figure id="sch1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pyrrolopyridines <b>7</b>, <b>9</b>, and <b>10</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Pyridine <b>11</b> was constructed in a two-step S<sub>N</sub>Ar sequence (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Starting from commercially available dichloropyridine <b>19</b>, amine addition at the 6-position occurred with good selectivity at ambient temperature to form pyridine <b>20</b>. Subsequent amine addition at the 2-position occurred at elevated temperatures to form pyridine <b>11</b>. Pyridine <b>8</b> was synthesized in an analogous manner.</div><figure id="sch2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Pyridine <b>11</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To provide sufficient quantities for the planned in vivo experiments, access to enantiopure <b>12</b> was required (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Addition of methylmagnesium bromide to <i>N</i>-benzyl-pyrrolidin-3-one (<b>21</b>) proceeded in good yield to provide the corresponding tertiary alcohol. Benzyl deprotection by hydrogenolysis led to alcohol <b>22</b>. Chiral resolution by preferential crystallization with <span class="smallcaps smallerCapital">l</span>-dihydroorotic acid from ethanol followed by recrystallization from methanol produced the desired pure (<i>S</i>)-enantiomer. S<sub>N</sub>Ar reaction of the core pyridine <b>19</b> with <i>trans</i>-dihydroxypyrrolidine <b>23</b> proceeded smoothly, and isolation of the desired major regioisomer was achieved in good yield after crystallization. The final S<sub>N</sub>Ar proceeded smoothly, and 132 g of pyridine <b>12</b> was isolated by crystallization from MTBE in high yield.</div><figure id="sch3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Pyridine <b>12</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11827" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11827" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this report we described the identification of fragments interacting with KHK which were subsequently optimized into moderately potent KHK inhibitors that could be used to modulate KHK activity in vivo. The fragment hits were identified via an NMR screen and confirmed by SPR. Selected fragments were cocrystallized with hKHK and a number of key interactions were observed with multiple fragments. In order to avoid discrepancy between the potencies against rat and human KHK, basic amines were avoided during optimization efforts. This led to the identification of pyridine <b>12</b>, a nonbasic moderately potent and highly selective KHK inhibitor with favorable ADME and safety profiles and good exposure in rats. Compound <b>12</b> was synthesized on a scale needed to support in vivo experiments, and inhibition of KHK and metabolism of fructose was demonstrated in rats. Compound <b>12</b> can facilitate the study of KHK as a potential therapeutic target.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20504" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20504" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> General</h3><div class="NLM_p last">Unless otherwise noted, the reported experiments followed these general guidelines: All chemicals, reagents, and solvents were purchased from commercial sources when available and used without further purification. Compound <b>4</b> is commercially available from Enamine or as previously reported in literature.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Compound <b>5</b> is commercially available from Enamine or as previously reported in literature.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Compound <b>6</b> is previously reported in literature.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Air- and moisture-sensitive reactions were carried out under an inert atmosphere of nitrogen, magnetically stirred, and monitored by thin layer chromatography (TLC), high performance liquid chromatography (HPLC), or UPLC (ultraperformance liquid chromatography). Reactions were carried out at room temperature (∼23 °C). Silica gel chromatography was performed using an automated system with prepackaged columns. Concentration under reduced pressure (in vacuo) was performed by rotary evaporation at 25–45 °C. Purified compounds were further dried under high vacuum and/or heat to remove residual solvent. Yields refer to dried purified compounds. NMR spectra were recorded either with a spectrometer at 600 MHz or with a spectrometer at 400 MHz for <sup>1</sup>H acquisitions. Chemical shifts were referenced to the residual <sup>1</sup>H solvent signals (CDCl<sub>3</sub>, δ 7.27; DMSO-<i>d</i><sub>6</sub>, δ 2.50; CD<sub>3</sub>OD, δ 3.31). Signals are listed as follows: chemical shift in ppm; multiplicity identified as s = singlet, br = broad, d = doublet, t = triplet, m = multiplet; coupling constants in Hz. Liquid chromatography–mass spectrometry (LCMS) was performed via atmospheric pressure chemical ionization (AP) or electrospray ionization (ES) sources. Purity is reported by relative UV area and is >95% unless noted. On the basis of their structures, the compounds reported in this work are not predicted to be PAINS. Specific interaction with hKHK is supported by data from orthogonal assays (SPR, NMR, functional) and cocrystal structures with hKHK. Additionally, compound <b>12</b> does not show activity in a number of assay formats as reported in the selectivity <a href="/doi/suppl/10.1021/acs.jmedchem.7b00947/suppl_file/jm7b00947_si_001.pdf" class="ext-link">Table S1</a>.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Synthesis of Analogues and Intermediates</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> (<i>R</i>)-(1-(5-Methyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)piperidin-3-yl)methanol (<b>3</b>)</h4><div class="NLM_p last">A vial was charged with 4-chloro-5-methyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (100 mg, 0.60 mmol), (<i>R</i>)-piperidin-3-ylmethanol (82.5 mg, 0.72 mmol), Hünig’s base (0.21 mL, 1.2 mmol), and acetonitrile (3 mL). The vial was sealed and heated to 60 °C for 15 h. The reaction was then cooled and poured onto half-saturated ammonium chloride and ethyl acetate. The layers were separated, and organic layer was washed with saturated sodium bicarbonate solution, dried over sodium sulfate, filtered, and concentrated in vacuo. Flash column chromatography (20% ethyl acetate/heptane to 100% ethyl acetate to 10% methanol/ethyl acetate), taking the pure fraction, provided <b>3</b> (20 mg, 14%). LCMS (AP+) calcd for C<sub>13</sub>H<sub>18</sub>N<sub>4</sub>O, 247.1; found, 247.3. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ 8.18 (s, 1H), 6.99 (d, <i>J</i> = 1.2 Hz, 1H), 4.19–4.11 (m, 1H), 4.02–3.92 (m, 1H), 3.55 (dd, <i>J</i> = 5.5, 10.9 Hz, 1H), 3.46 (dd, <i>J</i> = 7.8, 11.3 Hz, 1H), 3.01 (ddd, <i>J</i> = 2.7, 11.3, 12.8 Hz, 1H), 2.78 (dd, <i>J</i> = 10.1, 12.9 Hz, 1H), 2.44 (d, <i>J</i> = 1.2 Hz, 3H), 2.01–1.82 (m, 3H), 1.82–1.66 (m, 1H), 1.33–1.17 (m, 1H).</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> 2-Ethyl-7-(3-hydroxy-3-methylpyrrolidin-1-yl)-5-(trifluoromethyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-6-carbonitrile (<b>7</b>)</h4><div class="NLM_p">Step 1. A round bottomed flask was charged with <b>17</b> (25.0 g, 98.0 mol) and POCl<sub>3</sub> (40 mL), and the reaction was heated to reflux temperature for 2 h. The reaction was cooled to rt, and the mixture was added dropwise to ice–water. The mixture was then extracted with EtOAc (200 mL × 2), and the layers were separated. The combined organic phases were washed with brine (150 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to give 7-chloro-2-ethyl-5-(trifluoromethyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-6-carbonitrile (19 g, 71%) as a gray solid. LCMS (ES−) calcd for C<sub>11</sub>H<sub>7</sub>ClF<sub>3</sub>N<sub>3</sub> (M – H), 272.0; found, 272.0. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.10 (br s, 1H), 6.73 (s, 1H), 2.97 (q, <i>J</i> = 7.5 Hz, 2H), 1.45 (t, <i>J</i> = 7.5 Hz, 3H).</div><div class="NLM_p last">Step 2. To a solution of 7-chloro-2-ethyl-5-(trifluoromethyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-6-carbonitrile (100 mg, 0.37 mol) and 3-methylpyrrolidin-3-ol (75 mg, 0.55 mmol) in DMF (2 mL) was added Et<sub>3</sub>N (110 mg, 1.09 mmol). The mixture was stirred for 16 h at 80 °C. The mixture was purified by preparative TLC to give the <b>7</b> (72 mg, 59%) as a yellow solid. LCMS (ES+) calcd for C<sub>16</sub>H<sub>17</sub>F<sub>3</sub>N<sub>4</sub>O (M + H), 339.1; found, 339.1. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 6.43 (s, 1H), 4.52–4.42 (m, 1H), 4.16 (d, <i>J</i> = 10.5 Hz, 1H), 4.13–4.05 (m, 1H), 3.86 (d, <i>J</i> = 10.5 Hz, 1H), 2.87 (q, <i>J</i> = 7.5 Hz, 2H), 2.19–1.96 (m, 2H), 1.53 (s, 3H), 1.35 (t, <i>J</i> = 7.5 Hz, 3H).</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> 6-(4-(2-Hydroxyethyl)piperazin-1-yl)-2-(3-(hydroxymethyl)piperidin-1-yl)-4-(trifluoromethyl)nicotinonitrile (<b>8</b>)</h4><div class="NLM_p last">A vial was charged with <b>20</b> (73 mg, 0.22 mmol), DMF (0.25 mL), piperidin-3-ylmethanol (25 mg, 0.22 mmol), and K<sub>2</sub>CO<sub>3</sub> (35 mg, 0.25 mmol), and the mixture was stirred at 100 °C for 2 h. The reaction was cooled to rt and diluted with ethyl acetate (3 mL) and half-saturated NaCl solution (3 mL). The layers were separated and the organic was concentrated in vacuo and purified via preparatory reverse-phase HPLC to provide <b>8</b> (48 mg, 53%). LCMS (ES+) calcd for C<sub>19</sub>H<sub>26</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub> (M + H), 413.2; found, 414.2. <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 6.54 (s, 1H), 4.34–4.27 (m, 1H), 4.24–4.13 (m, 1H), 3.79–3.74 (m, 4H), 3.72 (t, <i>J</i> = 5.9 Hz, 2H), 3.55–3.39 (m, 2H), 3.06 (ddd, <i>J</i> = 3.1, 11.7, 13.0 Hz, 1H), 2.82 (dd, <i>J</i> = 9.4, 12.9 Hz, 1H), 2.64–2.60 (m, 4H), 2.59 (t, <i>J</i> = 5.9 Hz, 2H), 1.93–1.74 (m, 3H), 1.74–1.57 (m, 1H), 1.36–1.22 (m, 1H).</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> (<i>S</i>)-7-(3-Hydroxy-3-methylpyrrolidin-1-yl)-5-(trifluoromethyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-6-carbonitrile (<b>9</b>) and (<i>R</i>)-7-(3-Hydroxy-3-methylpyrrolidin-1-yl)-5-(trifluoromethyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-6-carbonitrile (<b>10</b>)</h4><div class="NLM_p">Step 1. Compound <b>18</b> (200 g, 0.88 mol) was dissolved in CH<sub>3</sub>CN (1.5 L). Then POCl<sub>3</sub> (673 g, 4.4 mol) was added carefully. After the addition, the resulting mixture was heated to 60 °C overnight. The reaction mixture was then cooled to rt and concentrated in vacuo. The residue was dissolved in ethyl acetate and slowly poured onto water (1.0 L). The layers were separated, and the organic layer was washed with 10% K<sub>2</sub>CO<sub>3</sub>, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Flash column chromatography was then used to provide 7-chloro-5-(trifluoromethyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-6-carbonitrile (105 g, 49%). LCMS calcd for C<sub>9</sub>H<sub>3</sub>ClF<sub>3</sub>N<sub>3</sub> (M + H), 246.0; found, 245.7 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.11 (br s, 1H), 8.29 (t, <i>J</i> = 2.8 Hz, 1H), 7.04 (dd, <i>J</i> = 3.0, 2.0 Hz, 1H).</div><div class="NLM_p">Step 2 (Milligram Synthesis). To a solution of 7-chloro-5-(trifluoromethyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-6-carbonitrile (400 mg, 1.64 mmol) and 3-methylpyrrolidin-3-ol (320 mg, 2.34 mmol) in DMF (5 mL) was added Et<sub>3</sub>N (500 mg, 4.95 mmol). The mixture was then stirred at 80 °C for 2 h. The mixture was then poured onto water (40 mL) and extracted with EtOAc (40 mL × 3). The organic layer was washed with H<sub>2</sub>O (30 mL × 3), brine (30 mL × 3), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The material was then purified by flash chromatography (0–70% EtOAc/petroleum ether to provide clean racemic material (360 mg, 71%) as yellow solid. The enantiomers were then separated by chiral SFC (column, Chiralpak IC-3 150 mm × 4.6 mm i.d., 3 μm; mobile phase, ethanol (0.05% DEA) in CO<sub>2</sub> from 5% to 40%; flow rate, 2.35 mL/min) to provide the two separated enantiomers:</div><div class="NLM_p"><b>9</b>: 150 mg, retention time of 4.123. LCMS (ES+) calcd for C<sub>14</sub>H<sub>13</sub>F<sub>3</sub>N<sub>4</sub>O (M + H), 311.1; found, 310.9. <sup>1</sup>H NMR (400 MHz, MeOD) δ 7.54 (d, <i>J</i> = 3.0 Hz, 1H), 6.62 (d, <i>J</i> = 3.0 Hz, 1H), 4.48–4.38 (m, 1H), 4.16–4.03 (m, 2H), 3.90–3.81 (m, 1H), 2.12–1.97 (m, 2H), 1.49 (s, 3H). [α]<sup>20</sup><sub>D</sub> +19.2 (<i>c</i> 0.64, CH<sub>3</sub>OH).</div><div class="NLM_p last"><b>10</b>: 160 mg; er 98.9:1.1; retention time, 4.414. LCMS (ES+) calcd for C<sub>14</sub>H<sub>13</sub>F<sub>3</sub>N<sub>4</sub>O (M + H), 311.1; found, 310.9. <sup>1</sup>H NMR (400 MHz, MeOD) δ 7.54 (d, <i>J</i> = 3.0 Hz, 1H), 6.62 (d, <i>J</i> = 3.0 Hz, 1H), 4.48–4.38 (m, 1H), 4.16–4.03 (m, 2H), 3.90–3.81 (m, 1H), 2.12–1.97 (m, 2H), 1.49 (s, 3H). [α]<sup>20</sup><sub>D</sub> −22.2 (<i>c</i> 1.00, CH<sub>3</sub>OH).</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> (<i>S</i>)-7-(3-Hydroxy-3-methylpyrrolidin-1-yl)-5-(trifluoromethyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-6-carbonitrile (<b>9</b>, Multigram Synthesis)</h4><div class="NLM_p">Step 1. A three-neck flask equipped with an addition funnel and thermometer was charged with methylmagnesium bromide (3.0 M in ether, 30 mL, 90 mmol) and tetrahydrofuran (100 mL) and cooled to −78 °C. A solution of benzyl 3-oxopyrrolidine-1-carboxylate (9.80 g, 44.7 mmol) in tetrahydrofuran (100 mL) was then added dropwise, keeping the internal temperature at <−70 °C. The reaction was then warmed to rt for 1 h, then cooled to 0 °C and quenched with saturated ammonium chloride (150 mL) with a slight exotherm. The mixture was then extracted with MTBE (3 × 100 mL). The combined organic layers were dried over magnesium sulfate, filtered, and concentrated in vacuo. The crude product was purified by flash column chromatography (0–100% ethyl acetate/heptane) to provide crude racemic product. Chiral SFC was then used to isolate benzyl (<i>S</i>)-3-hydroxy-3-methylpyrrolidine-1-carboxylate (3.0 g, 29%) as peak 1 (column, Chiral Tech i.d. 250 mm × 21.2 mm, 5 μm; isocratic, 90% CO<sub>2</sub>, 9.8% MeOH, 0.2% NH<sub>4</sub>OH; detection, 210 nm; flow rate, 80.0 mL/min; backpressure, 120 bar). LCMS (AP+) calcd for C<sub>13</sub>H<sub>17</sub>NO<sub>3</sub> (M + H), 236.1; found, 236.0. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.45–7.25 (m, 5H), 5.25–5.03 (m, 2H), 3.67–3.43 (m, 3H), 3.38–3.22 (m, 1H), 2.00–1.73 (m, 3H), 1.42 (s, 3H).</div><div class="NLM_p">Step 2. A Parr reactor was charged with benzyl (<i>S</i>)-3-hydroxy-3-methylpyrrolidine-1-carboxylate (3.50 g mg, 14.9 mmol), Pd/C (wet, 10 wt %, 792 mg, 0.025 mmol), and ethanol (50 mL) and then charged with 30 psi of hydrogen and stirred for 5 h (recharging H<sub>2</sub> pressure after 2 h). The reactor was vented and purged with nitrogen. The mixture was filtered through Celite, rinsing with ethanol. The filtrate was then concentrated in vacuo to provide (<i>S</i>)-3-methylpyrrolidin-3-ol (1.51 g, quant) as an oil that was taken into the next step without further purification.</div><div class="NLM_p last">Step 3. A round bottomed flask was charged with (<i>S</i>)-3-methylpyrrolidin-3-ol (1.41 g, 13.9 mmol), 7-chloro-5-(trifluoromethyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-6-carbonitrile (2.85 g, 11.6 mmol), and acetonitrile (40 mL). Triethylamine (3.26 mL, 23.3 mmol) was then added and the reaction heated to 80 °C for 1.5 h. Additional (<i>S</i>)-3-methylpyrrolidin-3-ol (270 mg, 2.67 mmol) was then added and the reaction stirred at 80 °C for 20 min. The reaction was cooled to rt and diluted with saturated ammonium chloride and ethyl acetate. The layers were separated, and the aqueous layer was extracted with ethyl acetate (×3). The combined organic layers were washed with saturated sodium bicarbonate solution, then brine and dried over sodium sulfate, filtered, and concentrated in vacuo. Ethanol (80 mL) was added to the resultant residue, and the mixture was heated to reflux and then cooled to rt. Solids formed that were collected via filtration and washed with ethanol to provide crude product (1.55 g, 43%). Several batches of material were combined (4.05 g) and diluted with acetonitrile (120 mL) and then heated to reflux and then cooled to rt over 45 min while stirring. The resultant solids were filtered, washed with acetonitrile, and dried in vacuo. The solids were then added to methanol and heated to dissolve. The mixture was concentrated in vacuo to provide the desired crystalline product (3.145 g, 78%). er > 99.95:0.05 (determined by chiral SFC). LCMS (ES+) calcd for C<sub>14</sub>H<sub>13</sub>F<sub>3</sub>N<sub>4</sub>O (M + H), 311.1; found, 311.2. <sup>1</sup>H NMR (400 MHz, DMSO) δ 11.64 (br s, 1H), 7.68 (d, <i>J</i> = 3.1 Hz, 1H), 6.67 (d, <i>J</i> = 3.1 Hz, 1H), 5.03 (br s, 1H), 4.41–4.24 (m, 1H), 4.15–3.92 (m, 2H), 3.77 (d, <i>J</i> = 10.5 Hz, 1H), 1.96 (s, 2H), 1.41 (s, 3H). Mp 264.2–264.3 °C.</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> (<i>S</i>)-2-(3-Hydroxy-3-methylpyrrolidin-1-yl)-6-(4-(2-hydroxyethyl)piperazin-1-yl)-4-(trifluoromethyl)nicotinonitrile (<b>11</b>)</h4><div class="NLM_p last">To a mixture of <b>20</b> (60 mg, 0.18 mmol) and (<i>S</i>)-<b>22</b> (60 mg, 0.19 mmol) in DMF (2 mL) was added Et<sub>3</sub>N (0.2 mL), and then the mixture was stirred at 60 °C for 20 h. The reaction was filtered and the filtrate was concentrated and purified by preparatory reverse-phase HPLC to provide <b>11</b> (38 mg, 63%) as a white solid. LCMS (ES+) for C<sub>18</sub>H<sub>24</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub> (M + H), 400.2; found, 400.0. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ 6.45 (s, 1H), 4.04–3.63 (m, 10H), 2.72–2.59 (m, 6H), 2.03–1.91 (m, 2H), 1.44 (s, 3H).</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 6-((3<i>S</i>,4<i>S</i>)-3,4-Dihydroxypyrrolidin-1-yl)-2-((<i>S</i>)-3-hydroxy-3-methylpyrrolidin-1-yl)-4-(trifluoromethyl)nicotinonitrile (<b>12</b>)</h4><div class="NLM_p">Step 1. A round bottomed flask was charged with 2,6-dichloro-4-(trifluoromethyl)nicotinonitrile (66.8 g, 647 mmol), sodium bicarbonate (105 g, 1.25 mol), and ethanol (1.56 L). (3<i>S</i>,4<i>S</i>)-Pyrrolidine-3,4-diol (150.0 g, 622.4 mmol) was then added in portions over 40 min while maintaining the internal temperature at <4 °C. The reaction was then warmed to rt and stirred for 22 h. The reaction was cooled to 0 °C, and additional sodium bicarbonate (77.0 g, 917 mmol) that was ground in a mortar and pestle was added in one portion and the mixture stirred for 22 h at rt. The solids were filtered and the filtrate concentrated to a slurry (∼<sup>1</sup>/<sub>4</sub> of the original volume). Water (100 mL) was added, and the mixture was stirred at rt for 1 h. The solids were collected via filtration, washed with water, then dried in a vacuum oven at 50 °C to provide crude material (186.0 g). This material was split into two equal portions (93.0 g × 2), and each was dissolved in ethyl acetate (830 mL) in a round bottomed flask at reflux temperature. Heptane (2.1 L) was then added to each batch, and the mixture was slowly cooled to rt over 4 h and then stirred for an additional 15 h at rt. The solids were collected via filtration and combined to provide 148.0 g. The solids were then added to MTBE (1.5 L) in a round-bottomed flask and heated to 56 °C. Heptane (1.0 L) was then added via addition funnel over 30 min and the mixture was cooled to rt and the solids were collected via filtration, washed with MTBE–heptane (3:2), and dried in a vacuum oven at 40 °C to obtain 2-chloro-6-((3<i>S</i>,4<i>S</i>)-3,4-dihydroxypyrrolidin-1-yl)-4-(trifluoromethyl)nicotinonitrile (123.87 g, 65%). LCMS (ES+) calcd for C<sub>11</sub>H<sub>9</sub>ClF<sub>3</sub>N<sub>3</sub>O<sub>2</sub>, 308.0; found, 308.0. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.94 (s, 1H), 5.36 (d, <i>J</i> = 3.5 Hz, 1H), 5.28 (d, <i>J</i> = 3.5 Hz, 1H), 4.11 (br s, 1H), 4.06 (br s, 1H), 3.71 (dd, <i>J</i> = 3.5, 11.7 Hz, 1H), 3.64 (dd, <i>J</i> = 2.9, 12.9 Hz, 1H), 3.57 (d, <i>J</i> = 11.2 Hz, 1H), 3.46 (d, <i>J</i> = 11.7 Hz, 1H).</div><div class="NLM_p last">Step 2. A round bottomed flask was charged with 2-chloro-6-((3<i>S</i>,4<i>S</i>)-3,4-dihydroxypyrrolidin-1-yl)-4-(trifluoromethyl)nicotinonitrile (110.0 g, 357.5 mmol), (<i>S</i>)-3-methylpyrrolidin-3-ol/<span class="smallcaps smallerCapital">l</span>-dihydroorotic acid complex (1:2, 160.0 g, 383.3 mmol), sodium bicarbonate (120.0 g, 1430 mmol), and ethanol (1.1 L), and then the mixture was heated to 77 °C (internal temperature) for 24 h with overhead stirring. Additional sodium bicarbonate (80.0 g, 952 mmol) was ground in a mortar and pestle then added to the reaction, which was stirred at 77 °C for an additional 24 h. The mixture was cooled to room temperature and filtered. The filtrate was partially concentrated in vacuo at 50 °C until a light slurry formed (∼<sup>1</sup>/<sub>4</sub> of the initial volume). The slurry was stirred at rt, and slowly water (1.0 L) was added. The mixture was stirred at rt for 18 h, then the solid was filtered off, washed with water, and dried in vacuo at 60 °C for 18 h to obtain the title compound (129.9 g, 98%). This material was combined with two smaller batches (4.9 and 1.5 g) and stirred in MTBE (2.0 L) at 50 °C for 20 h, then rt for 3 h. The solids were collected via filtration, washed with MTBE, and dried in vacuo at 60 °C for 20 h to obtain crystalline <b>12</b> (131.9 g, 97%). HPLC: 99.54%. LCMS (ES+) calcd for C<sub>16</sub>H<sub>19</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub> (M + H), 373.1; found, 373.1. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.18 (s, 1H), 5.23 (d, <i>J</i> = 3.5 Hz, 1H), 5.16 (d, <i>J</i> = 3.1 Hz, 1H), 4.83 (s, 1H), 4.10–4.04 (m, 1H), 4.04–3.97 (m, 1H), 3.82 (dt, <i>J</i> = 7.4, 10.1 Hz, 1H), 3.72 (ddd, <i>J</i> = 2.9, 7.9, 10.6 Hz, 1H), 3.66–3.48 (m, 5H), 3.36–3.28 (m, 1H), 1.95–1.78 (m, 2H), 1.33 (s, 3H). mp 202–204 °C. [α]<sup>20</sup><sub>D</sub> +3.5 (<i>c</i> 0.51, CH<sub>3</sub>OH).</div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 1-Cyano-3,3,3-trifluoroprop-1-en-2-yl 4-Methylbenzenesulfonate (<b>13</b>)</h4><div class="NLM_p">Step 1. To a suspension of potassium <i>tert</i>-butoxide (706 g, 6.30 mol) in toluene (8.0 L) was added dropwise a solution of methyl trifluoroacetate (895 g, 6.30 mol) in CH<sub>3</sub>CN (258 g, 6.30 mol), at which time internal temperature was increased to 70 °C. After the addition, the resulting mixture was heated to 80 °C for 4 h, and the reaction mixture was cooled to room temperature and filtered to give potassium (<i>Z</i>)-1-cyano-3,3,3-trifluoroprop-1-en-2-olate (820 g, 74%) as yellow solid. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 4.56 (s, 1H).</div><div class="NLM_p last">Step 2. To a suspension of potassium (<i>Z</i>)-1-cyano-3,3,3-trifluoroprop-1-en-2-olate (980 g, 5.6 mol) in MeCN (15 L) was added <i>p</i>-toluenesulfonic anhydride (1460 g, 4.48 mol) in portions at rt. After the addition was complete, the reaction mixture was refluxed under intense stirring for 20 h. The reaction mixture was cooled and evaporated to remove most of the solvent, and the residue was portioned between EtOAc (10 L) and water (8 L), further extracted with EtOAc (10 L). The combined organic extracts were washed with water (15 L) and brine (15 L), dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated to dryness, and purified by column chromatography to give <b>13</b> (440 g, 38%) as yellow oil (4:1 mixture of geometrical isomers). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) major: δ 7.97 (d, <i>J</i> = 8.5 Hz, 2H), 7.47–7.42 (m, 2H), 6.02 (s, 1H), 2.51 (s, 3H). Minor: δ 7.85 (d, <i>J</i> = 9.0 Hz, 2H), 7.44 (d, <i>J</i> = 8.5 Hz, 2H), 6.15 (s, 1 H), 2.52 (s, 3H).</div></div><div id="sec5_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Pent-2-ynenitrile (<b>14</b>)</h4><div class="NLM_p">Step 1: A round bottomed flask was charged with cyanogen bromide (250 g, 2.66 mol) and water (500 mL), and the suspension was cooled in an ice water bath. A solution of phenol (293 g, 2.79 mol) in CCl<sub>4</sub> (800 mL) was then added to the mixture in one portion, followed by the addition of Et<sub>3</sub>N (385 mL) at a rate to keep the internal temperature below 5 °C. After the addition, the mixture was stirred at this temperature for 4 h. The layers were separated and the organic layer was washed with water (500 mL × 3), then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to provide cyanatobenzene (200 g, 63%) as a brown oil, which was used directly in the next step without further purification.</div><div class="NLM_p last">Step 2. A round bottomed flask was charged with butyne (60 g, 1.1 mol) and ether (1.2 L) and then cooled to −60 °C under nitrogen. <i>n</i>-BuLi in hexane (444 mL, 1.10 mol) was then added dropwise, followed by the addition of a solution of cyanatobenzene (131 g, 1.1 mol) in ether (300 mL), keeping the temperature at <−60 °C. The mixture was stirred at −60 °C for 2 h and then warmed to rt. The reaction was quenched with the addition of 6 N aq NaOH (100 mL), and the layers were separated. The aqueous phase was extracted with ether (300 mL × 3). The combined organic phases were washed with 6 N aq NaOH (100 mL × 3), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and used directly in the next step as a solution of <b>14</b> in ether.</div></div><div id="sec5_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Ethyl 3-Amino-5-ethyl-1<i>H</i>-pyrrole-2-carboxylate (<b>15</b>)</h4><div class="NLM_p last">A round-bottomed flask was charged with anhydrous EtOH (700 mL). Sodium (51 g, 2.2 mol) was then added in portions. After dissolution had occurred, diethyl 2-aminomalonate hydrochloride (234 g, 1.11 mol) was added and the mixture was stirred for 30 min. A solution of <b>14</b> (88 g, 1.11 mol in ether) was then added, and the reaction was stirred at rt for 4 h. The mixture was then concentrated in vacuo, and the resultant residue was diluted with water (250 mL) and extracted with ethyl acetate (5000 mL × 3). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to give a crude product, which was further purified via flash column chromatography (ethyl acetate/petroleum ether = 1:50) to give <b>15</b> (30 g, 15%) as a yellow oil. LCMS (ES+) calcd for C<sub>9</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub> (M + H), 183.1; found, 183.1. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.51–7.52 (br m, 1H), 5.49 (d, <i>J</i> = 2.5 Hz, 1H), 4.43–4.03 (br m, 4H), 2.54 (q, <i>J</i> = 7.5 Hz, 2H), 1.35 (t, <i>J</i> = 7.0 Hz, 3H), 1.22 (t, <i>J</i> = 7.5 Hz, 3H).</div></div><div id="sec5_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 2-Ethyl-7-hydroxy-5-(trifluoromethyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-6-carbonitrile (<b>17</b>)</h4><div class="NLM_p">Step 1. A round bottomed flask was charged with <b>15</b> (45.0 g, 0.249 mol), <b>13</b> (145 g, 0.498 mol), and CH<sub>2</sub>Cl<sub>2</sub> (1.2 L) and then cooled to 10 °C. Hünig’s base (64.3 g, 0.498 mol) was added, and then the mixture was warmed to rt and stirred overnight. The mixture was washed with water (100 mL × 3) and the organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to provide a brown oil. Flash column chromatography (ethyl acetate/petroleum ether = 1:20) then provided ethyl 3-((1-cyano-3,3,3-trifluoroprop-1-en-2-yl)amino)-5-ethyl-1<i>H</i>-pyrrole-2-carboxylate (36 g, 48%) as a yellow solid that was taken forward without further purification.</div><div class="NLM_p last">Step 2. A round bottomed flask was charged with ethyl 3-((1-cyano-3,3,3-trifluoroprop-1-en-2-yl)amino)-5-ethyl-1<i>H</i>-pyrrole-2-carboxylate (30 g, 0.1 mol), DBU (15.2 g, 0.1 mol), and acetonitrile (300 mL) and then heated to reflux temperature overnight. The reaction mixture was cooled to rt, and the solvents were removed in vacuo to give a black solid. Flash column chromatography (ethyl acetate/petroleum ether = 1:5, then dichloromethane/methanol = 5:1) was used to provide <b>17</b> (20 g, 53%) as a yellow solid that was taken on to the next step.</div></div><div id="sec5_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 7-Hydroxy-5-(trifluoromethyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-6-carbonitrile (<b>18</b>)</h4><div class="NLM_p">Step 1. A round-bottomed flask was charged with ethyl 3-amino-1<i>H</i>-pyrrole-2-carboxylate<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (94.6 g, 0.614 mol) and CH<sub>3</sub>CN (1.5 L). <b>13</b> (187 g, 0.645 mol) and Hünig’s base (119.73 g, 0.921 mol) were then added. The reaction mixture was heated to reflux for 6 h and then cooled to rt. The material was concentrated in vacuo and purified by flash column chromatography (DCM/MeOH = 100:1) to provide ethyl 3-((1-cyano-3,3,3-trifluoroprop-1-en-2-yl)amino)-1<i>H</i>-pyrrole-2-carboxylate (94.5 g, 56.4%) as a yellow solid as a ∼5:4 mixture of <i>E</i>/<i>Z</i> isomers. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) major: δ 9.07 (br s, 1H), 7.07 (t, <i>J</i> = 2.8 Hz, 1H), 6.32 (s, 1H), 4.89 (s, 1H), 4.24 (q, <i>J</i> = 7.0 Hz, 2H), 1.27 (t, <i>J</i> = 7.0 Hz, 3H). Minor: δ 9.17 (br s, 1H), 6.96 (t, <i>J</i> = 3.0 Hz, 1H), 6.13 (t, <i>J</i> = 2.8 Hz, 1H), 4.75 (s, 1H), 4.20 (q, <i>J</i> = 7.0 Hz, 2H), 1.23 (t, <i>J</i> = 7.0 Hz, 3H).</div><div class="NLM_p last">Step 2. A round-bottomed flask was charged with ethyl 3-((1-cyano-3,3,3-trifluoroprop-1-en-2-yl)amino)-1<i>H</i>-pyrrole-2-carboxylate (204 g, 0.747 mol) and CH<sub>3</sub>CN (1.5 L). DBU (137.2 g, 0.897 mol) was then added, and the reaction was heated to reflux for 12 h. The reaction was cooled to rt and concentrated in vacuo. Flash column chromatography was then used to provide <b>18</b> (100 g, 59%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.60 (br s, 1H), 7.46 (t, <i>J</i> = 3.0 Hz, 1H), 6.47 (dd, <i>J</i> = 3.0, 2.0 Hz, 1H).</div></div><div id="sec5_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 2-Chloro-6-(4-(2-hydroxyethyl)piperazin-1-yl)-4-(trifluoromethyl)nicotinonitrile (<b>20</b>)</h4><div class="NLM_p last">To a solution of 2,6-dichloro-4-(trifluoromethyl)nicotinonitrile (60 mg, 0.25 mmol) and 2-(piperazin-1-yl)ethan-1-ol (32 mg, 0.25 mmol) in DMF (2 mL) was added NaHCO<sub>3</sub> (42 mg, 0.50 mmol). Then the mixture was stirred at rt for 20 h. The mixture was quenched with brine (10 mL) and extracted with EtOAc (15 mL × 3). The combined organic layers were washed with NH<sub>4</sub>Cl (15 mL × 2), brine (15 mL × 2), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give a residue which was purified by Prep-TLC (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 20:1) to provide <b>20</b> (60 mg, 72%) as a white solid. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ 7.12 (s, 1H), 3.84 (br s, 4H), 3.72 (t, <i>J</i> = 5.8 Hz, 2H), 2.71–2.65 (m, 4H), 2.62 (t, <i>J</i> = 5.8 Hz, 2H).</div></div><div id="sec5_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 3-Methylpyrrolidin-3-ol (<b>22</b>)</h4><div class="NLM_p">Step 1. A solution of 1-benzylpyrrolidin-3-one (350 g, 2.0 mol) in THF (500 mL) was added dropwise to a stirred solution of MeMgBr (3.0 M, 1.0 L, 3.0 mol) in THF (2.0 L) at 0 °C. The reaction mixture was stirred at 0 °C for 1 h. The reaction mixture was quenched with aqueous saturated NH<sub>4</sub>Cl (6.0 L), and the compound was extracted with ethyl acetate (1 L × 3). The organic layer was washed with brine, dried over sodium sulfate, and concentrated in vacuo. The residue was purified on silica gel by flash chromatography (PE/EtOAc = 5:1 to 1:1) to afford 1-benzyl-3-methylpyrrolidin-3-ol (300 g, 52%) as an oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.36–7.20 (m, 5H), 3.64 (s, 2H), 3.03–2.90 (m, 1H), 2.73 (d, <i>J</i> = 9.4 Hz, 1H), 2.38–2.28 (m, 1H), 2.23 (d, <i>J</i> = 9.6 Hz, 1H), 1.95–1.84 (m, 2H), 1.35 (s, 3H)</div><div class="NLM_p last">Step 2. A suspension of 1-benzyl-3-methylpyrrolidin-3-ol (700 g, 3.66 mol) and 10% Pd/C (50% wet, 100 g) in MeOH (5.0 L) was placed under H<sub>2</sub> in a Parr bottle at 60 psi for 48 h. The reaction mixture was filtered through a short pad of Celite and washed with MeOH. The filtrate was concentrated in vacuo to give <b>22</b> as an orange oil (300 g, 81%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.26–3.15 (m, 1H), 3.05–2.89 (m, 2H), 2.68 (d, <i>J</i> = 11.5 Hz, 1H), 1.91–1.81 (m, 1H), 1.80–1.69 (m, 1H), 1.37 (s, 3H).</div></div><div id="sec5_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>S</i>)-3-Methylpyrrolidin-3-ol/<span class="smallcaps smallerCapital">l</span>-Dihydroorotic Acid Complex (1:2)</h4><div class="NLM_p last">(<i>S</i>)-2,6-Dioxohexahydropyrimidine-4-carboxylic acid (281 g, 1.78 mol) in ethanol (12 L) was heated to reflux, and then 3-methylpyrrolidin-3-ol (120 g, 1.19 mol) in ethanol (500 mL) was added dropwise at 85 °C for 1 h. The reaction was refluxed for 12 h, then cooled to rt overnight. The solids were collected via filtration, washed with ethanol (1.0 L), and dried in vacuo to afford the title compound (240 g). The product was recrystallized by methanol (15 L × 4) to afford the title compound (60 g). The filtrates were concentrated and recrystallized by methanol (15 L) to afford a second crop of the product (40 g) for a total isolated amount of 100 g (20%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.09–9.46 (m, 3H), 7.42 (s, 2H), 3.94–3.77 (m, 2H), 3.31–3.15 (m, 2H), 2.99 (d, <i>J</i> = 11.5 Hz, 1H), 2.90 (d, <i>J</i> = 11.5 Hz, 1H), 2.74 (d, <i>J</i> = 7.0 Hz, 1H), 2.70 (d, <i>J</i> = 7.0 Hz, 1H), 2.54 (d, <i>J</i> = 4.3 Hz, 1H), 2.51–2.45 (m, 1H), 1.90–1.69 (m, 2H), 1.30 (s, 3H). % ee was checked by derivatization to Cbz-protected (<i>S</i>)-<b>22</b> and determined by SFC: >98% ee.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Protein Expression and Purification</h3><div class="NLM_p last">KHK protein sequences were obtained from NCBI under RefSeq ID’s NP_006479.1 (human) and NP_114061.1 (rat). Plasmids were generated using pET28a(+) vector with N-terminal His-tag followed by thrombin cleavage sequence. Recombinant proteins were expressed in <i>E. coli</i> BL21 (DE3) following standard IPTG induction conditions, and purification of soluble protein was done using Ni-NTA affinity chromatography, followed by size exclusion chromatography and dialysis in final buffer (25 mM Tris, pH 8.0, 250 mM NaCl, 2 mM TCEP). For NMR fragment screening, full length His-tagged human KHK was used as is. For KHK inhibition assays the His-tag was removed by thrombin digestion using biotinylated thrombin, and final cleanup was done through streptavidin agarose resin followed by dialysis in storage buffer (50 mM HEPES, pH 7.5, 250 mM NaCl, 2 mM TCEP). Final protein sequence was confirmed by mass spectrometry. For SPR studies, full length thrombin-cleaved human KHK was chemically biotinylated for immobilization. Sulfo-NHS-LC-LC-biotin was incubated with the protein solution in the presence of ATP analog AMP-PNP to protect the active site during biotinylation. Buffer exchange was done by successive passes through 10k MWCO Centricon filter until five full exchanges were accomplished. Protein concentration was monitored throughout, and approximately 80% of the starting material was recovered after biotinylation and cleanup.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> NMR Fragment Screening</h3><div class="NLM_p last">Full length His-tagged KHK was screened against a proprietary 2592 member fragment library using 1D saturation transfer difference (NMR-STD) spectroscopy in NMR. Fragment screen for KHK was carried out using 5 μM protein in 50 mM deuterated Tris-<i>d</i>, 100 mM NaCl, 2 mM deuterated TCEP-<i>d</i>, 5% deuterated glycerol-<i>d</i> at pH 7.5 at 298 K. AMP-PMP 240 μM was used as a positive control in NMR-STD experiments. Standard conditions were run for the NMR-STD method including NS = 512. Library compounds were run in either mixtures of 10 or 4 at a final concentration of 240 μM. The 1D STD NMR experiment was carried out using a Bruker Avance 600 MHz NMR spectrometer equipped with 1.7 mm cyroprobe at 298 K. In the STD experiment, a cascade of 60 50 ms Gaussian shaped (gaus1.1000) pulses were applied for on resonance saturation −2360 Hz from the carrier and applied for off resonance saturation −14819 Hz from the carrier for a total saturation time of 3 s. Each 50 ms shaped pulse was applied at a power level of 3.16 × 10<sup>–4</sup> W (35 dB) and was followed by a 20 ms delay. In the STD experiment, a 3.0 s gauss shaped pulse was applied for on resonance saturation −2360 Hz from the carrier and applied for off resonance saturation −14819 Hz from the carrier. Positive signals in the difference spectra indicate ligand binding, and the identification of the bound ligand in the mixture was determined by comparison to 1D <sup>1</sup>H reference NMR spectra of each fragment. Data were analyzed using an internal software package.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Surface Plasmon Resonance Experiments</h3><div class="NLM_p">Experiments were performed on a Fujifilm AP-3000 instrument. Full length biotinylated KHK was captured onto a SA-101 Fujifilm sensor stick to levels ranging from 7000 to 8000 RU. Compound binding experiments were performed in 50 mM HEPES, pH 7.4, 150 mM NaCl, 0.01% P20, 500 μM TCEP, and 3% DMSO at 25 °C. Binding responses were processed using Spotfire software (TIBCO) to zero, <i>x</i>-align, double reference, and correct for excluded volume effects of DMSO in the data.</div><div class="NLM_p last">Experiments were carried out for 11 compound concentrations with 2-fold dilutions and a top compound concentration of 300 μM. Compound samples are injected in a stop-flow fashion to allow 60 s association and at least 120 s dissociation with a blank buffer injection. Equilibrium dissociation constant (<i>K</i><sub>D</sub>) was determined using a steady-state affinity algorithm.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> X-ray Crystallography</h3><div class="NLM_p last">Recombinant hKHK was purified and crystallized following protocols described in the literature.<a onclick="showRef(event, 'cit14b cit14d'); return false;" href="javascript:void(0);" class="ref cit14b cit14d">(14b, 14d)</a> Apo crystals were soaked for 3 h in solutions containing 25 mM compound in crystal soaking buffer. Compound-bound crystals were then isolated and snap-frozen in liquid nitrogen prior to X-ray data collection. X-ray diffraction data were collected at 100 K with radiation of wavelength 1 Å at beamline 17-ID of the Advanced Photon Source at Argonne, on a Pilatus-6M detector. Data were processed using autoPROC<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> with XDS<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> for data integration and the program Scala from the CCP4 Suite<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> for merging and scaling. The structures are isomorphous with PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NBV">3NBV</a> (ref <a onclick="showRef(event, 'cit14d'); return false;" href="javascript:void(0);" class="ref cit14d">14d</a>), so phasing was done by rigid body refinement of the protein model from <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NBV">3NBV</a>. Refinement was carried out using autoBUSTER,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> while model building and visualization used Coot.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Data collection and refinement statistics are given in <a href="/doi/suppl/10.1021/acs.jmedchem.7b00947/suppl_file/jm7b00947_si_001.pdf" class="ext-link">Table S2</a>.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> In Vitro Human and Rat KHK Inhibition Assay</h3><div class="NLM_p">KHK takes ATP and phosphorylates fructose to fructose 1-phosphate, and activity was measured by coupling ADP production to pyruvate kinase–lactate dehydrogenase system with stoichiometric decrease in NADH absorbance at 340 nm. The assay was set up in a 384-well UV plate monitored in continuous mode at room temperature. Compounds were prepared in DMSO as a 40× stock solution and serially diluted using an 11-point scheme on a Biomek FX (Beckman Coulter). One microliter of each compound dilution was transferred to the assay plate and incubated at room temperature for 30 min with reaction mixture containing assay buffer (50 mM HEPES, pH 7.4, 140 mM KCl, 3.5 mM MgCl<sub>2</sub>, 2 mM TCEP, 0.01% Triton X-100), 0.8 mM fructose, 0.8 mM phosphoenol pyruvate, 0.7 mM NADH, 30 U/mL pyruvate kinase–lactate dehydrogenase (Sigma P0294), and 10 nM purified KHK. The reaction was initiated with the addition of 0.2 mM ATP, and the absorbance was measured in kinetic mode at 340 nm for 30 min on a SpectraMax reader (Molecular Devices). The concentrations provided are based on a final reaction volume of 40 μL.</div><div class="NLM_p last">A 2 μM final concentration of compound <b>8</b> reported by Maryanoff et al.<a onclick="showRef(event, 'cit14b'); return false;" href="javascript:void(0);" class="ref cit14b">(14b)</a> was used as 100% effect (HPE) control, and 2.5% DMSO which was present in all reaction wells was used as 0% effect (ZPE) control. Percent inhibition was calculated using the above controls and plotted as a function of compound concentration to generate the concentration response curve, and IC<sub>50</sub> was calculated on GraphPad Prism based on the nonlinear fit of the log-transformed data.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Animal Experimental Methods</h3><div class="NLM_p last">For these studies male Sprague Dawley rats (∼200 g body weight) were ordered from Charles River. All animals were acclimated for 1 week prior to study and fed PicoLab rodent diet 20 ad libitum. For the study in which hepatic and renal F1P was measured, rats with a jugular vein cannula were ordered. For all studies, rats were fasted overnight for 16 h before beginning the experiment. The morning of the study measuring F1P in hepatic and renal tissue, rats were administered the indicated oral dose of compound <b>12</b> formulated as a 10 mL/kg 0.5% methylcellulose nanomilled suspension. One hour following dose, rats received an iv 10 mL/kg bolus of fructose (500 mg/kg over 20 s). Two minutes following iv infusion, rats were euthanized by decapitation and the liver and kidneys were rapidly removed and snap-frozen in liquid nitrogen. Tissues were analyzed by LC/MS for F1P as indicated below. Noncannulated rats were used for the study measuring changes in plasma fructose study. Animals were administered with the indicated oral dose of compound <b>12</b> formulated as a 10 mL/kg 0.5% methylcellulose nanomilled suspension. Blood was collected into K<sub>2</sub>EDTA coated tubes via tail vein. Plasma was collected following centrifugation according to manufacturer’s recommendations. All samples were stored at −80 °C until processing.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Liver and Kidney Fructose 1-Phosphate (F1P) Measurements</h3><div class="NLM_p">Livers and kidneys were rapidly pulverized with a hammer on an aluminum block cooled in liquid nitrogen, ensuring the tissue remained frozen throughout the pulverization. Approximately 100 mg of tissue was aliquoted into a liquid nitrogen cooled 2 mL Lysing Matrix D tube. The tissue weight was determined and then suspended in homogenization buffer, 10 mM ammonium acetate with 10 mM ethylenediaminetetraacetic acid (EDTA), pH 8 solution containing 3 μM xylitol-<sup>13</sup>C<sub>5</sub> as an internal standard. Samples were lysed using a FastPrep 24 vendor at 4 °C for 40 s. Samples were centrifuged at 4 °C, 12 000 rpm for 10 min. Supernatant (125 μL) was transferred to a 1.5 mL Eppendorf tube containing 250 μL of mass spectroscopy grade water and centrifuged at 12 000 rpm for 5 min. Supernatant was transferred to a 96-deep-well plate and sealed until ready for analysis. All samples were stored at −80 °C until processing.</div><div class="NLM_p">The quantity of F1P in the samples was determined by analysis LC/MS<sup>2</sup> on a QTRAP5500 (ABSciex) coupled with Acquity UPLC (Waters) following the MRM transition of 259 → 97 with the following mass spec settings: curtain gas, 35; collision gas, medium; ion spray voltage, −4500 V; temperature, 700 °C; ion source gas 1, 40; ion source gas 2, 60; declustering potential, −47; entrance potential, −13.75; collision energy, −20.9; collision cell exit potential, −16.8.</div><div class="NLM_p last">The separation of F1P from other sugar phosphates was achieved by using Shodex RSpak JJ-50 2D PEEK column (2 mm × 150 mm) with isocratic flow of 10% acetonitrile, 90% water, 20 mM triethylammonium acetate, with pH adjusted to 5.8. In each sample, the relative concentration of F1P was quantified by integrating its retention peak and corrected against peak integration of the internal standard 1 μM xylitol-<sup>13</sup>C<sub>5</sub> (after the 1:3 dilution described above) with a correction ratio or fit into F1P standard curve. The standard curve was generated from spiking various concentrations of F1P in pooled metabolite extracts of tissue homogenates from animals fed a regular diet.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Measurements of Plasma Fructose</h3><div class="NLM_p">Blood was collected and transferred to BD Microtainer tubes coated with K<sub>2</sub>EDTA, centrifuged at 4 °C and the plasma transferred to a 96-well microtiter plate and stored at −80 °C until analysis. Fructose was extracted from plasma using 9 equiv of extraction solution (80% methanol, 20% 10 mM ammonium acetate with 10 mM EDTA, pH 8 solution containing internal standards (60 μM fructose-<sup>13</sup>C<sub>6</sub>)). The extracts were centrifuged at 14 000<i>g</i> at 4 °C. The supernatant was transferred into a 96 deep-well plate and further diluted with 2 equiv of liquid chromatography–mass spectroscopy grade water.</div><div class="NLM_p last">Prepared plasma samples were subjected to liquid chromatography–mass spectroscopy/mass spectroscopy analysis. Sugar separation was achieved using hydrophilic interaction chromatography (Asahipak NH2P-50 4E, 4.6 mm × 250 mm) under isocratic elution conditions with 0.8 mL/min flow rate using 75% acetonitrile, 25% water containing 5 mM ammonium acetate, pH 9.2. QTRAP5500 (Sciex, MA) mass spectrometry source parameter was set as the following: curtain gas, 35; ion spray voltage, −4500; temperature, 650 °C; ion source gas 1, 65; ion source gas 2, 60. MRM transitions for quantitation are set as the following: fructose/glucose, Q1 (179) → Q3 (89); fructose-13C6/glucose-13C6, Q1 (185) → Q3 (92); sorbitol, Q1 (181) → Q3 (89); sorbitol-13C6, Q1 (187) → Q3 (92). The analyte peak of interest was integrated using MultiQuan (Sciex) and converted into a concentration using a stable isotope labeled internal standard by the following equation: [(analyte peak area)/(fructose-<sup>13</sup>C<sub>6</sub> peak area)] × concentration of the fructose-<sup>13</sup>C<sub>6</sub>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00947">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13555" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13555" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00947" class="ext-link">10.1021/acs.jmedchem.7b00947</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Crystal structure describing the environment of Asp27(B) at the interface of the two KHK monomers, distribution of properties for fragment selection among confirmed hits, map of interactions for crystal structure of compound <b>12</b>, in vitro selectivity data for compound <b>12</b>, data collection and refinement statistics for crystal structures of compounds <b>3</b>, <b>4</b>, <b>5</b>, <b>7</b>, <b>8</b>, and <b>12</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00947/suppl_file/jm7b00947_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00947/suppl_file/jm7b00947_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00947/suppl_file/jm7b00947_si_001.pdf">jm7b00947_si_001.pdf (791.79 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00947/suppl_file/jm7b00947_si_002.csv">jm7b00947_si_002.csv (0.67 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates and structure factors for hKHK bound to compounds <b>3</b>, <b>4</b>, <b>5</b>, <b>7</b>, <b>8</b>, and <b>12</b> have been deposited to the RCSB with PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBM">5WBM</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBO">5WBO</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBP">5WBP</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBQ">5WBQ</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBR">5WBR</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBZ">5WBZ</a>, respectively. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b00947" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08453" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08453" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kim Huard</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5902-968X" title="Orcid link">http://orcid.org/0000-0002-5902-968X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#dc97b5b1f294a9bdaeb89c8cbab5a6b9aef2bfb3b1"><span class="__cf_email__" data-cfemail="b7fcdeda99ffc2d6c5d3f7e7d1decdd2c599d4d8da">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kay Ahn</span> - <span class="hlFld-Affiliation affiliation">Internal
Medicine, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Amor</span> - <span class="hlFld-Affiliation affiliation">Internal
Medicine, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David A. Beebe</span> - <span class="hlFld-Affiliation affiliation">Internal
Medicine, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kris A. Borzilleri</span> - <span class="hlFld-Affiliation affiliation">Structural
Biology and Biophysics, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Boris A. Chrunyk</span> - <span class="hlFld-Affiliation affiliation">Structural
Biology and Biophysics, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven B. Coffey</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yang Cong</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edward L. Conn</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey S. Culp</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew S. Dowling</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew F. Gorgoglione</span> - <span class="hlFld-Affiliation affiliation">Internal
Medicine, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jemy A. Gutierrez</span> - <span class="hlFld-Affiliation affiliation">Internal
Medicine, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John D. Knafels</span> - <span class="hlFld-Affiliation affiliation">Structural
Biology and Biophysics, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erik A. Lachapelle</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jayvardhan Pandit</span> - <span class="hlFld-Affiliation affiliation">Structural
Biology and Biophysics, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin D. Parris</span> - <span class="hlFld-Affiliation affiliation">Structural
Biology and Biophysics, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sylvie Perez</span> - <span class="hlFld-Affiliation affiliation">Internal
Medicine, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey A. Pfefferkorn</span> - <span class="hlFld-Affiliation affiliation">Internal
Medicine, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David A. Price</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian Raymer</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Trenton T. Ross</span> - <span class="hlFld-Affiliation affiliation">Internal
Medicine, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andre Shavnya</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aaron C. Smith</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timothy A. Subashi</span> - <span class="hlFld-Affiliation affiliation">Structural
Biology and Biophysics, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory J. Tesz</span> - <span class="hlFld-Affiliation affiliation">Internal
Medicine, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benjamin A. Thuma</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Meihua Tu</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John D. Weaver</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan Weng</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jane M. Withka</span> - <span class="hlFld-Affiliation affiliation">Structural
Biology and Biophysics, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gang Xing</span> - <span class="hlFld-Affiliation affiliation">Internal
Medicine, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas V. Magee</span> - <span class="hlFld-Affiliation affiliation">Internal
Medicine, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): All authors were employed by Pfizer for the duration of the work described in the manuscript.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e2900-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67547" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67547" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank David Hepworth, Kevin Beaumont, and Neal Sach for their contributions to the work reported here and the preparation of the manuscript. The research reported in this manuscript was funded by Pfizer. All authors were employed by Pfizer during the completion and analysis of the experiments herein reported. Use of the IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i40" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i40"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i41" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i41"> Abbreviations Used</h2><tr><td class="NLM_term">KHK</td><td class="NLM_def"><p class="first last">ketohexokinase</p></td></tr><tr><td class="NLM_term">F1P</td><td class="NLM_def"><p class="first last">fructose 1-phosphate</p></td></tr><tr><td class="NLM_term">hKHK</td><td class="NLM_def"><p class="first last">human ketohexokinase</p></td></tr><tr><td class="NLM_term">NAFLD</td><td class="NLM_def"><p class="first last">nonalcoholic fatty liver disease</p></td></tr><tr><td class="NLM_term">ChREBP</td><td class="NLM_def"><p class="first last">carbohydrate response element binding protein</p></td></tr><tr><td class="NLM_term">VLDL</td><td class="NLM_def"><p class="first last">very low density lipoprotein</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high throughput screening</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">rKHK</td><td class="NLM_def"><p class="first last">rat ketohexokinase</p></td></tr><tr><td class="NLM_term">FBDD</td><td class="NLM_def"><p class="first last">fragment-based drug discovery</p></td></tr><tr><td class="NLM_term">BAP</td><td class="NLM_def"><p class="first last">biotin acceptor peptide</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">STD</td><td class="NLM_def"><p class="first last">saturation transfer difference</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">FQ</td><td class="NLM_def"><p class="first last">fit quality</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">SFLogD</td><td class="NLM_def"><p class="first last">shake-flask log <i>D</i></p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub></td><td class="NLM_def"><p class="first last">apparent permeability</p></td></tr><tr><td class="NLM_term">Fu</td><td class="NLM_def"><p class="first last">fraction unbound in plasma</p></td></tr><tr><td class="NLM_term">DOSS</td><td class="NLM_def"><p class="first last">dioctyl sulfosuccinate</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsome</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">CYP450</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">LC/MS</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">G6P</td><td class="NLM_def"><p class="first last">glucose 6-phosphate</p></td></tr><tr><td class="NLM_term">F6P</td><td class="NLM_def"><p class="first last">fructose 6-phosphate</p></td></tr><tr><td class="NLM_term">G1P</td><td class="NLM_def"><p class="first last">glucose 1-phosphate</p></td></tr><tr><td class="NLM_term">DBU</td><td class="NLM_def"><p class="first last">1,8-diazabicyclo[5.4.0]indec-7-ene</p></td></tr><tr><td class="NLM_term">POCl<sub>3</sub></td><td class="NLM_def"><p class="first last">phosphoryl chloride</p></td></tr><tr><td class="NLM_term">MTBE</td><td class="NLM_def"><p class="first last">methyl <i>tert</i>-butyl ether</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88007" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88007" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Bonthron, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donaldson, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, B.</span><span> </span><span class="NLM_article-title">Molecular basis of essential fructosuria: molecular cloning and mutational analysis of human ketohexokinase (fructokinase)</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1627</span><span class="NLM_x">–</span> <span class="NLM_lpage">1631</span><span class="refDoi"> DOI: 10.1093/hmg/3.9.1627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1093%2Fhmg%2F3.9.1627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=7833921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADyaK2MXhtVGnt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1994&pages=1627-1631&author=D.+T.+Bonthronauthor=N.+Bradyauthor=I.+A.+Donaldsonauthor=B.+Steinmann&title=Molecular+basis+of+essential+fructosuria%3A+molecular+cloning+and+mutational+analysis+of+human+ketohexokinase+%28fructokinase%29&doi=10.1093%2Fhmg%2F3.9.1627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of essential fructosuria: molecular cloning and mutational analysis of human ketohexokinase (fructokinase)</span></div><div class="casAuthors">Bonthron, David T.; Brady, Nicola; Donaldson, Iain A.; Steinmann, Beat</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1627-31</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    </div><div class="casAbstract">Essential fructosuria is one of the oldest known inborn errors of metab.  It is a benign condition which is believed to result from deficiency of hepatic fructokinase (ketohexokinase, KHK, E.C.2.7.1.3.).  This enzyme catalyzes the first step of metab. of dietary fructose, conversion of fructose to fructose-1-phosphate.  Despite the early recognition of this disorder, the primary structure of human KHK and the mol. basis of essential fructosuria have not been previously defined.  In this report, the isolation and sequencing of full-length cDNA clones encoding human ketohexokinase are described.  Alternative mRNA species and alternative KHK isoenzymes are produced by alternative polyadenylation and splicing of the KHK gene.  The KHK proteins show a high level of sequence conservation relative to rat KHK.  Direct evidence that mutation of the KHK structural gene is the cause of essential fructosuria was also obtained.  In a well-characterized family, in which 3 of 8 siblings have fructosuria, all affected individuals are compd. heterozygotes for 2 mutations Gly40Arg and Ala43Thr.  Both mutations result from G→A transitions, and each alters the same conserved region of the KHK protein.  Neither mutation was seen in a sample of 52 unrelated control individuals.  An addnl. conservative amino acid change (Val49IIe) was present on the KHK allele bearing Ala43Thr.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnhKZtroZ3uLVg90H21EOLACvtfcHk0lhTTOGAtgvRVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhtVGnt78%253D&md5=1e3f908a2d87d3a49c4897aa84ac3345</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F3.9.1627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F3.9.1627%26sid%3Dliteratum%253Aachs%26aulast%3DBonthron%26aufirst%3DD.%2BT.%26aulast%3DBrady%26aufirst%3DN.%26aulast%3DDonaldson%26aufirst%3DI.%2BA.%26aulast%3DSteinmann%26aufirst%3DB.%26atitle%3DMolecular%2520basis%2520of%2520essential%2520fructosuria%253A%2520molecular%2520cloning%2520and%2520mutational%2520analysis%2520of%2520human%2520ketohexokinase%2520%2528fructokinase%2529%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D1994%26volume%3D3%26spage%3D1627%26epage%3D1631%26doi%3D10.1093%2Fhmg%2F3.9.1627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Asipu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayward, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonthron, D. T.</span><span> </span><span class="NLM_article-title">Properties of normal and mutant recombinant human ketohexokinases and implications for the pathogenesis of essential fructosuria</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2426</span><span class="NLM_x">–</span> <span class="NLM_lpage">2432</span><span class="refDoi"> DOI: 10.2337/diabetes.52.9.2426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.2337%2Fdiabetes.52.9.2426" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2003&pages=2426-2432&author=A.+Asipuauthor=B.+E.+Haywardauthor=J.+O%E2%80%99Reillyauthor=D.+T.+Bonthron&title=Properties+of+normal+and+mutant+recombinant+human+ketohexokinases+and+implications+for+the+pathogenesis+of+essential+fructosuria&doi=10.2337%2Fdiabetes.52.9.2426"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.52.9.2426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.52.9.2426%26sid%3Dliteratum%253Aachs%26aulast%3DAsipu%26aufirst%3DA.%26aulast%3DHayward%26aufirst%3DB.%2BE.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DJ.%26aulast%3DBonthron%26aufirst%3DD.%2BT.%26atitle%3DProperties%2520of%2520normal%2520and%2520mutant%2520recombinant%2520human%2520ketohexokinases%2520and%2520implications%2520for%2520the%2520pathogenesis%2520of%2520essential%2520fructosuria%26jtitle%3DDiabetes%26date%3D2003%26volume%3D52%26spage%3D2426%26epage%3D2432%26doi%3D10.2337%2Fdiabetes.52.9.2426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Ishimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanaspa, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diggle, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclean, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackman, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asipu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncal-Jimenez, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosugi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivard, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Iturbe, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Lozada, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonthron, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sautin, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. J.</span><span> </span><span class="NLM_article-title">Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">4320</span><span class="NLM_x">–</span> <span class="NLM_lpage">4325</span><span class="refDoi"> DOI: 10.1073/pnas.1119908109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1073%2Fpnas.1119908109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=22371574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC38XkslGltbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=4320-4325&author=T.+Ishimotoauthor=M.+A.+Lanaspaauthor=M.+T.+Leauthor=G.+E.+Garciaauthor=C.+P.+Diggleauthor=P.+S.+Macleanauthor=M.+R.+Jackmanauthor=A.+Asipuauthor=C.+A.+Roncal-Jimenezauthor=T.+Kosugiauthor=C.+J.+Rivardauthor=S.+Maruyamaauthor=B.+Rodriguez-Iturbeauthor=L.+G.+Sanchez-Lozadaauthor=D.+T.+Bonthronauthor=Y.+Y.+Sautinauthor=R.+J.+Johnson&title=Opposing+effects+of+fructokinase+C+and+A+isoforms+on+fructose-induced+metabolic+syndrome+in+mice&doi=10.1073%2Fpnas.1119908109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice</span></div><div class="casAuthors">Ishimoto, Takuji; Lanaspa, Miguel A.; Le, My Phuong T.; Garcia, Gabriela E.; Diggle, Christine P.; MacLean, Paul S.; Jackman, Matthew R.; Asipu, Aruna; Roncal-Jimenez, Carlos A.; Kosugi, Tomoki; Rivard, Christopher J.; Maruyama, Shoichi; Rodriguez-Iturbe, Bernardo; Snchez-Lozada, Laura G.; Bonthron, David T.; Sautin, Yuri Y.; Johnson, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4320-4325, S4320/1-S4320/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Fructose intake from added sugars correlates with the epidemic rise in obesity, metabolic syndrome, and nonalcoholic fatty liver disease.  Fructose intake also causes features of metabolic syndrome in lab. animals and humans.  The first enzyme in fructose metab. is fructokinase, which exists as two isoforms, A and C.  Here we show that fructose-induced metabolic syndrome is prevented in mice lacking both isoforms but is exacerbated in mice lacking fructokinase A.  Fructokinase C is expressed primarily in liver, intestine, and kidney and has high affinity for fructose, resulting in rapid metab. and marked ATP depletion.  In contrast, fructokinase A is widely distributed, has low affinity for fructose, and has less dramatic effects on ATP levels.  By reducing the amt. of fructose for metab. in the liver, fructokinase A protects against fructokinase C-mediated metabolic syndrome.  These studies provide insights into the mechanisms by which fructose causes obesity and metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobK1Ob9TEhNbVg90H21EOLACvtfcHk0ljf9DfHQTT9ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkslGltbc%253D&md5=fd8c85c10a00df73910e0937a4220b47</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1119908109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1119908109%26sid%3Dliteratum%253Aachs%26aulast%3DIshimoto%26aufirst%3DT.%26aulast%3DLanaspa%26aufirst%3DM.%2BA.%26aulast%3DLe%26aufirst%3DM.%2BT.%26aulast%3DGarcia%26aufirst%3DG.%2BE.%26aulast%3DDiggle%26aufirst%3DC.%2BP.%26aulast%3DMaclean%26aufirst%3DP.%2BS.%26aulast%3DJackman%26aufirst%3DM.%2BR.%26aulast%3DAsipu%26aufirst%3DA.%26aulast%3DRoncal-Jimenez%26aufirst%3DC.%2BA.%26aulast%3DKosugi%26aufirst%3DT.%26aulast%3DRivard%26aufirst%3DC.%2BJ.%26aulast%3DMaruyama%26aufirst%3DS.%26aulast%3DRodriguez-Iturbe%26aufirst%3DB.%26aulast%3DSanchez-Lozada%26aufirst%3DL.%2BG.%26aulast%3DBonthron%26aufirst%3DD.%2BT.%26aulast%3DSautin%26aufirst%3DY.%2BY.%26aulast%3DJohnson%26aufirst%3DR.%2BJ.%26atitle%3DOpposing%2520effects%2520of%2520fructokinase%2520C%2520and%2520A%2520isoforms%2520on%2520fructose-induced%2520metabolic%2520syndrome%2520in%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D4320%26epage%3D4325%26doi%3D10.1073%2Fpnas.1119908109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vos, M. B.</span><span> </span><span class="NLM_article-title">Fructose and liver function--is this behind nonalcoholic liver disease?</span> <span class="citation_source-journal">Curr. Opin. Clin. Nutr. Metab. Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">495</span><span class="refDoi"> DOI: 10.1097/MCO.0000000000000203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1097%2FMCO.0000000000000203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=26203597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlWiu73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2015&pages=490-495&author=R.+Jinauthor=M.+B.+Vos&title=Fructose+and+liver+function%2D%2Dis+this+behind+nonalcoholic+liver+disease%3F&doi=10.1097%2FMCO.0000000000000203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Fructose and liver function - is this behind nonalcoholic liver disease?</span></div><div class="casAuthors">Jin, Ran; Vos, Miriam B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Clinical Nutrition and Metabolic Care</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">490-495</span>CODEN:
                <span class="NLM_cas:coden">COCMF3</span>;
        ISSN:<span class="NLM_cas:issn">1363-1950</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: The purpose was to summarize recent advances in the understanding of nonalcoholic fatty liver disease (NAFLD) pathophysiol. and the role of fructose in NAFLD.  Recent findings: Epidemiol. studies continue to point to a strong assocn. between high fructose intake and NAFLD and its severity.  New studies of NAFLD reveal the importance of upregulated de novo lipogenesis as a key feature in its pathophysiol. along with increased visceral adiposity and alteration of gut microbiome.  Studies of fructose in NAFLD show how this nutrient may uniquely exacerbate the phenotype of NAFLD.  The timing of exposure to fructose may be important with early (in utero) exposure being particularly harmful.  Summary: Fructose is a potentially modifiable environmental exposure that appears to exacerbate NAFLD through multiple mechanisms.  Although larger, longer clin. studies are still needed, it appears that limitation of fructose sources in the diet is beneficial in NAFLD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2sBxW3w-0brVg90H21EOLACvtfcHk0ljf9DfHQTT9ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlWiu73K&md5=3fa2f3c01e39749ce02a616fe5388632</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1097%2FMCO.0000000000000203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMCO.0000000000000203%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DR.%26aulast%3DVos%26aufirst%3DM.%2BB.%26atitle%3DFructose%2520and%2520liver%2520function--is%2520this%2520behind%2520nonalcoholic%2520liver%2520disease%253F%26jtitle%3DCurr.%2520Opin.%2520Clin.%2520Nutr.%2520Metab.%2520Care%26date%3D2015%26volume%3D18%26spage%3D490%26epage%3D495%26doi%3D10.1097%2FMCO.0000000000000203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schultz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguila, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandarim-de-Lacerda, C. A.</span><span> </span><span class="NLM_article-title">Hepatic adverse effects of fructose consumption independent of overweight/obesity</span> <span class="citation_source-journal">Int. J. Mol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">21873</span><span class="NLM_x">–</span> <span class="NLM_lpage">21886</span><span class="refDoi"> DOI: 10.3390/ijms141121873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.3390%2Fijms141121873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=24196354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltlOnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=21873-21886&author=A.+Schultzauthor=D.+Neilauthor=M.+B.+Aguilaauthor=C.+A.+Mandarim-de-Lacerda&title=Hepatic+adverse+effects+of+fructose+consumption+independent+of+overweight%2Fobesity&doi=10.3390%2Fijms141121873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic adverse effects of fructose consumption independent of overweight/obesity</span></div><div class="casAuthors">Schultz, Alini; Neil, Debora; Aguila, Marcia B.; Mandarim-de-Lacerda, Carlos A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">21873-21886, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The chronic intake of fructose has been linked to insulin resistance, obesity, dyslipidemia and nonalcoholic fatty liver disease (NAFLD), which in turn, may progress to nonalcoholic steatohepatitis (NASH).  We aimed to evaluate the magnitude of the effects of the chronic consumption of high-fructose (HFr) and high fat (HF) alone or combined.  Four groups of male mice were fed different diets for 16 wk: std. chow (9% fat: SC), HF diet (42% fat), HFr diet (34% fructose) and HF/HFr diet (42% fat, 34% fructose).  The food intake was not different among the groups, and the body mass was not greater in the HFr group than in the SC group.  The homeostasis model assessment for insulin resistance (HOMA-IR), as well as plasmatic total cholesterol and triglycerides were greater in the groups HF, HFr and HF/HFr group than in the SC group.  We obsd. in the groups HF, HFr and HF/HFr, compared to the group SC, nonalcoholic fatty liver disease (NAFLD) with a predominance of lipogenesis mediated by SREBP-1c and PPAR-γ, and a redn. of the oxidn. mediated by PPAR-α.  We also obsd. an increase in gluconeogenesis mediated by the GLUT-2 and the PEPCK.  Importantly, we identified areas of necroinflammation indicating a transition from NAFLD to nonalcoholic steatohepatitis in the HFr and HF/HFr groups.  This study is relevant in demonstrating that fructose consumption, even in the absence of obesity, causes serious and deleterious changes in the liver with the presence of the dyslipidemia, insulin resistance (IR) and NAFLD with areas of necroinflammation.  These conditions are assocd. with a poor prognosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0l1MojOHkD7Vg90H21EOLACvtfcHk0ljf9DfHQTT9ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltlOnsLw%253D&md5=72e7b26099845396727bb9c4e5f75ab5</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.3390%2Fijms141121873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms141121873%26sid%3Dliteratum%253Aachs%26aulast%3DSchultz%26aufirst%3DA.%26aulast%3DNeil%26aufirst%3DD.%26aulast%3DAguila%26aufirst%3DM.%2BB.%26aulast%3DMandarim-de-Lacerda%26aufirst%3DC.%2BA.%26atitle%3DHepatic%2520adverse%2520effects%2520of%2520fructose%2520consumption%2520independent%2520of%2520overweight%252Fobesity%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2013%26volume%3D14%26spage%3D21873%26epage%3D21886%26doi%3D10.3390%2Fijms141121873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sun, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Empie, M. W.</span><span> </span><span class="NLM_article-title">Fructose metabolism in humans - what isotopic tracer studies tell us</span> <span class="citation_source-journal">Nutr. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="refDoi"> DOI: 10.1186/1743-7075-9-89</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1186%2F1743-7075-9-89" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVOrtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=89&author=S.+Z.+Sunauthor=M.+W.+Empie&title=Fructose+metabolism+in+humans+-+what+isotopic+tracer+studies+tell+us&doi=10.1186%2F1743-7075-9-89"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Fructose metabolism in humans - what isotopic tracer studies tell us</span></div><div class="casAuthors">Sun, Sam Z.; Empie, Mark W.</div><div class="citationInfo"><span class="NLM_cas:title">Nutrition & Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89</span>CODEN:
                <span class="NLM_cas:coden">NMUEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1743-7075</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Fructose consumption and its implications on public health are currently under study.  This work reviewed the metabolic fate of dietary fructose based on isotope tracer studies in humans.  The mean oxidn. rate of dietary fructose was 45.0% ± 10.7 (mean ± SD) in non-exercising subjects within 3-6 h and 45.8% ± 7.3 in exercising subjects within 2-3 h.  When fructose was ingested together with glucose, the mean oxidn. rate of the mixed sugars increased to 66.0% ± 8.2 in exercising subjects.  The mean conversion rate from fructose to glucose was 41% ± 10.5 (mean ± SD) in 3-6 h after ingestion.  The conversion amt. from fructose to glycogen remains to be further clarified.  A small percentage of ingested fructose (<1%) appears to be directly converted to plasma TG.  However, hyperlipidemic effects of larger amts. of fructose consumption are obsd. in studies using infused labeled acetate to quantify longer term de novo lipogenesis.  While the mechanisms for the hyperlipidemic effect remain controversial, energy source shifting and lipid sparing may play a role in the effect, in addn. to de novo lipogenesis.  Finally, approx. a quarter of ingested fructose can be converted into lactate within a few of hours.  The reviewed data provides a profile of how dietary fructose is utilized in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKxogOzIq04rVg90H21EOLACvtfcHk0liZ8hzAnMzRew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVOrtrs%253D&md5=061bfbe4e8f8039444d472da4893e169</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1186%2F1743-7075-9-89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1743-7075-9-89%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%2BZ.%26aulast%3DEmpie%26aufirst%3DM.%2BW.%26atitle%3DFructose%2520metabolism%2520in%2520humans%2520-%2520what%2520isotopic%2520tracer%2520studies%2520tell%2520us%26jtitle%3DNutr.%2520Metab.%26date%3D2012%26volume%3D9%26spage%3D89%26doi%3D10.1186%2F1743-7075-9-89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Abdelmalek, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unalp-Arida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colvin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonalcoholic Steatohepatitis Clinical Research Network.</span><span> </span><span class="NLM_article-title">Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1961</span><span class="NLM_x">–</span> <span class="NLM_lpage">1971</span><span class="refDoi"> DOI: 10.1002/hep.23535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1002%2Fhep.23535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=20301112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnslyqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=1961-1971&author=M.+F.+Abdelmalekauthor=A.+Suzukiauthor=C.+Guyauthor=A.+Unalp-Aridaauthor=R.+Colvinauthor=R.+J.+Johnsonauthor=A.+M.+Diehlauthor=Nonalcoholic+Steatohepatitis+Clinical+Research+Network.&title=Increased+fructose+consumption+is+associated+with+fibrosis+severity+in+patients+with+nonalcoholic+fatty+liver+disease&doi=10.1002%2Fhep.23535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4dR"><div class="casContent"><span class="casTitleNuber">4d</span><div class="casTitle"><span class="NLM_cas:atitle">Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease</span></div><div class="casAuthors">Abdelmalek, Manal F.; Suzuki, Ayako; Guy, Cynthia; Unalp-Arida, Aynur; Colvin, Ryan; Johnson, Richard J.; Diehl, Anna Mae</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1961-1971</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The rising incidence of obesity and diabetes coincides with a marked increase in fructose consumption.  Fructose consumption is higher in individuals with nonalcoholic fatty liver disease (NAFLD) than in age-matched and body mass index (BMI)-matched controls.  Because fructose elicits metabolic perturbations that may be hepatotoxic, we investigated the relationship between fructose consumption and disease severity in NAFLD.  We studied 427 adults enrolled in the NASH Clin. Research Network for whom Block food questionnaire data were collected within 3 mo of a liver biopsy.  Fructose consumption was estd. based on reporting (frequency × amt.) of Kool-aid, fruit juices, and nondietary soda intake, expressed as servings per wk, and classified into none, min. to moderate (<7 servings/wk), and daily (≥7 servings/wk).  The assocn. of fructose intake with metabolic and histol. features of NAFLD was analyzed using multiple linear and ordinal logistic regression analyses with and without controlling for other confounding factors.  Increased fructose consumption was univariately assocd. with decreased age (P < 0.0001), male sex (P < 0.0001), hypertriglyceridemia (P < 0.04), low high-d. lipoprotein (HDL) cholesterol (<0.0001), decreased serum glucose (P < 0.001), increased calorie intake (P < 0.0001), and hyperuricemia (P < 0.0001).  After controlling for age, sex, BMI, and total calorie intake, daily fructose consumption was assocd. with lower steatosis grade and higher fibrosis stage (P < 0.05 for each).  In older adults (age ≥ 48 years), daily fructose consumption was assocd. with increased hepatic inflammation (P < 0.05) and hepatocyte ballooning (P = 0.05).  Conclusion: In patients with NAFLD, daily fructose ingestion is assocd. with reduced hepatic steatosis but increased fibrosis.  These results identify a readily modifiable environmental risk factor that may ameliorate disease progression in patients with NAFLD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoelIWrtgd0ZrVg90H21EOLACvtfcHk0liZ8hzAnMzRew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnslyqsbg%253D&md5=7b9b16653f15980048b9bc3148262989</span></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1002%2Fhep.23535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.23535%26sid%3Dliteratum%253Aachs%26aulast%3DAbdelmalek%26aufirst%3DM.%2BF.%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DGuy%26aufirst%3DC.%26aulast%3DUnalp-Arida%26aufirst%3DA.%26aulast%3DColvin%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DR.%2BJ.%26aulast%3DDiehl%26aufirst%3DA.%2BM.%26aulast%3D%26atitle%3DIncreased%2520fructose%2520consumption%2520is%2520associated%2520with%2520fibrosis%2520severity%2520in%2520patients%2520with%2520nonalcoholic%2520fatty%2520liver%2520disease%26jtitle%3DHepatology%26date%3D2010%26volume%3D51%26spage%3D1961%26epage%3D1971%26doi%3D10.1002%2Fhep.23535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Ouyang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sautin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruchette, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdelmalek, M. F.</span><span> </span><span class="NLM_article-title">Fructose consumption as a risk factor for non-alcoholic fatty liver disease</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">999</span><span class="refDoi"> DOI: 10.1016/j.jhep.2008.02.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1016%2Fj.jhep.2008.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=18395287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvVSksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=993-999&author=X.+Ouyangauthor=P.+Cirilloauthor=Y.+Sautinauthor=S.+McCallauthor=J.+L.+Bruchetteauthor=A.+M.+Diehlauthor=R.+J.+Johnsonauthor=M.+F.+Abdelmalek&title=Fructose+consumption+as+a+risk+factor+for+non-alcoholic+fatty+liver+disease&doi=10.1016%2Fj.jhep.2008.02.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4eR"><div class="casContent"><span class="casTitleNuber">4e</span><div class="casTitle"><span class="NLM_cas:atitle">Fructose consumption as a risk factor for non-alcoholic fatty liver disease</span></div><div class="casAuthors">Ouyang, Xiaosen; Cirillo, Pietro; Sautin, Yuri; McCall, Shannon; Bruchette, James L.; Diehl, Anna Mae; Johnson, Richard J.; Abdelmalek, Manal F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">993-999</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">While the rise in non-alc. fatty liver disease (NAFLD) parallels the increase in obesity and diabetes, a significant increase in dietary fructose consumption in industrialized countries has also occurred.  The increased consumption of high fructose corn syrup, primarily in the form of soft drinks, is linked with complications of the insulin resistance syndrome.  Furthermore, the hepatic metab. of fructose favors de novo lipogenesis and ATP depletion.  We hypothesize that increased fructose consumption contributes to the development of NAFLD.  A dietary history and paired serum and liver tissue were obtained from patients with evidence of biopsy-proven NAFLD (n = 49) without cirrhosis and controls (n = 24) matched for gender, age (±5 years), and body mass index (±3 points).  Consumption of fructose in patients with NAFLD was nearly 2- to 3-fold higher than controls [365 kcal vs 170 kcal (p < 0.05)].  In patients with NAFLD (n = 6), hepatic mRNA expression of fructokinase (KHK), an important enzyme for fructose metab., and fatty acid synthase, an important enzyme for lipogenesis were increased (p = 0.04 and p = 0.02, resp.).  In an AML hepatocyte cell line, fructose resulted in dose-dependent increase in KHK protein and activity.  The pathogenic mechanism underlying the development of NAFLD may be assocd. with excessive dietary fructose consumption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-_vja7yTvALVg90H21EOLACvtfcHk0liZ8hzAnMzRew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvVSksLk%253D&md5=f18d8203b7ff8d756359ca120296a6da</span></div><a href="/servlet/linkout?suffix=cit4e&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2008.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2008.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DOuyang%26aufirst%3DX.%26aulast%3DCirillo%26aufirst%3DP.%26aulast%3DSautin%26aufirst%3DY.%26aulast%3DMcCall%26aufirst%3DS.%26aulast%3DBruchette%26aufirst%3DJ.%2BL.%26aulast%3DDiehl%26aufirst%3DA.%2BM.%26aulast%3DJohnson%26aufirst%3DR.%2BJ.%26aulast%3DAbdelmalek%26aufirst%3DM.%2BF.%26atitle%3DFructose%2520consumption%2520as%2520a%2520risk%2520factor%2520for%2520non-alcoholic%2520fatty%2520liver%2520disease%26jtitle%3DJ.%2520Hepatol.%26date%3D2008%26volume%3D48%26spage%3D993%26epage%3D999%26doi%3D10.1016%2Fj.jhep.2008.02.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Softic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, C. R.</span><span> </span><span class="NLM_article-title">Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease</span> <span class="citation_source-journal">Dig. Dis. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1282</span><span class="NLM_x">–</span> <span class="NLM_lpage">1293</span><span class="refDoi"> DOI: 10.1007/s10620-016-4054-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1007%2Fs10620-016-4054-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=26856717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC28Xis1aksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2016&pages=1282-1293&author=S.+Softicauthor=D.+E.+Cohenauthor=C.+R.+Kahn&title=Role+of+dietary+fructose+and+hepatic+de+novo+lipogenesis+in+fatty+liver+disease&doi=10.1007%2Fs10620-016-4054-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease</span></div><div class="casAuthors">Softic, Samir; Cohen, David E.; Kahn, C. Ronald</div><div class="citationInfo"><span class="NLM_cas:title">Digestive Diseases and Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1282-1293</span>CODEN:
                <span class="NLM_cas:coden">DDSCDJ</span>;
        ISSN:<span class="NLM_cas:issn">0163-2116</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Nonalcoholic fatty liver disease (NAFLD) is a liver manifestation of metabolic syndrome.  Overconsumption of high-fat diet (HFD) and increased intake of sugar-sweetened beverages are major risk factors for development of NAFLD.  Today the most commonly consumed sugar is high fructose corn syrup.  Hepatic lipids may be derived from dietary intake, esterification of plasma free fatty acids (FFA) or hepatic de novo lipogenesis (DNL).  A central abnormality in NAFLD is enhanced DNL.  Hepatic DNL is increased in individuals with NAFLD, while the contribution of dietary fat and plasma FFA to hepatic lipids is not significantly altered.  The importance of DNL in NAFLD is further established in mouse studies with knockout of genes involved in this process.  Dietary fructose increases levels of enzymes involved in DNL even more strongly than HFD.  Several properties of fructose metab. make it particularly lipogenic.  Fructose is absorbed via portal vein and delivered to the liver in much higher concns. as compared to other tissues.  Fructose increases protein levels of all DNL enzymes during its conversion into triglycerides.  Addnl., fructose supports lipogenesis in the setting of insulin resistance as fructose does not require insulin for its metab., and it directly stimulates SREBP1c, a major transcriptional regulator of DNL.  Fructose also leads to ATP depletion and suppression of mitochondrial fatty acid oxidn., resulting in increased prodn. of reactive oxygen species.  Furthermore, fructose promotes ER stress and uric acid formation, addnl. insulin independent pathways leading to DNL.  In summary, fructose metab. supports DNL more strongly than HFD and hepatic DNL is a central abnormality in NAFLD.  Disrupting fructose metab. in the liver may provide a new therapeutic option for the treatment of NAFLD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrovDr4GnQvCrVg90H21EOLACvtfcHk0liZ8hzAnMzRew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xis1aksrc%253D&md5=02f8d6d99e6f494749dc06f8a96d7eba</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1007%2Fs10620-016-4054-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10620-016-4054-0%26sid%3Dliteratum%253Aachs%26aulast%3DSoftic%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DD.%2BE.%26aulast%3DKahn%26aufirst%3DC.%2BR.%26atitle%3DRole%2520of%2520dietary%2520fructose%2520and%2520hepatic%2520de%2520novo%2520lipogenesis%2520in%2520fatty%2520liver%2520disease%26jtitle%3DDig.%2520Dis.%2520Sci.%26date%3D2016%26volume%3D61%26spage%3D1282%26epage%3D1293%26doi%3D10.1007%2Fs10620-016-4054-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Herman, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuel, V. T.</span><span> </span><span class="NLM_article-title">The sweet path to metabolic demise: fructose and lipid synthesis</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">719</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span><span class="refDoi"> DOI: 10.1016/j.tem.2016.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1016%2Fj.tem.2016.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=27387598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKnsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=719-730&author=M.+A.+Hermanauthor=V.+T.+Samuel&title=The+sweet+path+to+metabolic+demise%3A+fructose+and+lipid+synthesis&doi=10.1016%2Fj.tem.2016.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis</span></div><div class="casAuthors">Herman, Mark A.; Samuel, Varman T.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">719-730</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Epidemiol. studies link fructose consumption with metabolic disease, an assocn. attributable in part to fructose-mediated lipogenesis.  The mechanisms governing fructose-induced lipogenesis and disease remain debated.  Acutely, fructose increases de novo lipogenesis through the efficient and uninhibited action of ketohexokinase and aldolase B which yields substrates for fatty-acid synthesis.  Chronic fructose consumption further enhances the capacity for hepatic fructose metab. by activating several key transcription factors (i.e., SREBP1c and ChREBP) which augment the expression of lipogenic enzymes, increasing lipogenesis and further compounding hypertriglyceridemia and hepatic steatosis.  Hepatic insulin resistance develops from diacylglycerol-PKCε-mediated impairment of insulin signaling and possibly addnl. mechanisms.  Initiatives that decrease fructose consumption and therapies that block fructose-mediated lipogenesis will be necessary to avert future metabolic pandemics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlgluy07wBArVg90H21EOLACvtfcHk0lhBXxhsbW8OvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKnsbnN&md5=2ae1fabbad2bfb2b1674e1b799b54717</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2016.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2016.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DHerman%26aufirst%3DM.%2BA.%26aulast%3DSamuel%26aufirst%3DV.%2BT.%26atitle%3DThe%2520sweet%2520path%2520to%2520metabolic%2520demise%253A%2520fructose%2520and%2520lipid%2520synthesis%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2016%26volume%3D27%26spage%3D719%26epage%3D730%26doi%3D10.1016%2Fj.tem.2016.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kim, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krawczyk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doridot, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trauger, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noh, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meissen, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatnik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, M. A.</span><span> </span><span class="NLM_article-title">ChREBP regulates fructose-induced glucose production independently of insulin signaling</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">4372</span><span class="NLM_x">–</span> <span class="NLM_lpage">4386</span><span class="refDoi"> DOI: 10.1172/JCI81993</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1172%2FJCI81993" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2016&pages=4372-4386&author=M.+S.+Kimauthor=S.+A.+Krawczykauthor=L.+Doridotauthor=A.+J.+Fowlerauthor=J.+X.+Wangauthor=S.+A.+Traugerauthor=H.+L.+Nohauthor=H.+J.+Kangauthor=J.+K.+Meissenauthor=M.+Blatnikauthor=J.+K.+Kimauthor=M.+Laiauthor=M.+A.+Herman&title=ChREBP+regulates+fructose-induced+glucose+production+independently+of+insulin+signaling&doi=10.1172%2FJCI81993"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1172%2FJCI81993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI81993%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.%2BS.%26aulast%3DKrawczyk%26aufirst%3DS.%2BA.%26aulast%3DDoridot%26aufirst%3DL.%26aulast%3DFowler%26aufirst%3DA.%2BJ.%26aulast%3DWang%26aufirst%3DJ.%2BX.%26aulast%3DTrauger%26aufirst%3DS.%2BA.%26aulast%3DNoh%26aufirst%3DH.%2BL.%26aulast%3DKang%26aufirst%3DH.%2BJ.%26aulast%3DMeissen%26aufirst%3DJ.%2BK.%26aulast%3DBlatnik%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DJ.%2BK.%26aulast%3DLai%26aufirst%3DM.%26aulast%3DHerman%26aufirst%3DM.%2BA.%26atitle%3DChREBP%2520regulates%2520fructose-induced%2520glucose%2520production%2520independently%2520of%2520insulin%2520signaling%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2016%26volume%3D126%26spage%3D4372%26epage%3D4386%26doi%3D10.1172%2FJCI81993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Erion, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vatner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonemitsu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillum, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manchem, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhanot, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cline, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shulman, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuel, V. T.</span><span> </span><span class="NLM_article-title">The role of the carbohydrate response element-binding protein in male fructose-fed rats</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span><span class="refDoi"> DOI: 10.1210/en.2012-1725</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1210%2Fen.2012-1725" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=36-44&author=D.+M.+Erionauthor=V.+Popovauthor=J.+J.+Hsiaoauthor=D.+Vatnerauthor=K.+Mitchellauthor=S.+Yonemitsuauthor=Y.+Nagaiauthor=M.+Kahnauthor=M.+P.+Gillumauthor=J.+Dongauthor=S.+F.+Murrayauthor=V.+P.+Manchemauthor=S.+Bhanotauthor=G.+W.+Clineauthor=G.+I.+Shulmanauthor=V.+T.+Samuel&title=The+role+of+the+carbohydrate+response+element-binding+protein+in+male+fructose-fed+rats&doi=10.1210%2Fen.2012-1725"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1210%2Fen.2012-1725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2012-1725%26sid%3Dliteratum%253Aachs%26aulast%3DErion%26aufirst%3DD.%2BM.%26aulast%3DPopov%26aufirst%3DV.%26aulast%3DHsiao%26aufirst%3DJ.%2BJ.%26aulast%3DVatner%26aufirst%3DD.%26aulast%3DMitchell%26aufirst%3DK.%26aulast%3DYonemitsu%26aufirst%3DS.%26aulast%3DNagai%26aufirst%3DY.%26aulast%3DKahn%26aufirst%3DM.%26aulast%3DGillum%26aufirst%3DM.%2BP.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DMurray%26aufirst%3DS.%2BF.%26aulast%3DManchem%26aufirst%3DV.%2BP.%26aulast%3DBhanot%26aufirst%3DS.%26aulast%3DCline%26aufirst%3DG.%2BW.%26aulast%3DShulman%26aufirst%3DG.%2BI.%26aulast%3DSamuel%26aufirst%3DV.%2BT.%26atitle%3DThe%2520role%2520of%2520the%2520carbohydrate%2520response%2520element-binding%2520protein%2520in%2520male%2520fructose-fed%2520rats%26jtitle%3DEndocrinology%26date%3D2013%26volume%3D154%26spage%3D36%26epage%3D44%26doi%3D10.1210%2Fen.2012-1725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Stanhope, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medici, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bremer, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunez, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keim, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havel, P. J.</span><span> </span><span class="NLM_article-title">A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults</span> <span class="citation_source-journal">Am. J. Clin. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">1144</span><span class="NLM_x">–</span> <span class="NLM_lpage">1154</span><span class="refDoi"> DOI: 10.3945/ajcn.114.100461</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.3945%2Fajcn.114.100461" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=25904601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOgtrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2015&pages=1144-1154&author=K.+L.+Stanhopeauthor=V.+Mediciauthor=A.+A.+Bremerauthor=V.+Leeauthor=H.+D.+Lamauthor=M.+V.+Nunezauthor=G.+X.+Chenauthor=N.+L.+Keimauthor=P.+J.+Havel&title=A+dose-response+study+of+consuming+high-fructose+corn+syrup-sweetened+beverages+on+lipid%2Flipoprotein+risk+factors+for+cardiovascular+disease+in+young+adults&doi=10.3945%2Fajcn.114.100461"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults</span></div><div class="casAuthors">Stanhope, Kimber L.; Medici, Valentina; Bremer, Andrew A.; Lee, Vivien; Lam, Hazel D.; Nunez, Marinelle V.; Chen, Guoxia X.; Keim, Nancy L.; Havel, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Clinical Nutrition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1144-1454</span>CODEN:
                <span class="NLM_cas:coden">AJCNAC</span>;
        ISSN:<span class="NLM_cas:issn">0002-9165</span>.
    
            (<span class="NLM_cas:orgname">American Society for Nutrition</span>)
        </div><div class="casAbstract">Background: National Health and Nutrition Examn. Survey data show an increased risk of cardiovascular disease (CVD) mortality with an increased intake of added sugar.  Objective: We detd. the dose-response effects of consuming beverages sweetened with high-fructose corn syrup (HFCS) at zero, low, medium, and high proportions of energy requirements (Ereq) on circulating lipid/lipoprotein risk factors for CVD and uric acid in adults [age: 18-40 y; body mass index (in kg/m2): 18-35].  Design: We conducted a parallel-arm, nonrandomized, double-blinded intervention study in which adults participated in 3.5 inpatient days of baseline testing at the University of California Davis Clin. and Translational Science Center's Clin. Research Center.  Participants then consumed beverages sweetened with HFCS at 0% (aspartame sweetened, n = 23), 10% (n = 18), 17.5% (n = 16), or 25% (n = 28) of Ereq during 13 outpatient days and during 3.5 inpatient days of intervention testing at the research center.  We conducted 24-h serial blood collections during the baseline and intervention testing periods.  Results: Consuming beverages contg. 10%, 17.5%, or 25% Ereq from HFCS produced significant linear dose-response increases of lipid/lipoprotein risk factors for CVD and uric acid: postprandial triglyceride (0%: 0 ± 4; 10%: 22 ± 8; 17.5%: 25 ± 5: 25%: 37 ± 5 mg/dL, mean of Δ ± SE, P < 0.0001 effect of HFCS-dose), fasting LDL cholesterol (0%: -1.0 ± 3.1; 10%: 7.4 ± 3.2; 17.5%: 8.2 ± 3.1; 25%: 15.9 ± 3.1 mg/dL, P < 0.0001), and 24-h mean uric acid concns. (0%: -0.13 ± 0.07; 10%: 0.15 ± 0.06; 17.5%: 0.30 ± 0.07; 25%: 0.59 ± 0.09 mg/dL, P < 0.0001).  Compared with beverages contg. 0% HFCS, all 3 doses of HFCS-contg. beverages increased concns. of postprandial triglyceride, and the 2 higher doses increased fasting and/or postprandial concns. of non-HDL cholesterol, LDL cholesterol, apolipoprotein B, apolipoprotein CIII, and uric acid.  Conclusions: Consuming beverages contg. 10%, 17.5%, or 25% Ereq from HFCS produced dose-dependent increases in circulating lipid/lipoprotein risk factors for CVD and uric acid within 2 wk.  These results provide mechanistic support for the epidemiol. evidence that the risk of cardiovascular mortality is pos. assocd. with consumption of increasing amts. of added sugars.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb3V0OYkg-Q7Vg90H21EOLACvtfcHk0lhyPD51o4aUpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOgtrfP&md5=86ffd09c1984920985eb5a5c735be761</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.3945%2Fajcn.114.100461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3945%252Fajcn.114.100461%26sid%3Dliteratum%253Aachs%26aulast%3DStanhope%26aufirst%3DK.%2BL.%26aulast%3DMedici%26aufirst%3DV.%26aulast%3DBremer%26aufirst%3DA.%2BA.%26aulast%3DLee%26aufirst%3DV.%26aulast%3DLam%26aufirst%3DH.%2BD.%26aulast%3DNunez%26aufirst%3DM.%2BV.%26aulast%3DChen%26aufirst%3DG.%2BX.%26aulast%3DKeim%26aufirst%3DN.%2BL.%26aulast%3DHavel%26aufirst%3DP.%2BJ.%26atitle%3DA%2520dose-response%2520study%2520of%2520consuming%2520high-fructose%2520corn%2520syrup-sweetened%2520beverages%2520on%2520lipid%252Flipoprotein%2520risk%2520factors%2520for%2520cardiovascular%2520disease%2520in%2520young%2520adults%26jtitle%3DAm.%2520J.%2520Clin.%2520Nutr.%26date%3D2015%26volume%3D101%26spage%3D1144%26epage%3D1154%26doi%3D10.3945%2Fajcn.114.100461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Stanhope, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keim, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffen, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bremer, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatcher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyachenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGahan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauss, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otokozawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beysen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellerstein, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berglund, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havel, P. J.</span><span> </span><span class="NLM_article-title">Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">1322</span><span class="NLM_x">–</span> <span class="NLM_lpage">1334</span><span class="refDoi"> DOI: 10.1172/JCI37385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1172%2FJCI37385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=19381015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFyrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=1322-1334&author=K.+L.+Stanhopeauthor=J.+M.+Schwarzauthor=N.+L.+Keimauthor=S.+C.+Griffenauthor=A.+A.+Bremerauthor=J.+L.+Grahamauthor=B.+Hatcherauthor=C.+L.+Coxauthor=A.+Dyachenkoauthor=W.+Zhangauthor=J.+P.+McGahanauthor=A.+Seibertauthor=R.+M.+Kraussauthor=S.+Chiuauthor=E.+J.+Schaeferauthor=M.+Aiauthor=S.+Otokozawaauthor=K.+Nakajimaauthor=T.+Nakanoauthor=C.+Beysenauthor=M.+K.+Hellersteinauthor=L.+Berglundauthor=P.+J.+Havel&title=Consuming+fructose-sweetened%2C+not+glucose-sweetened%2C+beverages+increases+visceral+adiposity+and+lipids+and+decreases+insulin+sensitivity+in+overweight%2Fobese+humans&doi=10.1172%2FJCI37385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans</span></div><div class="casAuthors">Stanhope, Kimber L.; Schwarz, Jean Marc; Keim, Nancy L.; Griffen, Steven C.; Bremer, Andrew A.; Graham, James L.; Hatcher, Bonnie; Cox, Chad L.; Dyachenko, Artem; Zhang, Wei; McGahan, John P.; Seibert, Anthony; Krauss, Ronald M.; Chiu, Sally; Schaefer, Ernst J.; Ai, Masumi; Otokozawa, Seiko; Nakajima, Katsuyuki; Nakano, Takamitsu; Beysen, Carine; Hellerstein, Marc K.; Berglund, Lars; Havel, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1322-1334</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Studies in animals have documented that, compared with glucose, dietary fructose induces dyslipidemia and insulin resistance.  To assess the relative effects of these dietary sugars during sustained consumption in humans, overweight and obese subjects consumed glucose- or fructose-sweetened beverages providing 25% of energy requirements for 10 wk.  Although both groups exhibited similar wt. gain during the intervention, visceral adipose vol. was significantly increased only in subjects consuming fructose.  Fasting plasma triglyceride concns. increased by approx. 10% during 10 wk of glucose consumption but not after fructose consumption.  In contrast, hepatic de novo lipogenesis (DNL) and the 23-h postprandial triglyceride AUC were increased specifically during fructose consumption.  Similarly, markers of altered lipid metab. and lipoprotein remodeling, including fasting apoB, LDL, small dense LDL, oxidized LDL, and postprandial concns. of remnant-like particle-triglyceride and -cholesterol significantly increased during fructose but not glucose consumption.  In addn., fasting plasma glucose and insulin levels increased and insulin sensitivity decreased in subjects consuming fructose but not in those consuming glucose.  These data suggest that dietary fructose specifically increases DNL, promotes dyslipidemia, decreases insulin sensitivity, and increases visceral adiposity in overweight/obese adults.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGNXGbG-wmzLVg90H21EOLACvtfcHk0lhyPD51o4aUpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFyrtrg%253D&md5=aeac5902da6dc4d0ae1a023f3b22d536</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1172%2FJCI37385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI37385%26sid%3Dliteratum%253Aachs%26aulast%3DStanhope%26aufirst%3DK.%2BL.%26aulast%3DSchwarz%26aufirst%3DJ.%2BM.%26aulast%3DKeim%26aufirst%3DN.%2BL.%26aulast%3DGriffen%26aufirst%3DS.%2BC.%26aulast%3DBremer%26aufirst%3DA.%2BA.%26aulast%3DGraham%26aufirst%3DJ.%2BL.%26aulast%3DHatcher%26aufirst%3DB.%26aulast%3DCox%26aufirst%3DC.%2BL.%26aulast%3DDyachenko%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DMcGahan%26aufirst%3DJ.%2BP.%26aulast%3DSeibert%26aufirst%3DA.%26aulast%3DKrauss%26aufirst%3DR.%2BM.%26aulast%3DChiu%26aufirst%3DS.%26aulast%3DSchaefer%26aufirst%3DE.%2BJ.%26aulast%3DAi%26aufirst%3DM.%26aulast%3DOtokozawa%26aufirst%3DS.%26aulast%3DNakajima%26aufirst%3DK.%26aulast%3DNakano%26aufirst%3DT.%26aulast%3DBeysen%26aufirst%3DC.%26aulast%3DHellerstein%26aufirst%3DM.%2BK.%26aulast%3DBerglund%26aufirst%3DL.%26aulast%3DHavel%26aufirst%3DP.%2BJ.%26atitle%3DConsuming%2520fructose-sweetened%252C%2520not%2520glucose-sweetened%252C%2520beverages%2520increases%2520visceral%2520adiposity%2520and%2520lipids%2520and%2520decreases%2520insulin%2520sensitivity%2520in%2520overweight%252Fobese%2520humans%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2009%26volume%3D119%26spage%3D1322%26epage%3D1334%26doi%3D10.1172%2FJCI37385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lustig, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noworolski, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erkin-Cakmak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gugliucci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, J. M.</span><span> </span><span class="NLM_article-title">Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome</span> <span class="citation_source-journal">Obesity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span><span class="refDoi"> DOI: 10.1002/oby.21371</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1002%2Foby.21371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=26499447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvV2lsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=453-460&author=R.+H.+Lustigauthor=K.+Mulliganauthor=S.+M.+Noworolskiauthor=V.+W.+Taiauthor=M.+J.+Wenauthor=A.+Erkin-Cakmakauthor=A.+Gugliucciauthor=J.+M.+Schwarz&title=Isocaloric+fructose+restriction+and+metabolic+improvement+in+children+with+obesity+and+metabolic+syndrome&doi=10.1002%2Foby.21371"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome</span></div><div class="casAuthors">Lustig, Robert H.; Mulligan, Kathleen; Noworolski, Susan M.; Tai, Viva W.; Wen, Michael J.; Erkin-Cakmak, Ayca; Gugliucci, Alejandro; Schwarz, Jean-Marc</div><div class="citationInfo"><span class="NLM_cas:title">Obesity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">453-460</span>CODEN:
                <span class="NLM_cas:coden">OBESAX</span>;
        ISSN:<span class="NLM_cas:issn">1930-7381</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : Dietary fructose is implicated in metabolic syndrome, but intervention studies are confounded by pos. caloric balance, changes in adiposity, or artifactually high amts.  This study detd. whether isocaloric substitution of starch for sugar would improve metabolic parameters in Latino (n = 27) and African-American (n = 16) children with obesity and metabolic syndrome.  Methods : Participants consumed a diet for 9 days to deliver comparable percentages of protein, fat, and carbohydrate as their self-reported diet; however, dietary sugar was reduced from 28% to 10% and substituted with starch.  Participants recorded daily wts., with calories adjusted for wt. maintenance.  Participants underwent dual-energy X-ray absorptiometry and oral glucose tolerance testing on Days 0 and 10.  Biochem. analyses were controlled for wt. change by repeated measures ANCOVA.  Results : Redns. in diastolic blood pressure (-5 mmHg; P = 0.002), lactate (-0.3 mmol/L; P < 0.001), triglyceride, and LDL-cholesterol (-46% and -0.3 mmol/L; P < 0.001) were noted.  Glucose tolerance and hyperinsulinemia improved (P < 0.001).  Wt. reduced by 0.9 ± 0.2 kg (P < 0.001) and fat-free mass by 0.6 kg (P = 0.04).  Post hoc sensitivity anal. demonstrates that results in the subcohort that did not lose wt. (n = 10) were directionally consistent.  Conclusions : Isocaloric fructose restriction improved surrogate metabolic parameters in children with obesity and metabolic syndrome irresp. of wt. change.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK8UFgsIj787Vg90H21EOLACvtfcHk0lhyPD51o4aUpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvV2lsbs%253D&md5=4486cd76573a96339298ecb5b7694da8</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1002%2Foby.21371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Foby.21371%26sid%3Dliteratum%253Aachs%26aulast%3DLustig%26aufirst%3DR.%2BH.%26aulast%3DMulligan%26aufirst%3DK.%26aulast%3DNoworolski%26aufirst%3DS.%2BM.%26aulast%3DTai%26aufirst%3DV.%2BW.%26aulast%3DWen%26aufirst%3DM.%2BJ.%26aulast%3DErkin-Cakmak%26aufirst%3DA.%26aulast%3DGugliucci%26aufirst%3DA.%26aulast%3DSchwarz%26aufirst%3DJ.%2BM.%26atitle%3DIsocaloric%2520fructose%2520restriction%2520and%2520metabolic%2520improvement%2520in%2520children%2520with%2520obesity%2520and%2520metabolic%2520syndrome%26jtitle%3DObesity%26date%3D2016%26volume%3D24%26spage%3D453%26epage%3D460%26doi%3D10.1002%2Foby.21371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schwarz, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noworolski, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyachenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herraiz, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bersot, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schambelan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, K.</span><span> </span><span class="NLM_article-title">Effect of a high-fructose weight-maintaining diet on lipogenesis and liver fat</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">2434</span><span class="NLM_x">–</span> <span class="NLM_lpage">2442</span><span class="refDoi"> DOI: 10.1210/jc.2014-3678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1210%2Fjc.2014-3678" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=25825943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOru7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=2434-2442&author=J.+M.+Schwarzauthor=S.+M.+Noworolskiauthor=M.+J.+Wenauthor=A.+Dyachenkoauthor=J.+L.+Priorauthor=M.+E.+Weinbergauthor=L.+A.+Herraizauthor=V.+W.+Taiauthor=N.+Bergeronauthor=T.+P.+Bersotauthor=M.+N.+Raoauthor=M.+Schambelanauthor=K.+Mulligan&title=Effect+of+a+high-fructose+weight-maintaining+diet+on+lipogenesis+and+liver+fat&doi=10.1210%2Fjc.2014-3678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of a high-fructose weight-maintaining diet on lipogenesis and liver fat</span></div><div class="casAuthors">Schwarz, Jean-Marc; Noworolski, Susan M.; Wen, Michael J.; Dyachenko, Artem; Prior, Jessica L.; Weinberg, Melissa E.; Herraiz, Laurie A.; Tai, Viva W.; Bergeron, Nathalie; Bersot, Thomas P.; Rao, Madhu N.; Schambelan, Morris; Mulligan, Kathleen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2434-2442</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Context: Consumption of high-fructose diets promotes hepatic fatty acid synthesis (de novo lipogenesis [DNL]) and an atherogenic lipid profile.  It is unclear whether these effects occur independent of pos. energy balance and wt. gain.  Objectives: We compared the effects of a high-fructose, (25% of energy content) wt.-maintaining diet to those of an isocaloric diet with the same macronutrient distribution but in which complex carbohydrate (CCHO) was substituted for fructose.  Design, Setting, and Participants: Eight healthy men were studied as inpatients for consecutive 9-day periods.  Stable isotope tracers were used to measure fractional hepatic DNL and endogenous glucose prodn. (EGP) and its suppression during a euglycemic-hyperinsulinemic clamp.  Liver fat was measured by magnetic resonance spectroscopy.  Results: Wt. remained stable.  Regardless of the order in which the diets were fed, the high-fructose diet was assocd. with both higher DNL (av., 18.6 ± 1.4% vs 11.0 ± 1.4% for CCHO; P = .001) and higher liver fat (median, +137% of CCHO; P = .016) in all participants.  Fasting EGP and insulin-mediated glucose disposal did not differ significantly, but EGP during hyperinsulinemia was greater (0.60 ± 0.07 vs 0.46 ± 0.06 mg/kg/min; P = .013) with the high-fructose diet, suggesting blunted suppression of EGP.  Conclusion: Short-term high-fructose intake was assocd. with increased DNL and liver fat in healthy men fed wt.-maintaining diets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS65RvfxkRA7Vg90H21EOLACvtfcHk0ljSJpiREVdWtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOru7fO&md5=ce05c14d39d8b6e743eaeff71b3c18ed</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1210%2Fjc.2014-3678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2014-3678%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarz%26aufirst%3DJ.%2BM.%26aulast%3DNoworolski%26aufirst%3DS.%2BM.%26aulast%3DWen%26aufirst%3DM.%2BJ.%26aulast%3DDyachenko%26aufirst%3DA.%26aulast%3DPrior%26aufirst%3DJ.%2BL.%26aulast%3DWeinberg%26aufirst%3DM.%2BE.%26aulast%3DHerraiz%26aufirst%3DL.%2BA.%26aulast%3DTai%26aufirst%3DV.%2BW.%26aulast%3DBergeron%26aufirst%3DN.%26aulast%3DBersot%26aufirst%3DT.%2BP.%26aulast%3DRao%26aufirst%3DM.%2BN.%26aulast%3DSchambelan%26aufirst%3DM.%26aulast%3DMulligan%26aufirst%3DK.%26atitle%3DEffect%2520of%2520a%2520high-fructose%2520weight-maintaining%2520diet%2520on%2520lipogenesis%2520and%2520liver%2520fat%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2015%26volume%3D100%26spage%3D2434%26epage%3D2442%26doi%3D10.1210%2Fjc.2014-3678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Abid, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taha, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nseir, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosovski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assy, N.</span><span> </span><span class="NLM_article-title">Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">918</span><span class="NLM_x">–</span> <span class="NLM_lpage">924</span><span class="refDoi"> DOI: 10.1016/j.jhep.2009.05.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1016%2Fj.jhep.2009.05.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=19765850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1CqurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2009&pages=918-924&author=A.+Abidauthor=O.+Tahaauthor=W.+Nseirauthor=R.+Farahauthor=M.+Grosovskiauthor=N.+Assy&title=Soft+drink+consumption+is+associated+with+fatty+liver+disease+independent+of+metabolic+syndrome&doi=10.1016%2Fj.jhep.2009.05.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome</span></div><div class="casAuthors">Abid, Ali; Taha, Ola; Nseir, William; Farah, Raymond; Grosovski, Maria; Assy, Nimer</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">918-924</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Background/Aims: The independent role of soft drink consumption in non-alc. fatty liver disease (NAFLD) patients remains unclear.  We aimed to assess the assocn. between consumption of soft drinks and fatty liver in patients with or without metabolic syndrome.  Methods: We recruited 31 patients (age: 43 ± 12 years) with NAFLD and risk factors for metabolic syndrome, 29 patients with NAFLD and without risk factors for metabolic syndrome, and 30 gender- and age-matched individuals without NAFLD.  The degree of fatty infiltration was measured by ultrasound.  Data on phys. activity and intake of food and soft drinks were collected during two 7-day periods over 6 mo using a food questionnaire.  Insulin resistance, inflammation, and oxidant-antioxidant markers were measured.  Results: We found that 80% of patients with NAFLD had excessive intake of soft drink beverages (>500 cm3/day) compared to 17% of healthy controls (p < 0.001).  The NAFLD group consumed five times more carbohydrates from soft drinks compared to healthy controls (40% vs. 8%, p < 0.001).  Seven percent of patients consumed one soft drink per day, 55% consumed two or three soft drinks per day, and 38% consumed more than four soft drinks per day for most days and for the 6-mo period.  The most common soft drinks were Coca-Cola (regular: 32%; diet: 21%) followed by fruit juices (47%).  Patients with NAFLD with metabolic syndrome had similar malonyldialdehyde, paraoxonase, and C-reactive protein (CRP) levels but higher homeostasis model assessment (HOMA) and higher ferritin than NAFLD patients without metabolic syndrome (HOMA: 8.3 ± 8 vs. 3.7 ± 3.7 mg/dL, p < 0.001; ferritin: 186 ± 192 vs. 87 ± 84 mg/dL, p < 0.01).  Logistic regression anal. showed that soft drink consumption is a strong predictor of fatty liver (odds ratio: 2.0; p < 0.04) independent of metabolic syndrome and CRP level.  Conclusions: NAFLD patients display higher soft drink consumption independent of metabolic syndrome diagnosis.  These findings might optimize NAFLD risk stratification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMa47NLmenfrVg90H21EOLACvtfcHk0ljSJpiREVdWtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1CqurvM&md5=3d004438b6f78fc3a33d11c058d2ebd4</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2009.05.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2009.05.033%26sid%3Dliteratum%253Aachs%26aulast%3DAbid%26aufirst%3DA.%26aulast%3DTaha%26aufirst%3DO.%26aulast%3DNseir%26aufirst%3DW.%26aulast%3DFarah%26aufirst%3DR.%26aulast%3DGrosovski%26aufirst%3DM.%26aulast%3DAssy%26aufirst%3DN.%26atitle%3DSoft%2520drink%2520consumption%2520is%2520associated%2520with%2520fatty%2520liver%2520disease%2520independent%2520of%2520metabolic%2520syndrome%26jtitle%3DJ.%2520Hepatol.%26date%3D2009%26volume%3D51%26spage%3D918%26epage%3D924%26doi%3D10.1016%2Fj.jhep.2009.05.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Assy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasser, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamayse, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nseir, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beniashvili, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djibre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosovski, M.</span><span> </span><span class="NLM_article-title">Soft drink consumption linked with fatty liver in the absence of traditional risk factors</span> <span class="citation_source-journal">Can. J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">811</span><span class="NLM_x">–</span> <span class="NLM_lpage">816</span><span class="refDoi"> DOI: 10.1155/2008/810961</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1155%2F2008%2F810961" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=18925303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A280%3ADC%252BD1cnms1Wqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=811-816&author=N.+Assyauthor=G.+Nasserauthor=I.+Kamayseauthor=W.+Nseirauthor=Z.+Beniashviliauthor=A.+Djibreauthor=M.+Grosovski&title=Soft+drink+consumption+linked+with+fatty+liver+in+the+absence+of+traditional+risk+factors&doi=10.1155%2F2008%2F810961"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Soft drink consumption linked with fatty liver in the absence of traditional risk factors</span></div><div class="casAuthors">Assy Nimer; Nasser Gattas; Kamayse Iad; Nseir William; Beniashvili Zaza; Djibre Agness; Grosovski Maria</div><div class="citationInfo"><span class="NLM_cas:title">Canadian journal of gastroenterology = Journal canadien de gastroenterologie</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">811-6</span>
        ISSN:<span class="NLM_cas:issn">0835-7900</span>.
    </div><div class="casAbstract">BACKGROUND:  Little is known about dietary habits and their relationships with liver disease in nonalcoholic fatty liver disease (NAFLD) patients, particularly in the absence of obesity, diabetes or hyperlipidemia.  OBJECTIVE:  To assess the association between soft drink consumption and the presence of fatty liver in NAFLD patients who do not have classic risk factors.  METHODS:  Three hundred ten patients with NAFLD diagnosed by ultrasound were assessed for 36 months in a cross-sectional manner.  Thirty-one patients (10%) who had NAFLD without classic risk factors were compared with 30 healthy controls.  Physical activity was assessed during the preceding week and year, and every six months for 36 months.  Data on daily dietary intake of food and soft drink, and the source of added sugar were collected during two seven-day periods, at the beginning of the study, and within two weeks after the metabolic tests by using a validated food questionnaire given by a trained dietician.  Insulin resistance and lipid peroxidation were assessed by homeostasis model assessment-insulin resistance index (HOMA-IRI) and malondialdehyde (MDA) levels, respectively.  RESULTS:  Eighty per cent of patients (25 of 31) consumed an excessive amount of soft drink beverages (more than 50 g/day of added sugar) for 36 months, compared with 20% in healthy controls (P<0.001).  Twenty per cent of patients consumed one drink per day, 40% consumed two to three drinks per day, and 40% consumed more than four drinks per day for most days during 36 months.  The most common soft drinks consumed were regular Coca-Cola (40% of patients), Diet Coke (40%) and flavoured fruit juices (20%).  Ultrasound findings revealed mild fatty liver in 44% of cases (n=14), moderate fatty liver in 38% (n=12), and severe fatty liver in 18% (n=5).  HOMA-IRI and MDA levels were significantly higher in patients with NAFLD than in healthy controls (HOMA-IRI, 3.7 versus 1.7, P<0.001; and MDA, 420+/-300 micromol/mL versus 200+/-100 micromol/mL; P<0.001).  When controlled for other factors, including dietary composition and physical activity, soft drink beverage consumption was the only independent variable that was able to predict the presence of fatty liver in 82.5% of cases with a sensitivity of 100%, a specificity of 76%, a positive predictive value of 57% and a negative predictive value of 100%.  CONCLUSION:  The present study may add important insight into the role of sugar-sweetened beverage consumption as a cause of fatty liver in patients without risk factors.  Patients are encouraged to change their long-standing drinking behaviour.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRRjkNsMhLchnp3bfzSLaX5fW6udTcc2ebId3bBzyBbMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cnms1Wqsw%253D%253D&md5=64201069a40bf629800a1c96179fb12c</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1155%2F2008%2F810961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2008%252F810961%26sid%3Dliteratum%253Aachs%26aulast%3DAssy%26aufirst%3DN.%26aulast%3DNasser%26aufirst%3DG.%26aulast%3DKamayse%26aufirst%3DI.%26aulast%3DNseir%26aufirst%3DW.%26aulast%3DBeniashvili%26aufirst%3DZ.%26aulast%3DDjibre%26aufirst%3DA.%26aulast%3DGrosovski%26aufirst%3DM.%26atitle%3DSoft%2520drink%2520consumption%2520linked%2520with%2520fatty%2520liver%2520in%2520the%2520absence%2520of%2520traditional%2520risk%2520factors%26jtitle%3DCan.%2520J.%2520Gastroenterol.%26date%3D2008%26volume%3D22%26spage%3D811%26epage%3D816%26doi%3D10.1155%2F2008%2F810961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Ishimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanaspa, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivard, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncal-Jimenez, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlicky, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicerchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahan, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdelmalek, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackman, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLean, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diggle, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asipu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inaba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosugi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Lozada, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sautin, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonthron, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. J.</span><span> </span><span class="NLM_article-title">High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1632</span><span class="NLM_x">–</span> <span class="NLM_lpage">1643</span><span class="refDoi"> DOI: 10.1002/hep.26594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1002%2Fhep.26594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=23813872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWqsLvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2013&pages=1632-1643&author=T.+Ishimotoauthor=M.+A.+Lanaspaauthor=C.+J.+Rivardauthor=C.+A.+Roncal-Jimenezauthor=D.+J.+Orlickyauthor=C.+Cicerchiauthor=R.+H.+McMahanauthor=M.+F.+Abdelmalekauthor=H.+R.+Rosenauthor=M.+R.+Jackmanauthor=P.+S.+MacLeanauthor=C.+P.+Diggleauthor=A.+Asipuauthor=S.+Inabaauthor=T.+Kosugiauthor=W.+Satoauthor=S.+Maruyamaauthor=L.+G.+Sanchez-Lozadaauthor=Y.+Y.+Sautinauthor=J.+O.+Hillauthor=D.+T.+Bonthronauthor=R.+J.+Johnson&title=High-fat+and+high-sucrose+%28western%29+diet+induces+steatohepatitis+that+is+dependent+on+fructokinase&doi=10.1002%2Fhep.26594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase</span></div><div class="casAuthors">Ishimoto, Takuji; Lanaspa, Miguel A.; Rivard, Christopher J.; Roncal-Jimenez, Carlos A.; Orlicky, David J.; Cicerchi, Christina; McMahan, Rachel H.; Abdelmalek, Manal F.; Rosen, Hugo R.; Jackman, Matthew R.; MacLean, Paul S.; Diggle, Christine P.; Asipu, Aruna; Inaba, Shinichiro; Kosugi, Tomoki; Sato, Waichi; Maruyama, Shoichi; Sanchez-Lozada, Laura G.; Sautin, Yuri Y.; Hill, James O.; Bonthron, David T.; Johnson, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1632-1643</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Fructose intake from added sugars has been implicated as a cause of nonalcoholic fatty liver disease.  Here we tested the hypothesis that fructose may interact with a high-fat diet to induce fatty liver, and to det. if this was dependent on a key enzyme in fructose metab., fructokinase.  Wild-type or fructokinase knockout mice were fed a low-fat (11%), high-fat (36%), or high-fat (36%) and high-sucrose (30%) diet for 15 wk.  Both wild-type and fructokinase knockout mice developed obesity with mild hepatic steatosis and no evidence of hepatic inflammation on a high-fat diet compared to a low-fat diet.  In contrast, wild-type mice fed a high-fat and high-sucrose diet developed more severe hepatic steatosis with low-grade inflammation and fibrosis, as noted by increased CD68, tumor necrosis factor alpha, monocyte chemoattractant protein-1, alpha-smooth muscle actin, and collagen I and TIMP1 expression.  These changes were prevented in the fructokinase knockout mice.  Conclusion: An additive effect of high-fat and high-sucrose diet on the development of hepatic steatosis exists.  Further, the combination of sucrose with high-fat diet may induce steatohepatitis.  The protection in fructokinase knockout mice suggests a key role for fructose (from sucrose) in this development of steatohepatitis.  These studies emphasize the important role of fructose in the development of fatty liver and nonalcoholic steatohepatitis. (Hepatol. 2013;58:1632-1643).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4FrhsSKjOl7Vg90H21EOLACvtfcHk0lipApISNY9IGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWqsLvE&md5=d4544aba25dd28f735c4e0b76e02cc48</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fhep.26594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.26594%26sid%3Dliteratum%253Aachs%26aulast%3DIshimoto%26aufirst%3DT.%26aulast%3DLanaspa%26aufirst%3DM.%2BA.%26aulast%3DRivard%26aufirst%3DC.%2BJ.%26aulast%3DRoncal-Jimenez%26aufirst%3DC.%2BA.%26aulast%3DOrlicky%26aufirst%3DD.%2BJ.%26aulast%3DCicerchi%26aufirst%3DC.%26aulast%3DMcMahan%26aufirst%3DR.%2BH.%26aulast%3DAbdelmalek%26aufirst%3DM.%2BF.%26aulast%3DRosen%26aufirst%3DH.%2BR.%26aulast%3DJackman%26aufirst%3DM.%2BR.%26aulast%3DMacLean%26aufirst%3DP.%2BS.%26aulast%3DDiggle%26aufirst%3DC.%2BP.%26aulast%3DAsipu%26aufirst%3DA.%26aulast%3DInaba%26aufirst%3DS.%26aulast%3DKosugi%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DW.%26aulast%3DMaruyama%26aufirst%3DS.%26aulast%3DSanchez-Lozada%26aufirst%3DL.%2BG.%26aulast%3DSautin%26aufirst%3DY.%2BY.%26aulast%3DHill%26aufirst%3DJ.%2BO.%26aulast%3DBonthron%26aufirst%3DD.%2BT.%26aulast%3DJohnson%26aufirst%3DR.%2BJ.%26atitle%3DHigh-fat%2520and%2520high-sucrose%2520%2528western%2529%2520diet%2520induces%2520steatohepatitis%2520that%2520is%2520dependent%2520on%2520fructokinase%26jtitle%3DHepatology%26date%3D2013%26volume%3D58%26spage%3D1632%26epage%3D1643%26doi%3D10.1002%2Fhep.26594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Lanaspa, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicerchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlicky, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzycki, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inaba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncal-Jimenez, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diggle, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asipu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrash, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosugi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Lozada, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McManaman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonthron, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sautin, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. J.</span><span> </span><span class="NLM_article-title">Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2434</span><span class="refDoi"> DOI: 10.1038/ncomms3434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1038%2Fncomms3434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=24022321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A280%3ADC%252BC3sbntValtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=2434&author=M.+A.+Lanaspaauthor=T.+Ishimotoauthor=N.+Liauthor=C.+Cicerchiauthor=D.+J.+Orlickyauthor=P.+Ruzyckiauthor=C.+Rivardauthor=S.+Inabaauthor=C.+A.+Roncal-Jimenezauthor=E.+S.+Balesauthor=C.+P.+Diggleauthor=A.+Asipuauthor=J.+M.+Petrashauthor=T.+Kosugiauthor=S.+Maruyamaauthor=L.+G.+Sanchez-Lozadaauthor=J.+L.+McManamanauthor=D.+T.+Bonthronauthor=Y.+Y.+Sautinauthor=R.+J.+Johnson&title=Endogenous+fructose+production+and+metabolism+in+the+liver+contributes+to+the+development+of+metabolic+syndrome&doi=10.1038%2Fncomms3434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome</span></div><div class="casAuthors">Lanaspa Miguel A; Ishimoto Takuji; Li Nanxing; Cicerchi Christina; Orlicky David J; Ruzycki Philip; Ruzicky Philip; Rivard Christopher; Inaba Shinichiro; Roncal-Jimenez Carlos A; Bales Elise S; Diggle Christine P; Asipu Aruna; Petrash J Mark; Kosugi Tomoki; Maruyama Shoichi; Sanchez-Lozada Laura G; McManaman James L; Bonthron David T; Sautin Yuri Y; Johnson Richard J</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2434</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Carbohydrates with high glycaemic index are proposed to promote the development of obesity, insulin resistance and fatty liver, but the mechanism by which this occurs remains unknown.  High serum glucose concentrations are known to induce the polyol pathway and increase fructose generation in the liver.  Here we show that this hepatic, endogenously produced fructose causes systemic metabolic changes.  We demonstrate that mice unable to metabolize fructose are protected from an increase in energy intake and body weight, visceral obesity, fatty liver, elevated insulin levels and hyperleptinaemia after exposure to 10% glucose for 14 weeks.  In normal mice, glucose consumption is accompanied by aldose reductase and polyol pathway activation in steatotic areas.  In this regard, we show that aldose reductase-deficient mice are protected against glucose-induced fatty liver.  We conclude that endogenous fructose generation and metabolism in the liver represents an important mechanism by which glucose promotes the development of metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSyyD60uMeGg_69nzq6467DfW6udTcc2ebvpCk0oqSVZLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbntValtA%253D%253D&md5=dabbcf5d4c20a391b47ceafe21cd6413</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fncomms3434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms3434%26sid%3Dliteratum%253Aachs%26aulast%3DLanaspa%26aufirst%3DM.%2BA.%26aulast%3DIshimoto%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DCicerchi%26aufirst%3DC.%26aulast%3DOrlicky%26aufirst%3DD.%2BJ.%26aulast%3DRuzycki%26aufirst%3DP.%26aulast%3DRivard%26aufirst%3DC.%26aulast%3DInaba%26aufirst%3DS.%26aulast%3DRoncal-Jimenez%26aufirst%3DC.%2BA.%26aulast%3DBales%26aufirst%3DE.%2BS.%26aulast%3DDiggle%26aufirst%3DC.%2BP.%26aulast%3DAsipu%26aufirst%3DA.%26aulast%3DPetrash%26aufirst%3DJ.%2BM.%26aulast%3DKosugi%26aufirst%3DT.%26aulast%3DMaruyama%26aufirst%3DS.%26aulast%3DSanchez-Lozada%26aufirst%3DL.%2BG.%26aulast%3DMcManaman%26aufirst%3DJ.%2BL.%26aulast%3DBonthron%26aufirst%3DD.%2BT.%26aulast%3DSautin%26aufirst%3DY.%2BY.%26aulast%3DJohnson%26aufirst%3DR.%2BJ.%26atitle%3DEndogenous%2520fructose%2520production%2520and%2520metabolism%2520in%2520the%2520liver%2520contributes%2520to%2520the%2520development%2520of%2520metabolic%2520syndrome%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D2434%26doi%3D10.1038%2Fncomms3434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Sachs, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sternfeld, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, G.</span><span> </span><span class="NLM_article-title">Essential fructosuria: Its pathophysiology</span> <span class="citation_source-journal">AMA Am. J. Dis. Child.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1942</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span><span class="refDoi"> DOI: 10.1001/archpedi.1942.02010020037004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1001%2Farchpedi.1942.02010020037004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADyaH38XitlSktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1942&pages=252-269&author=B.+Sachsauthor=L.+Sternfeldauthor=G.+Kraus&title=Essential+fructosuria%3A+Its+pathophysiology&doi=10.1001%2Farchpedi.1942.02010020037004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Essential fructosuria. Its pathophysiology</span></div><div class="casAuthors">Sachs, Benjamin; Sternfeld, Leon; Kraus, George</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Diseases of Children</span>
        (<span class="NLM_cas:date">1942</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">252-69</span>CODEN:
                <span class="NLM_cas:coden">AJDCAI</span>;
        ISSN:<span class="NLM_cas:issn">0002-922X</span>.
    </div><div class="casAbstract">Tests of kidney and liver function were normal in the 2 cases of essential fructosuria studied.  After ingestion of fructose there was little rise in the lactic acid content of the blood of the patients while that of normal individuals rose appreciably.  The mechanism for fructosuria appears to lie in the failure of part of the ingested fructose to be broken down to lactic acid.  A tabular review of 55 cases reported in the literature is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIP5k-IUS0N7Vg90H21EOLACvtfcHk0lipApISNY9IGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaH38XitlSktg%253D%253D&md5=3178112bf02c60846edee1ba6a27c201</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1001%2Farchpedi.1942.02010020037004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpedi.1942.02010020037004%26sid%3Dliteratum%253Aachs%26aulast%3DSachs%26aufirst%3DB.%26aulast%3DSternfeld%26aufirst%3DL.%26aulast%3DKraus%26aufirst%3DG.%26atitle%3DEssential%2520fructosuria%253A%2520Its%2520pathophysiology%26jtitle%3DAMA%2520Am.%2520J.%2520Dis.%2520Child.%26date%3D1942%26volume%3D63%26spage%3D252%26epage%3D269%26doi%3D10.1001%2Farchpedi.1942.02010020037004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Bais, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rofe, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conyers, R. A.</span><span> </span><span class="NLM_article-title">The purification and properties of human liver ketohexokinase. A role for ketohexokinase and fructose-bisphosphate aldolase in the metabolic production of oxalate from xylitol</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">230</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span><span class="refDoi"> DOI: 10.1042/bj2300053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1042%2Fbj2300053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=230&publication_year=1985&pages=53-60&author=R.+Baisauthor=H.+M.+Jamesauthor=A.+M.+Rofeauthor=R.+A.+Conyers&title=The+purification+and+properties+of+human+liver+ketohexokinase.+A+role+for+ketohexokinase+and+fructose-bisphosphate+aldolase+in+the+metabolic+production+of+oxalate+from+xylitol&doi=10.1042%2Fbj2300053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1042%2Fbj2300053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2300053%26sid%3Dliteratum%253Aachs%26aulast%3DBais%26aufirst%3DR.%26aulast%3DJames%26aufirst%3DH.%2BM.%26aulast%3DRofe%26aufirst%3DA.%2BM.%26aulast%3DConyers%26aufirst%3DR.%2BA.%26atitle%3DThe%2520purification%2520and%2520properties%2520of%2520human%2520liver%2520ketohexokinase.%2520A%2520role%2520for%2520ketohexokinase%2520and%2520fructose-bisphosphate%2520aldolase%2520in%2520the%2520metabolic%2520production%2520of%2520oxalate%2520from%2520xylitol%26jtitle%3DBiochem.%2520J.%26date%3D1985%26volume%3D230%26spage%3D53%26epage%3D60%26doi%3D10.1042%2Fbj2300053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Trinh, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asipu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonthron, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, S. E. V.</span><span> </span><span class="NLM_article-title">Structures of alternatively spliced isoforms of human ketohexokinase</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span><span class="refDoi"> DOI: 10.1107/S0907444908041115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1107%2FS0907444908041115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=19237742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Chs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=201-211&author=C.+H.+Trinhauthor=A.+Asipuauthor=D.+T.+Bonthronauthor=S.+E.+V.+Phillips&title=Structures+of+alternatively+spliced+isoforms+of+human+ketohexokinase&doi=10.1107%2FS0907444908041115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of alternatively spliced isoforms of human ketohexokinase</span></div><div class="casAuthors">Trinh, Chi H.; Asipu, Aruna; Bonthron, David T.; Phillips, Simon E. V.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">201-211, S201/1</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A mol. understanding of the unique aspects of dietary fructose metab. may be the key to understanding and controlling the current epidemic of fructose-related obesity, diabetes and related adverse metabolic states in Western populations.  Fructose catabolism is initiated by its phosphorylation to fructose 1-phosphate, which is performed by ketohexokinase (KHK).  Here, the crystal structures of the two alternatively spliced isoforms of human ketohexokinase, hepatic KHK-C and the peripheral isoform KHK-A, and of the ternary complex of KHK-A with the substrate fructose and AMP-PNP are reported.  The structure of the KHK-A ternary complex revealed an active site with both the substrate fructose and the ATP analog in positions ready for phosphorylation following a reaction mechanism similar to that of the pfkB family of carbohydrate kinases.  Hepatic KHK deficiency causes the benign disorder essential fructosuria.  The effects of the disease-causing mutations (Gly40Arg and Ala43Thr) have been modeled in the context of the KHK structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLVyR1D5ZQrbVg90H21EOLACvtfcHk0lhPE0TIxJ_X7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Chs7o%253D&md5=0a54cabf6e404115beb59b7e0feed670</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1107%2FS0907444908041115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444908041115%26sid%3Dliteratum%253Aachs%26aulast%3DTrinh%26aufirst%3DC.%2BH.%26aulast%3DAsipu%26aufirst%3DA.%26aulast%3DBonthron%26aufirst%3DD.%2BT.%26aulast%3DPhillips%26aufirst%3DS.%2BE.%2BV.%26atitle%3DStructures%2520of%2520alternatively%2520spliced%2520isoforms%2520of%2520human%2520ketohexokinase%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2009%26volume%3D65%26spage%3D201%26epage%3D211%26doi%3D10.1107%2FS0907444908041115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Maryanoff, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McComsey, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabut, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luci, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masucci, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abad, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrounia, I.</span><span> </span><span class="NLM_article-title">Inhibitors of ketohexokinase: discovery of pyrimidinopyrimidines with specific substitution that complements the ATP-binding site</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">–</span> <span class="NLM_lpage">543</span><span class="refDoi"> DOI: 10.1021/ml200070g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200070g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltlGhsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=538-543&author=B.+E.+Maryanoffauthor=J.+C.+O%E2%80%99Neillauthor=D.+F.+McComseyauthor=S.+C.+Yabutauthor=D.+K.+Luciauthor=A.+D.+Jordanauthor=J.+A.+Masucciauthor=W.+J.+Jonesauthor=M.+C.+Abadauthor=A.+C.+Gibbsauthor=I.+Petrounia&title=Inhibitors+of+ketohexokinase%3A+discovery+of+pyrimidinopyrimidines+with+specific+substitution+that+complements+the+ATP-binding+site&doi=10.1021%2Fml200070g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Ketohexokinase: Discovery of Pyrimidinopyrimidines with Specific Substitution that Complements the ATP-Binding Site</span></div><div class="casAuthors">Maryanoff, Bruce E.; O'Neill, John C.; McComsey, David F.; Yabut, Stephen C.; Luci, Diane K.; Jordan, Alfonzo D.; Masucci, John A.; Jones, William J.; Abad, Marta C.; Gibbs, Alan C.; Petrounia, Ioanna</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">538-543</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Attenuation of fructose metab. by the inhibition of ketohexokinase (KHK; fructokinase) should reduce body wt., free fatty acids, and triglycerides, thereby offering a novel approach to treat diabetes and obesity in response to modern diets.  We have identified potent, selective inhibitors of human hepatic KHK within a series of pyrimidinopyrimidines (1).  For example, 8, 38, and 47 exhibited KHK IC50 values of 12, 7, and 8 nM, resp., and also showed potent cellular KHK inhibition (IC50 < 500 nM), which relates to their intrinsic potency vs KHK and their ability to penetrate cells.  X-ray cocrystal structures of KHK complexes of 3, 8, and 47 revealed the important interactions within the enzyme's ATP-binding pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoenT0KLTIMX7Vg90H21EOLACvtfcHk0lh4yzGYPE0Lgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltlGhsr8%253D&md5=8ed0465ad9571e67ac226935994fa5fb</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1021%2Fml200070g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200070g%26sid%3Dliteratum%253Aachs%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%2BC.%26aulast%3DMcComsey%26aufirst%3DD.%2BF.%26aulast%3DYabut%26aufirst%3DS.%2BC.%26aulast%3DLuci%26aufirst%3DD.%2BK.%26aulast%3DJordan%26aufirst%3DA.%2BD.%26aulast%3DMasucci%26aufirst%3DJ.%2BA.%26aulast%3DJones%26aufirst%3DW.%2BJ.%26aulast%3DAbad%26aufirst%3DM.%2BC.%26aulast%3DGibbs%26aufirst%3DA.%2BC.%26aulast%3DPetrounia%26aufirst%3DI.%26atitle%3DInhibitors%2520of%2520ketohexokinase%253A%2520discovery%2520of%2520pyrimidinopyrimidines%2520with%2520specific%2520substitution%2520that%2520complements%2520the%2520ATP-binding%2520site%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D538%26epage%3D543%26doi%3D10.1021%2Fml200070g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Maryanoff, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McComsey, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabut, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luci, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connelly, M. A.</span><span> </span><span class="NLM_article-title">Pyrimidinopyrimidine inhibitors of ketohexokinase: Exploring the ring C2 group that interacts with Asp-27B in the ligand binding pocket</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5326</span><span class="NLM_x">–</span> <span class="NLM_lpage">5329</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1016%2Fj.bmcl.2012.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=22795331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVCjtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5326-5329&author=B.+E.+Maryanoffauthor=J.+C.+O%E2%80%99Neillauthor=D.+F.+McComseyauthor=S.+C.+Yabutauthor=D.+K.+Luciauthor=A.+C.+Gibbsauthor=M.+A.+Connelly&title=Pyrimidinopyrimidine+inhibitors+of+ketohexokinase%3A+Exploring+the+ring+C2+group+that+interacts+with+Asp-27B+in+the+ligand+binding+pocket&doi=10.1016%2Fj.bmcl.2012.06.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14cR"><div class="casContent"><span class="casTitleNuber">14c</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrimidinopyrimidine inhibitors of ketohexokinase: Exploring the ring C2 group that interacts with Asp-27B in the ligand binding pocket</span></div><div class="casAuthors">Maryanoff, Bruce E.; O'Neill, John C.; McComsey, David F.; Yabut, Stephen C.; Luci, Diane K.; Gibbs, Alan C.; Connelly, Margery A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5326-5329</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inhibitors of ketohexokinase (KHK) have potential for the treatment of diabetes and obesity.  We have continued studies on a pyrimidinopyrimidine series of potent KHK inhibitors by exploring the 2-position substituent (R3) that interacts with Asp-27B in the ATP-binding region of KHK (viz. 1, 2; Table 1).  We found that increased spacing between the terminal ammonium group and the heterocyclic scaffold (viz. 16-20), such that interaction with Asp-27B is not possible, still results in potent KHK inhibition (IC50 = 15-50 nM).  We propose a new interaction with Asp-194, which serves to expand the pyrimidinopyrimidine pharmacophore.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGradcYZ9M9bdLVg90H21EOLACvtfcHk0lh4yzGYPE0Lgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVCjtLzK&md5=0da67e40de493f46030c88682482270e</span></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%2BC.%26aulast%3DMcComsey%26aufirst%3DD.%2BF.%26aulast%3DYabut%26aufirst%3DS.%2BC.%26aulast%3DLuci%26aufirst%3DD.%2BK.%26aulast%3DGibbs%26aufirst%3DA.%2BC.%26aulast%3DConnelly%26aufirst%3DM.%2BA.%26atitle%3DPyrimidinopyrimidine%2520inhibitors%2520of%2520ketohexokinase%253A%2520Exploring%2520the%2520ring%2520C2%2520group%2520that%2520interacts%2520with%2520Asp-27B%2520in%2520the%2520ligand%2520binding%2520pocket%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5326%26epage%3D5329%26doi%3D10.1016%2Fj.bmcl.2012.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Gibbs, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abad, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tounge, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewandowski, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Struble, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sui, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L. C.</span><span> </span><span class="NLM_article-title">Electron density guided fragment-based lead discovery of ketohexokinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7979</span><span class="NLM_x">–</span> <span class="NLM_lpage">7991</span><span class="refDoi"> DOI: 10.1021/jm100677s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100677s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGntr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7979-7991&author=A.+C.+Gibbsauthor=M.+C.+Abadauthor=X.+Zhangauthor=B.+A.+Toungeauthor=F.+A.+Lewandowskiauthor=G.+T.+Strubleauthor=W.+Sunauthor=Z.+Suiauthor=L.+C.+Kuo&title=Electron+density+guided+fragment-based+lead+discovery+of+ketohexokinase+inhibitors&doi=10.1021%2Fjm100677s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14dR"><div class="casContent"><span class="casTitleNuber">14d</span><div class="casTitle"><span class="NLM_cas:atitle">Electron Density Guided Fragment-Based Lead Discovery of Ketohexokinase Inhibitors</span></div><div class="casAuthors">Gibbs, Alan C.; Abad, Marta C.; Zhang, Xuqing; Tounge, Brett A.; Lewandowski, Francis A.; Struble, Geoffrey T.; Sun, Weimei; Sui, Zhihua; Kuo, Lawrence C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7979-7991</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A fragment-based drug design paradigm has been successfully applied in the discovery of lead series of ketohexokinase inhibitors.  The paradigm consists of three iterations of design, synthesis, and x-ray crystallog. screening to progress low mol. wt. fragments to leadlike compds.  Applying electron d. of fragments within the protein binding site as defined by x-ray crystallog., one can generate target specific leads without the use of affinity data.  Our approach contrasts with most fragment-based drug design methodol. where soln. activity is a main design guide.  Herein we describe the discovery of submicromolar ketohexokinase inhibitors with promising druglike properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOp4ro7Ui4WrVg90H21EOLACvtfcHk0lh4yzGYPE0Lgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGntr%252FF&md5=3abdf4ac63d4afcf6a4db484d0d87259</span></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=10.1021%2Fjm100677s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100677s%26sid%3Dliteratum%253Aachs%26aulast%3DGibbs%26aufirst%3DA.%2BC.%26aulast%3DAbad%26aufirst%3DM.%2BC.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DTounge%26aufirst%3DB.%2BA.%26aulast%3DLewandowski%26aufirst%3DF.%2BA.%26aulast%3DStruble%26aufirst%3DG.%2BT.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DSui%26aufirst%3DZ.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26atitle%3DElectron%2520density%2520guided%2520fragment-based%2520lead%2520discovery%2520of%2520ketohexokinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7979%26epage%3D7991%26doi%3D10.1021%2Fjm100677s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Abad, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span> </span><span class="NLM_article-title">Electron density guided fragment-based drug design-a lead generation example</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">493</span><span class="NLM_x">, </span> <span class="NLM_fpage">487</span><span class="NLM_x">–</span> <span class="NLM_lpage">508</span><span class="refDoi"> DOI: 10.1016/B978-0-12-381274-2.00019-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1016%2FB978-0-12-381274-2.00019-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=493&publication_year=2011&pages=487-508&author=M.+C.+Abadauthor=A.+C.+Gibbsauthor=X.+Zhang&title=Electron+density+guided+fragment-based+drug+design-a+lead+generation+example&doi=10.1016%2FB978-0-12-381274-2.00019-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14e&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-381274-2.00019-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-381274-2.00019-4%26sid%3Dliteratum%253Aachs%26aulast%3DAbad%26aufirst%3DM.%2BC.%26aulast%3DGibbs%26aufirst%3DA.%2BC.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DElectron%2520density%2520guided%2520fragment-based%2520drug%2520design-a%2520lead%2520generation%2520example%26jtitle%3DMethods%2520Enzymol.%26date%3D2011%26volume%3D493%26spage%3D487%26epage%3D508%26doi%3D10.1016%2FB978-0-12-381274-2.00019-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, G.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abad, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sui, Z.</span><span> </span><span class="NLM_article-title">Optimization of a pyrazole hit from FBDD into a novel series of indazoles as ketohexokinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4762</span><span class="NLM_x">–</span> <span class="NLM_lpage">4767</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.06.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1016%2Fj.bmcl.2011.06.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=21767952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC3MXps1Snu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4762-4767&author=X.+Zhangauthor=F.+Songauthor=G.-H.+Kuoauthor=A.+Xiangauthor=A.+C.+Gibbsauthor=M.+C.+Abadauthor=W.+Sunauthor=L.+C.+Kuoauthor=Z.+Sui&title=Optimization+of+a+pyrazole+hit+from+FBDD+into+a+novel+series+of+indazoles+as+ketohexokinase+inhibitors&doi=10.1016%2Fj.bmcl.2011.06.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14fR"><div class="casContent"><span class="casTitleNuber">14f</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of a pyrazole hit from FBDD into a novel series of indazoles as ketohexokinase inhibitors</span></div><div class="casAuthors">Zhang, Xuqing; Song, Fengbing; Kuo, Gee-Hong; Xiang, Amy; Gibbs, Alan C.; Abad, Marta C.; Sun, Weimei; Kuo, Lawrence C.; Sui, Zhihua</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4762-4767</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of indazoles, e.g. I-III, have been discovered as KHK inhibitors from a pyrazole hit identified through fragment-based drug discovery (FBDD).  The optimization process guided by both X-ray crystallog. and soln. activity resulted in lead-like compds. with good pharmaceutical properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzfA7mcimTDLVg90H21EOLACvtfcHk0lgedca8KRWLLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXps1Snu74%253D&md5=80b3561f1d3ef419c2ec3a4d7dc3154d</span></div><a href="/servlet/linkout?suffix=cit14f&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.06.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.06.067%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DSong%26aufirst%3DF.%26aulast%3DKuo%26aufirst%3DG.-H.%26aulast%3DXiang%26aufirst%3DA.%26aulast%3DGibbs%26aufirst%3DA.%2BC.%26aulast%3DAbad%26aufirst%3DM.%2BC.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DSui%26aufirst%3DZ.%26atitle%3DOptimization%2520of%2520a%2520pyrazole%2520hit%2520from%2520FBDD%2520into%2520a%2520novel%2520series%2520of%2520indazoles%2520as%2520ketohexokinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4762%26epage%3D4767%26doi%3D10.1016%2Fj.bmcl.2011.06.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lanter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sui, Z.</span><span> </span><span class="NLM_article-title">Medicinal chemistry inspired fragment-based drug discovery</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">493</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span><span class="refDoi"> DOI: 10.1016/B978-0-12-381274-2.00016-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1016%2FB978-0-12-381274-2.00016-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=493&publication_year=2011&pages=421-445&author=J.+Lanterauthor=X.+Zhangauthor=Z.+Sui&title=Medicinal+chemistry+inspired+fragment-based+drug+discovery&doi=10.1016%2FB978-0-12-381274-2.00016-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-381274-2.00016-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-381274-2.00016-9%26sid%3Dliteratum%253Aachs%26aulast%3DLanter%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DSui%26aufirst%3DZ.%26atitle%3DMedicinal%2520chemistry%2520inspired%2520fragment-based%2520drug%2520discovery%26jtitle%3DMethods%2520Enzymol.%26date%3D2011%26volume%3D493%26spage%3D421%26epage%3D445%26doi%3D10.1016%2FB978-0-12-381274-2.00016-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Johnson, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlanson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, D. C.</span><span> </span><span class="NLM_article-title">Fragment-to-Lead Medicinal Chemistry Publications in 2015</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01123</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01123" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1KlsbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=89-99&author=C.+N.+Johnsonauthor=D.+A.+Erlansonauthor=C.+W.+Murrayauthor=D.+C.+Rees&title=Fragment-to-Lead+Medicinal+Chemistry+Publications+in+2015&doi=10.1021%2Facs.jmedchem.6b01123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-to-Lead Medicinal Chemistry Publications in 2015</span></div><div class="casAuthors">Johnson, Christopher N.; Erlanson, Daniel A.; Murray, Christopher W.; Rees, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-99</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Fragment-based drug discovery (FBDD) is now well-established as a technol. for generating new chem. leads and drugs.  This Miniperspective provides a tabulated overview of the fragment-to-lead literature published in the year 2015, together with a commentary on trends obsd. across the FBDD field during this time.  It is hoped that this tabulated summary will provide a useful point of ref. for both FBDD practitioners and the wider medicinal chem. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojX6ZlmVXQrLVg90H21EOLACvtfcHk0lgedca8KRWLLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1KlsbnP&md5=da9d027787d70d4276378cb01f8e0ce2</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01123%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DRees%26aufirst%3DD.%2BC.%26atitle%3DFragment-to-Lead%2520Medicinal%2520Chemistry%2520Publications%2520in%25202015%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D89%26epage%3D99%26doi%3D10.1021%2Facs.jmedchem.6b01123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Lau, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Withka, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hepworth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magee, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakken, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendsch, Z. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thanabal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolodziej, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narasimhan, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Hoorn, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. E.</span><span> </span><span class="NLM_article-title">Design of a multi-purpose fragment screening library using molecular complexity and orthogonal diversity metrics</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">636</span><span class="refDoi"> DOI: 10.1007/s10822-011-9434-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1007%2Fs10822-011-9434-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=621-636&author=W.+F.+Lauauthor=J.+M.+Withkaauthor=D.+Hepworthauthor=T.+V.+Mageeauthor=Y.+J.+Duauthor=G.+A.+Bakkenauthor=M.+D.+Millerauthor=Z.+S.+Hendschauthor=V.+Thanabalauthor=S.+A.+Kolodziejauthor=L.+Xingauthor=Q.+Huauthor=L.+S.+Narasimhanauthor=R.+Loveauthor=M.+E.+Charltonauthor=S.+Hughesauthor=W.+P.+van+Hoornauthor=J.+E.+Mills&title=Design+of+a+multi-purpose+fragment+screening+library+using+molecular+complexity+and+orthogonal+diversity+metrics&doi=10.1007%2Fs10822-011-9434-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs10822-011-9434-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-011-9434-0%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DW.%2BF.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DMagee%26aufirst%3DT.%2BV.%26aulast%3DDu%26aufirst%3DY.%2BJ.%26aulast%3DBakken%26aufirst%3DG.%2BA.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DHendsch%26aufirst%3DZ.%2BS.%26aulast%3DThanabal%26aufirst%3DV.%26aulast%3DKolodziej%26aufirst%3DS.%2BA.%26aulast%3DXing%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DNarasimhan%26aufirst%3DL.%2BS.%26aulast%3DLove%26aufirst%3DR.%26aulast%3DCharlton%26aufirst%3DM.%2BE.%26aulast%3DHughes%26aufirst%3DS.%26aulast%3Dvan%2BHoorn%26aufirst%3DW.%2BP.%26aulast%3DMills%26aufirst%3DJ.%2BE.%26atitle%3DDesign%2520of%2520a%2520multi-purpose%2520fragment%2520screening%2520library%2520using%2520molecular%2520complexity%2520and%2520orthogonal%2520diversity%2520metrics%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2011%26volume%3D25%26spage%3D621%26epage%3D636%26doi%3D10.1007%2Fs10822-011-9434-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Lee, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambler, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boscoe, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bree, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodfuehrer, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehnhardt, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dower, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drozda, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frisbie, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavrin, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hepworth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hope, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamtekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilty, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovering, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathias, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papaioannou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiah, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samardjiev, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samas, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, M. W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soutter, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strohbach, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symanowicz, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomason, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trzupek, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zapf, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S. W.</span><span> </span><span class="NLM_article-title">Discovery of clinical candidate 1-{[(2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a potent, selective inhibitor of interleukin-1 receptor associated kinase 4 (IRAK4), by fragment-based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">5521</span><span class="NLM_x">–</span> <span class="NLM_lpage">5542</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00231</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00231" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnslGqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5521-5542&author=K.+L.+Leeauthor=C.+M.+Amblerauthor=D.+R.+Andersonauthor=B.+P.+Boscoeauthor=A.+G.+Breeauthor=J.+I.+Brodfuehrerauthor=J.+S.+Changauthor=C.+Choiauthor=S.+Chungauthor=K.+J.+Curranauthor=J.+E.+Dayauthor=C.+M.+Dehnhardtauthor=K.+Dowerauthor=S.+E.+Drozdaauthor=R.+K.+Frisbieauthor=L.+K.+Gavrinauthor=J.+A.+Goldbergauthor=S.+Hanauthor=M.+Hegenauthor=D.+Hepworthauthor=H.+R.+Hopeauthor=S.+Kamtekarauthor=I.+C.+Kiltyauthor=A.+Leeauthor=L.-L.+Linauthor=F.+E.+Loveringauthor=M.+D.+Loweauthor=J.+P.+Mathiasauthor=H.+M.+Morganauthor=E.+A.+Murphyauthor=N.+Papaioannouauthor=A.+Patnyauthor=B.+S.+Pierceauthor=V.+R.+Raoauthor=E.+Saiahauthor=I.+J.+Samardjievauthor=B.+M.+Samasauthor=M.+W.+H.+Shenauthor=J.+H.+Shinauthor=H.+H.+Soutterauthor=J.+W.+Strohbachauthor=P.+T.+Symanowiczauthor=J.+R.+Thomasonauthor=J.+D.+Trzupekauthor=R.+Vargasauthor=F.+Vincentauthor=J.+Yanauthor=C.+W.+Zapfauthor=S.+W.+Wright&title=Discovery+of+clinical+candidate+1-%7B%5B%282S%2C3S%2C4S%29-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl%5Dmethoxy%7D-7-methoxyisoquinoline-6-carboxamide+%28PF-06650833%29%2C+a+potent%2C+selective+inhibitor+of+interleukin-1+receptor+associated+kinase+4+%28IRAK4%29%2C+by+fragment-based+drug+design&doi=10.1021%2Facs.jmedchem.7b00231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design</span></div><div class="casAuthors">Lee, Katherine L.; Ambler, Catherine M.; Anderson, David R.; Boscoe, Brian P.; Bree, Andrea G.; Brodfuehrer, Joanne I.; Chang, Jeanne S.; Choi, Chulho; Chung, Seungwon; Curran, Kevin J.; Day, Jacqueline E.; Dehnhardt, Christoph M.; Dower, Ken; Drozda, Susan E.; Frisbie, Richard K.; Gavrin, Lori K.; Goldberg, Joel A.; Han, Seungil; Hegen, Martin; Hepworth, David; Hope, Heidi R.; Kamtekar, Satwik; Kilty, Iain C.; Lee, Arthur; Lin, Lih-Ling; Lovering, Frank E.; Lowe, Michael D.; Mathias, John P.; Morgan, Heidi M.; Murphy, Elizabeth A.; Papaioannou, Nikolaos; Patny, Akshay; Pierce, Betsy S.; Rao, Vikram R.; Saiah, Eddine; Samardjiev, Ivan J.; Samas, Brian M.; Shen, Marina W. H.; Shin, Julia H.; Soutter, Holly H.; Strohbach, Joseph W.; Symanowicz, Peter T.; Thomason, Jennifer R.; Trzupek, John D.; Vargas, Richard; Vincent, Fabien; Yan, Jiangli; Zapf, Christoph W.; Wright, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5521-5542</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Through fragment-based drug design focused on engaging the active site of IRAK4 and leveraging three-dimensional topol. in a ligand-efficient manner, a micromolar hit identified from a screen of a Pfizer fragment library was optimized to afford IRAK4 inhibitors with nanomolar potency in cellular assays.  The medicinal chem. effort featured the judicious placement of lipophilicity, informed by cocrystal structures with IRAK4 and optimization of ADME properties to deliver clin. candidate I.  This compd. benefitted from a 5-unit increase in lipophilic efficiency from the fragment hit, excellent kinase selectivity, and pharmacokinetic properties suitable for oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrCep64bhMbVg90H21EOLACvtfcHk0linD_GepLpzcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnslGqu7c%253D&md5=9771ad2d33089f6ef3dba3556536ff1a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00231%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BL.%26aulast%3DAmbler%26aufirst%3DC.%2BM.%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DBoscoe%26aufirst%3DB.%2BP.%26aulast%3DBree%26aufirst%3DA.%2BG.%26aulast%3DBrodfuehrer%26aufirst%3DJ.%2BI.%26aulast%3DChang%26aufirst%3DJ.%2BS.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DChung%26aufirst%3DS.%26aulast%3DCurran%26aufirst%3DK.%2BJ.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DDower%26aufirst%3DK.%26aulast%3DDrozda%26aufirst%3DS.%2BE.%26aulast%3DFrisbie%26aufirst%3DR.%2BK.%26aulast%3DGavrin%26aufirst%3DL.%2BK.%26aulast%3DGoldberg%26aufirst%3DJ.%2BA.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DHope%26aufirst%3DH.%2BR.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DKilty%26aufirst%3DI.%2BC.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DL.-L.%26aulast%3DLovering%26aufirst%3DF.%2BE.%26aulast%3DLowe%26aufirst%3DM.%2BD.%26aulast%3DMathias%26aufirst%3DJ.%2BP.%26aulast%3DMorgan%26aufirst%3DH.%2BM.%26aulast%3DMurphy%26aufirst%3DE.%2BA.%26aulast%3DPapaioannou%26aufirst%3DN.%26aulast%3DPatny%26aufirst%3DA.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DRao%26aufirst%3DV.%2BR.%26aulast%3DSaiah%26aufirst%3DE.%26aulast%3DSamardjiev%26aufirst%3DI.%2BJ.%26aulast%3DSamas%26aufirst%3DB.%2BM.%26aulast%3DShen%26aufirst%3DM.%2BW.%2BH.%26aulast%3DShin%26aufirst%3DJ.%2BH.%26aulast%3DSoutter%26aufirst%3DH.%2BH.%26aulast%3DStrohbach%26aufirst%3DJ.%2BW.%26aulast%3DSymanowicz%26aufirst%3DP.%2BT.%26aulast%3DThomason%26aufirst%3DJ.%2BR.%26aulast%3DTrzupek%26aufirst%3DJ.%2BD.%26aulast%3DVargas%26aufirst%3DR.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DZapf%26aufirst%3DC.%2BW.%26aulast%3DWright%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%25201-%257B%255B%25282S%252C3S%252C4S%2529-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl%255Dmethoxy%257D-7-methoxyisoquinoline-6-carboxamide%2520%2528PF-06650833%2529%252C%2520a%2520potent%252C%2520selective%2520inhibitor%2520of%2520interleukin-1%2520receptor%2520associated%2520kinase%25204%2520%2528IRAK4%2529%252C%2520by%2520fragment-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5521%26epage%3D5542%26doi%3D10.1021%2Facs.jmedchem.7b00231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Mayer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, B.</span><span> </span><span class="NLM_article-title">Characterization of ligand binding by saturation transfer difference NMR spectroscopy</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1784</span><span class="NLM_x">–</span> <span class="NLM_lpage">1788</span><span class="refDoi"> DOI: 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADyaK1MXktVCntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=1784-1788&author=M.+Mayerauthor=B.+Meyer&title=Characterization+of+ligand+binding+by+saturation+transfer+difference+NMR+spectroscopy&doi=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of ligand binding by saturation transfer difference NMR spectroscopy</span></div><div class="casAuthors">Mayer, Moriz; Meyer, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1784-1788</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">The difference between a satn. transfer spectrum and a normal NMR spectrum provides a new and fast method (satn. transfer difference (STD) NMR spectroscopy) to screen compd. libraries for binding activity to proteins.  STD NMR spectroscopy of mixts. of potential ligands with as little as 1 nmol of protein yields 1D and 2D NMR spectra that exclusively show signals from mols. with binding affinity.  In addn., the ligand's binding epitope is easily identified because ligand residues in direct contact to the protein show much stronger STD signals.  For example, the binding specificity of Lewisb-hexasaccharide to Aleulria aurantia agglutinin (AAA) can be mapped to the two fucosyl residues.  The efficiency of the STD NMR technique is shown by the binding of N-acetylglucosamine (GlcNAc) to wheat germ agglutinin (WGA).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf8j8HiAqDArVg90H21EOLACvtfcHk0linD_GepLpzcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVCntb0%253D&md5=03f825af40d22911062112dc6074cf46</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819990614%252938%253A12%253C1784%253A%253AAID-ANIE1784%253E3.0.CO%253B2-Q%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DB.%26atitle%3DCharacterization%2520of%2520ligand%2520binding%2520by%2520saturation%2520transfer%2520difference%2520NMR%2520spectroscopy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1999%26volume%3D38%26spage%3D1784%26epage%3D1788%26doi%3D10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Reynolds, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tounge, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bembenek, S. D.</span><span> </span><span class="NLM_article-title">Ligand binding efficiency: trends, physical basis, and implications</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2432</span><span class="NLM_x">–</span> <span class="NLM_lpage">2438</span><span class="refDoi"> DOI: 10.1021/jm701255b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701255b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktFSgsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2432-2438&author=C.+H.+Reynoldsauthor=B.+A.+Toungeauthor=S.+D.+Bembenek&title=Ligand+binding+efficiency%3A+trends%2C+physical+basis%2C+and+implications&doi=10.1021%2Fjm701255b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand binding efficiency: trends, physical basis, and implications</span></div><div class="casAuthors">Reynolds, Charles H.; Tounge, Brett A.; Bembenek, Scott D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2432-2438</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ligand efficiency (i.e., potency/size) has emerged as an important metric in drug discovery.  In general, smaller, more efficient ligands are believed to have improved prospects for good drug properties (e.g., bioavailability).  Our anal. of thousands of ligands across a variety of targets shows that ligand efficiency is dependent on ligand size with smaller ligands having greater efficiencies, on av., than larger ligands.  We propose two primary causes for this size dependence: the inevitable redn. in the quality of fit between ligand and receptor as the ligand becomes larger and more complex and the redn. in accessible ligand surface area on a per atom basis as size increases.  These results have far-ranging implications for anal. of high-throughput screening hits, fragment-based approaches to drug discovery, and even computational models of potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkrPWFEZZEMrVg90H21EOLACvtfcHk0ljZSNGx1ZIFdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktFSgsbw%253D&md5=a9a41b44dbca7f34562c40b56c7ae683</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm701255b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701255b%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DTounge%26aufirst%3DB.%2BA.%26aulast%3DBembenek%26aufirst%3DS.%2BD.%26atitle%3DLigand%2520binding%2520efficiency%253A%2520trends%252C%2520physical%2520basis%252C%2520and%2520implications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2432%26epage%3D2438%26doi%3D10.1021%2Fjm701255b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">The prediction of human clearance from hepatic microsomal metabolism data</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=11727321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFOlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=36-44&author=R.+S.+Obach&title=The+prediction+of+human+clearance+from+hepatic+microsomal+metabolism+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human clearance from hepatic microsomal metabolism data</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-44</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">PharmaPress Ltd.</span>)
        </div><div class="casAbstract">A review with 42 refs.  Human liver microsomal intrinsic clearance has become a commonly measured parameter during drug discovery, and such data are used to design compds. predicted to possess optimal drug disposition characteristics.  Liver microsomal intrinsic clearance values can be scaled and used to predict hepatic clearance in humans.  Clearance, when combined with the vol. of distribution, dets. the half-life of a drug.  Hepatic clearance, when combined with absorption, dets. the oral bioavailability of a drug.  Half-life and oral bioavailability are key determinants of the dosing regimen, ie, size of dose and frequency of administration.  Thus, the accurate prediction of human clearance is important in the selection of new compds. for progression into development, as new drugs on the market must not only be efficacious and safe, but must also be convenient to use for patients and physicians.  Over the past decade, exploring methods whereby human clearance can be predicted from in vitro data has been an area of active research in drug metab. science.  Human liver microsomes have been a key tool in this research.  This in vitro system possesses many of the major drug metabolizing enzymes and is thus applicable to a wide variety of compds.  This review describes the theor. and practical aspects of predicting clearance from human liver microsomal intrinsic clearance data, a summary of advantages and shortcomings of this in vitro system, a synopsis of recent applications of human liver microsomal intrinsic clearance data in clearance predictions, and a discussion of potential future directions for this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsU3SBmySKm7Vg90H21EOLACvtfcHk0ljZSNGx1ZIFdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFOlsQ%253D%253D&md5=421bc7764c3d7f501b69aa97996d1db9</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DThe%2520prediction%2520of%2520human%2520clearance%2520from%2520hepatic%2520microsomal%2520metabolism%2520data%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2001%26volume%3D4%26spage%3D36%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Hay, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaumont, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, M.</span><span> </span><span class="NLM_article-title">Modulation of the partition coefficient between octanol and buffer at pH 7.4 and pKa to achieve the optimum balance of blood clearance and volume of distribution for a series of tetrahydropyran histamine type 3 receptor antagonists</span> <span class="citation_source-journal">Drug. Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1864</span><span class="NLM_x">–</span> <span class="NLM_lpage">1870</span><span class="refDoi"> DOI: 10.1124/dmd.109.027888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1124%2Fdmd.109.027888" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1864-1870&author=T.+Hayauthor=R.+Jonesauthor=K.+Beaumontauthor=M.+Kemp&title=Modulation+of+the+partition+coefficient+between+octanol+and+buffer+at+pH+7.4+and+pKa+to+achieve+the+optimum+balance+of+blood+clearance+and+volume+of+distribution+for+a+series+of+tetrahydropyran+histamine+type+3+receptor+antagonists&doi=10.1124%2Fdmd.109.027888"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.027888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.027888%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DT.%26aulast%3DJones%26aufirst%3DR.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DKemp%26aufirst%3DM.%26atitle%3DModulation%2520of%2520the%2520partition%2520coefficient%2520between%2520octanol%2520and%2520buffer%2520at%2520pH%25207.4%2520and%2520pKa%2520to%2520achieve%2520the%2520optimum%2520balance%2520of%2520blood%2520clearance%2520and%2520volume%2520of%2520distribution%2520for%2520a%2520series%2520of%2520tetrahydropyran%2520histamine%2520type%25203%2520receptor%2520antagonists%26jtitle%3DDrug.%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1864%26epage%3D1870%26doi%3D10.1124%2Fdmd.109.027888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitney-Pickett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gebhard, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federico, J. J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varma, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempshall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kattan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span> </span><span class="NLM_article-title">Development of a new permeability assay using low-efflux MDCKII cells</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">4974</span><span class="NLM_x">–</span> <span class="NLM_lpage">4985</span><span class="refDoi"> DOI: 10.1002/jps.22674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1002%2Fjps.22674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=21766308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4974-4985&author=L.+Diauthor=C.+Whitney-Pickettauthor=J.+P.+Umlandauthor=H.+Zhangauthor=X.+Zhangauthor=D.+F.+Gebhardauthor=Y.+Laiauthor=J.+J.+Federicoauthor=R.+E.+Davidsonauthor=R.+Smithauthor=E.+L.+Reynerauthor=C.+Leeauthor=B.+Fengauthor=C.+Rotterauthor=M.+V.+Varmaauthor=S.+Kempshallauthor=K.+Fennerauthor=A.+F.+El-Kattanauthor=T.+E.+Listonauthor=M.+D.+Troutman&title=Development+of+a+new+permeability+assay+using+low-efflux+MDCKII+cells&doi=10.1002%2Fjps.22674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new permeability assay using low-efflux MDCKII cells</span></div><div class="casAuthors">Di, Li; Whitney-Pickett, Carrie; Umland, John P.; Zhang, Hui; Zhang, Xun; Gebhard, David F.; Lai, Yurong; Federico, James J.; Davidson, Ralph E.; Smith, Russ; Reyner, Eric L.; Lee, Caroline; Feng, Bo; Rotter, Charles; Varma, Manthena V.; Kempshall, Sarah; Fenner, Katherine; El-kattan, Ayman F.; Liston, Theodore E.; Troutman, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4974-4985</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Permeability is an important property of drug candidates.  The Madin-Darby canine kidney cell line (MDCK) permeability assay is widely used and the primary concern of using MDCK cells is the presence of endogenous transporters of nonhuman origin.  The canine P-glycoprotein (Pgp) can interfere with permeability and transporter studies, leading to less reliable data.  A new cell line, MDCKII-LE (low efflux), has been developed by selecting a subpopulation of low-efflux cells from MDCKII-WT using an iterative fluorescence-activated cell sorting technique with calcein-AM as a Pgp and efflux substrate.  MDCKII-LE cells are a subpopulation of MDCKII cells with over 200-fold lower canine Pgp mRNA level and fivefold lower protein level than MDCKII-WT.  MDCKII-LE cells showed less functional efflux activity than MDCKII-WT based on efflux ratios.  Notably, MDCKII-MDR1 showed about 1.5-fold decreased expression of endogenous canine Pgp, suggesting that using the net flux ratio might not completely cancel out the background endogenous transporter activities.  MDCKII-LE cells offer clear advantages over the MDCKII-WT by providing less efflux transporter background signals and minimizing interference from canine Pgp.  The MDCKII-LE apparent permeability values well differentiates compds. from high to medium/low human intestinal absorption and can be used for Biopharmaceutical Classification System.  The MDCKII-LE permeability assay (4-in-1 cassette dosing) is high throughput with good precision, reproducibility, robustness, and cost-effective. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTVtRmYnbF17Vg90H21EOLACvtfcHk0ljJj8wTc3h-OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D&md5=97f647fc215ea6d04882351ffc912a1e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fjps.22674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22674%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGebhard%26aufirst%3DD.%2BF.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DFederico%26aufirst%3DJ.%2BJ.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DReyner%26aufirst%3DE.%2BL.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DRotter%26aufirst%3DC.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DFenner%26aufirst%3DK.%26aulast%3DEl-Kattan%26aufirst%3DA.%2BF.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520new%2520permeability%2520assay%2520using%2520low-efflux%2520MDCKII%2520cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4974%26epage%3D4985%26doi%3D10.1002%2Fjps.22674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Banker, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. A.</span><span> </span><span class="NLM_article-title">Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">974</span><span class="refDoi"> DOI: 10.1002/jps.10332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1002%2Fjps.10332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=12712416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1ehsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=967-974&author=M.+J.+Bankerauthor=T.+H.+Clarkauthor=J.+A.+Williams&title=Development+and+validation+of+a+96-well+equilibrium+dialysis+apparatus+for+measuring+plasma+protein+binding&doi=10.1002%2Fjps.10332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding</span></div><div class="casAuthors">Banker, Michael J.; Clark, Tracey H.; Williams, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">967-974</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A 96-well equil. dialysis block was designed and constructed that is compatible with most std. 96-well format lab. supplies and instruments.  The unique design of the dialysis app. allows one to dispense and aspirate from either or both the sample and dialyzate sides from the top of the app., which is not possible with systems currently on the market.  This feature permits the investigator to analyze a large no. of samples, time points, or replicates in the same expt.  The novel alignment of the dialysis membrane vertically in the well maximizes the surface-to-vol. ratio, eliminates problems assocd. with trapped air pockets, and allows one to add or remove samples independently or all at once.  Furthermore, the design of the app. allows both the sample and dialyzate sides of the dialysis well to be accessible by robotic systems, so assays can be readily automated.  Teflon construction is used to minimize nonspecific binding of test samples to the app.  The device is reusable, easily assembled, and can be shaken in controlled temp. environments to decrease the time required to reach equil. as well as facilitate dissoln. of test compds.  Plasma protein binding values obtained for 10 diverse compds. using std. dialysis equipment and the 96-well dialysis block validates this method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp9qyX_9tHHrVg90H21EOLACvtfcHk0ljJj8wTc3h-OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1ehsrs%253D&md5=0948f0a11373c57be06be9e0d604ad40</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fjps.10332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.10332%26sid%3Dliteratum%253Aachs%26aulast%3DBanker%26aufirst%3DM.%2BJ.%26aulast%3DClark%26aufirst%3DT.%2BH.%26aulast%3DWilliams%26aufirst%3DJ.%2BA.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%252096-well%2520equilibrium%2520dialysis%2520apparatus%2520for%2520measuring%2520plasma%2520protein%2520binding%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2003%26volume%3D92%26spage%3D967%26epage%3D974%26doi%3D10.1002%2Fjps.10332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Zonouzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izakian, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S. W.</span><span> </span><span class="NLM_article-title">Novel synthesis of some new fluorescent 2-amino-3-cyanopyridines</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">2713</span><span class="NLM_x">–</span> <span class="NLM_lpage">2721</span><span class="refDoi"> DOI: 10.3987/COM-12-12566</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.3987%2FCOM-12-12566" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2012&pages=2713-2721&author=A.+Zonouziauthor=Z.+Izakianauthor=S.+W.+Ng&title=Novel+synthesis+of+some+new+fluorescent+2-amino-3-cyanopyridines&doi=10.3987%2FCOM-12-12566"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3987%2FCOM-12-12566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FCOM-12-12566%26sid%3Dliteratum%253Aachs%26aulast%3DZonouzi%26aufirst%3DA.%26aulast%3DIzakian%26aufirst%3DZ.%26aulast%3DNg%26aufirst%3DS.%2BW.%26atitle%3DNovel%2520synthesis%2520of%2520some%2520new%2520fluorescent%25202-amino-3-cyanopyridines%26jtitle%3DHeterocycles%26date%3D2012%26volume%3D85%26spage%3D2713%26epage%3D2721%26doi%3D10.3987%2FCOM-12-12566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Ishikawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, S.</span><span> </span><span class="NLM_article-title">Preparation of perfluoroalkylated benzoheterocyclic compounds using hexafluoro-1,2-epoxypropane</span> <span class="citation_source-journal">Bull. Chem. Soc. Jpn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2164</span><span class="NLM_x">–</span> <span class="NLM_lpage">2167</span><span class="refDoi"> DOI: 10.1246/bcsj.50.2164</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1246%2Fbcsj.50.2164" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1977&pages=2164-2167&author=N.+Ishikawaauthor=S.+Sasaki&title=Preparation+of+perfluoroalkylated+benzoheterocyclic+compounds+using+hexafluoro-1%2C2-epoxypropane&doi=10.1246%2Fbcsj.50.2164"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1246%2Fbcsj.50.2164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fbcsj.50.2164%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DN.%26aulast%3DSasaki%26aufirst%3DS.%26atitle%3DPreparation%2520of%2520perfluoroalkylated%2520benzoheterocyclic%2520compounds%2520using%2520hexafluoro-1%252C2-epoxypropane%26jtitle%3DBull.%2520Chem.%2520Soc.%2520Jpn.%26date%3D1977%26volume%3D50%26spage%3D2164%26epage%3D2167%26doi%3D10.1246%2Fbcsj.50.2164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Bagal, S. K.; Cui, J. J.; Greasley, S. E.; Lunney, E. A.; McAlpine, I. J.; Nagata, A.; Ninkovic, S.; Omoto, K.; Skerratt, S. E.; Storer, R. I.; Warmus, J. S.</span><span> </span><span class="NLM_article-title">N-Pyrazolyl Pyridinylbenzamides as Tropomyosin-Related Kinase Inhibitors and Their Preparation</span>. WO2015170218 A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+K.+Bagal&author=J.+J.+Cui&author=S.+E.+Greasley&author=E.+A.+Lunney&author=I.+J.+McAlpine&author=A.+Nagata&author=S.+Ninkovic&author=K.+Omoto&author=S.+E.+Skerratt&author=R.+I.+Storer&author=J.+S.+Warmus&title=N-Pyrazolyl+Pyridinylbenzamides+as+Tropomyosin-Related+Kinase+Inhibitors+and+Their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBagal%26aufirst%3DS.%2BK.%26atitle%3DN-Pyrazolyl%2520Pyridinylbenzamides%2520as%2520Tropomyosin-Related%2520Kinase%2520Inhibitors%2520and%2520Their%2520Preparation%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Gangjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisliuk, R. L.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of classical and nonclassical 2-amino-4-oxo-5-substituted-6-methylpyrrolo[3,2-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span><span class="refDoi"> DOI: 10.1021/jm701052u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701052u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=68-76&author=A.+Gangjeeauthor=W.+Liauthor=J.+Yangauthor=R.+L.+Kisliuk&title=Design%2C+synthesis%2C+and+biological+evaluation+of+classical+and+nonclassical+2-amino-4-oxo-5-substituted-6-methylpyrrolo%5B3%2C2-d%5Dpyrimidines+as+dual+thymidylate+synthase+and+dihydrofolate+reductase+inhibitors&doi=10.1021%2Fjm701052u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm701052u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701052u%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DKisliuk%26aufirst%3DR.%2BL.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520classical%2520and%2520nonclassical%25202-amino-4-oxo-5-substituted-6-methylpyrrolo%255B3%252C2-d%255Dpyrimidines%2520as%2520dual%2520thymidylate%2520synthase%2520and%2520dihydrofolate%2520reductase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D68%26epage%3D76%26doi%3D10.1021%2Fjm701052u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Vonrhein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flensburg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smart, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paciorek, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Womack, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bricogne, G.</span><span> </span><span class="NLM_article-title">Data processing and analysis with the autoPROC toolbox</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span><span class="refDoi"> DOI: 10.1107/S0907444911007773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1107%2FS0907444911007773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=21460447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=293-302&author=C.+Vonrheinauthor=C.+Flensburgauthor=P.+Kellerauthor=A.+Sharffauthor=O.+Smartauthor=W.+Paciorekauthor=T.+Womackauthor=G.+Bricogne&title=Data+processing+and+analysis+with+the+autoPROC+toolbox&doi=10.1107%2FS0907444911007773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Data processing and analysis with the autoPROC toolbox</span></div><div class="casAuthors">Vonrhein, Clemens; Flensburg, Claus; Keller, Peter; Sharff, Andrew; Smart, Oliver; Paciorek, Wlodek; Womack, Thomas; Bricogne, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-302</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A typical diffraction expt. will generate many images and data sets from different crystals in a very short time.  This creates a challenge for the high-throughput operation of modern synchrotron beamlines as well as for the subsequent data processing.  Novice users in particular may feel overwhelmed by the tables, plots and nos. that the different data-processing programs and software packages present to them.  Here, some of the more common problems that a user has to deal with when processing a set of images that will finally make up a processed data set are shown, concg. on difficulties that may often show up during the first steps along the path of turning the expt. (i.e. data collection) into a model (i.e. interpreted electron d.).  Difficulties such as unexpected crystal forms, issues in crystal handling and suboptimal choices of data-collection strategies can often be dealt with, or at least diagnosed, by analyzing specific data characteristics during processing.  In the end, one wants to distinguish problems over which one has no immediate control once the expt. is finished from problems that can be remedied a posteriori.  A new software package, autoPROC, is also presented that combines third-party processing programs with new tools and an automated workflow script that is intended to provide users with both guidance and insight into the offline processing of data affected by the difficulties mentioned above, with particular emphasis on the automated treatment of multi-sweep data sets collected on multi-axis goniostats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmah7iUrMLXLVg90H21EOLACvtfcHk0liFtkq1FxfNhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D&md5=a0a3579f6b371b6312819883864aa80d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1107%2FS0907444911007773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911007773%26sid%3Dliteratum%253Aachs%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DFlensburg%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DP.%26aulast%3DSharff%26aufirst%3DA.%26aulast%3DSmart%26aufirst%3DO.%26aulast%3DPaciorek%26aufirst%3DW.%26aulast%3DWomack%26aufirst%3DT.%26aulast%3DBricogne%26aufirst%3DG.%26atitle%3DData%2520processing%2520and%2520analysis%2520with%2520the%2520autoPROC%2520toolbox%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D293%26epage%3D302%26doi%3D10.1107%2FS0907444911007773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">Xds</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=Xds&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0liFtkq1FxfNhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXds%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krissinel, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. S.</span><span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+W.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0liFtkq1FxfNhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, W.; Roversi, P.; Sharff, A.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span>BUSTER; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=A.+Sharff&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0liIHAbOIBObcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c','cit4d','cit4e'],'ref5':['cit5a','cit5b','cit5c'],'ref6':['cit6'],'ref7':['cit7a','cit7b'],'ref8':['cit8a','cit8b'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b','cit14c','cit14d','cit14e','cit14f'],'ref15':['cit15a','cit15b'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 21 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kentaro Futatsugi, Aaron C. Smith, Meihua Tu, Brian Raymer, Kay Ahn, Steven B. Coffey, Matthew S. Dowling, Dilinie P. Fernando, Jemy A. Gutierrez, Kim Huard, Jayasankar Jasti, Amit S. Kalgutkar, John D. Knafels, Jayvardhan Pandit, Kevin D. Parris, Sylvie Perez, Jeffrey A. Pfefferkorn, David A. Price, Tim Ryder, Andre Shavnya, Ingrid A. Stock, Andy S. Tsai, Gregory J. Tesz, Benjamin A. Thuma, Yan Weng, Hanna M. Wisniewska, Gang Xing, Jun Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Thomas V. Magee</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13546-13560. <a href="https://doi.org/10.1021/acs.jmedchem.0c00944" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00944</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00944%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPF-06835919%25253A%252BA%252BPotent%252BInhibitor%252Bof%252BKetohexokinase%252B%252528KHK%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BMetabolic%252BDisorders%252BDriven%252Bby%252Bthe%252BOverconsumption%252Bof%252BFructose%26aulast%3DFutatsugi%26aufirst%3DKentaro%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D02062020%26date%3D27092020%26date%3D10092020%26volume%3D63%26issue%3D22%26spage%3D13546%26epage%3D13560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">F. Anthony Romero, Christopher T. Jones, Yingzi Xu, Martijn Fenaux, <span class="NLM_string-name hlFld-ContribAuthor">Randall L. Halcomb</span>. </span><span class="cited-content_cbyCitation_article-title">The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (10)
                                     , 5031-5073. <a href="https://doi.org/10.1021/acs.jmedchem.9b01701" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01701</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01701%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BRace%252Bto%252BBash%252BNASH%25253A%252BEmerging%252BTargets%252Band%252BDrug%252BDevelopment%252Bin%252Ba%252BComplex%252BLiver%252BDisease%26aulast%3DRomero%26aufirst%3DF.%2BAnthony%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D14102019%26date%3D29012020%26date%3D13012020%26volume%3D63%26issue%3D10%26spage%3D5031%26epage%3D5073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christopher J. Helal, Mark Bundesmann, Susan Hammond, Melissa Holmstrom, Jacquelyn Klug-McLeod, Bruce A. Lefker, Dale McLeod, Chakrapani Subramanyam, Oleg Zakaryants, <span class="NLM_string-name hlFld-ContribAuthor">Sylvie Sakata</span>. </span><span class="cited-content_cbyCitation_article-title">Quick Building Blocks (QBB): An Innovative and Efficient Business Model To Speed Medicinal Chemistry Analog Synthesis. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (8)
                                     , 1104-1109. <a href="https://doi.org/10.1021/acsmedchemlett.9b00205" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00205%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DQuick%252BBuilding%252BBlocks%252B%252528QBB%252529%25253A%252BAn%252BInnovative%252Band%252BEfficient%252BBusiness%252BModel%252BTo%252BSpeed%252BMedicinal%252BChemistry%252BAnalog%252BSynthesis%26aulast%3DHelal%26aufirst%3DChristopher%2BJ.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D06052019%26date%3D05072019%26date%3D18072019%26date%3D05072019%26volume%3D10%26issue%3D8%26spage%3D1104%26epage%3D1109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Paul N. Mortenson, Daniel A. Erlanson, Iwan J. P. de Esch, Wolfgang Jahnke, <span class="NLM_string-name hlFld-ContribAuthor">Christopher N. Johnson</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-to-Lead Medicinal Chemistry Publications in 2017. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (8)
                                     , 3857-3872. <a href="https://doi.org/10.1021/acs.jmedchem.8b01472" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01472%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-to-Lead%252BMedicinal%252BChemistry%252BPublications%252Bin%252B2017%26aulast%3DMortenson%26aufirst%3DPaul%2BN.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D21092018%26date%3D21112018%26volume%3D62%26issue%3D8%26spage%3D3857%26epage%3D3872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kevin J. Filipski, Matthew F. Sammons, Samit K. Bhattacharya, Jane Panteleev, Janice A. Brown, Paula M. Loria, Markus Boehm, Aaron C. Smith, Andre Shavnya, Edward L. Conn, Kun Song, Yan Weng, Carie Facemire, Harald Jüppner, <span class="NLM_string-name hlFld-ContribAuthor">Valerie Clerin</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Orally Bioavailable Selective Inhibitors of the Sodium-Phosphate Cotransporter NaPi2a (SLC34A1). </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (5)
                                     , 440-445. <a href="https://doi.org/10.1021/acsmedchemlett.8b00013" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00013%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BOrally%252BBioavailable%252BSelective%252BInhibitors%252Bof%252Bthe%252BSodium-Phosphate%252BCotransporter%252BNaPi2a%252B%252528SLC34A1%252529%26aulast%3DFilipski%26aufirst%3DKevin%2BJ.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D10012018%26date%3D04042018%26date%3D12042018%26volume%3D9%26issue%3D5%26spage%3D440%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kendra K.  Bence</span>, <span class="hlFld-ContribAuthor ">Morris J.  Birnbaum</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic drivers of non-alcoholic fatty liver disease. </span><span class="cited-content_cbyCitation_journal-name">Molecular Metabolism</span><span> <strong>2021,</strong> <em>50 </em>, 101143. <a href="https://doi.org/10.1016/j.molmet.2020.101143" title="DOI URL">https://doi.org/10.1016/j.molmet.2020.101143</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molmet.2020.101143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molmet.2020.101143%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Metabolism%26atitle%3DMetabolic%252Bdrivers%252Bof%252Bnon-alcoholic%252Bfatty%252Bliver%252Bdisease%26aulast%3DBence%26aufirst%3DKendra%2BK.%26date%3D2021%26volume%3D50%26spage%3D101143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongfei  Jiang</span>, <span class="hlFld-ContribAuthor ">Qian  Lin</span>, <span class="hlFld-ContribAuthor ">Leina  Ma</span>, <span class="hlFld-ContribAuthor ">Shudi  Luo</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Jiang</span>, <span class="hlFld-ContribAuthor ">Jing  Fang</span>, <span class="hlFld-ContribAuthor ">Zhimin  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Fructose and fructose kinase in cancer and other pathologies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Genetics and Genomics</span><span> <strong>2021,</strong> <em>38 </em><a href="https://doi.org/10.1016/j.jgg.2021.06.006" title="DOI URL">https://doi.org/10.1016/j.jgg.2021.06.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jgg.2021.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jgg.2021.06.006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Genetics%2520and%2520Genomics%26atitle%3DFructose%252Band%252Bfructose%252Bkinase%252Bin%252Bcancer%252Band%252Bother%252Bpathologies%26aulast%3DJiang%26aufirst%3DHongfei%26date%3D2021%26volume%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ralf  Glatthar</span>, <span class="hlFld-ContribAuthor ">Robert H.  Arch</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Approaches for Nonalcoholic Steatohepatitis (
              NASH
              ). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-71. <a href="https://doi.org/10.1002/0471266949.bmc274" title="DOI URL">https://doi.org/10.1002/0471266949.bmc274</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc274%26sid%3Dliteratum%253Aachs%26atitle%3DTherapeutic%252BApproaches%252Bfor%252BNonalcoholic%252BSteatohepatitis%252B%252528%252BNASH%252B%252529%26aulast%3DGlatthar%26aufirst%3DRalf%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D71%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Federico</span>, <span class="hlFld-ContribAuthor ">Valerio  Rosato</span>, <span class="hlFld-ContribAuthor ">Mario  Masarone</span>, <span class="hlFld-ContribAuthor ">Pietro  Torre</span>, <span class="hlFld-ContribAuthor ">Marcello  Dallio</span>, <span class="hlFld-ContribAuthor ">Mario  Romeo</span>, <span class="hlFld-ContribAuthor ">Marcello  Persico</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights. </span><span class="cited-content_cbyCitation_journal-name">Nutrients</span><span> <strong>2021,</strong> <em>13 </em>
                                    (4)
                                     , 1314. <a href="https://doi.org/10.3390/nu13041314" title="DOI URL">https://doi.org/10.3390/nu13041314</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/nu13041314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fnu13041314%26sid%3Dliteratum%253Aachs%26jtitle%3DNutrients%26atitle%3DThe%252BRole%252Bof%252BFructose%252Bin%252BNon-Alcoholic%252BSteatohepatitis%25253A%252BOld%252BRelationship%252Band%252BNew%252BInsights%26aulast%3DFederico%26aufirst%3DAlessandro%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D4%26spage%3D1314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy L.  Foley</span>, <span class="hlFld-ContribAuthor ">Woodrow  Burchett</span>, <span class="hlFld-ContribAuthor ">Qiuxia  Chen</span>, <span class="hlFld-ContribAuthor ">Mark E.  Flanagan</span>, <span class="hlFld-ContribAuthor ">Brendon  Kapinos</span>, <span class="hlFld-ContribAuthor ">Xianyang  Li</span>, <span class="hlFld-ContribAuthor ">Justin I.  Montgomery</span>, <span class="hlFld-ContribAuthor ">Anokha S.  Ratnayake</span>, <span class="hlFld-ContribAuthor ">Hongyao  Zhu</span>, <span class="hlFld-ContribAuthor ">Marie-Claire  Peakman</span>. </span><span class="cited-content_cbyCitation_article-title">Selecting Approaches for Hit Identification and Increasing Options by Building the Efficient Discovery of Actionable Chemical Matter from DNA-Encoded Libraries. </span><span class="cited-content_cbyCitation_journal-name">SLAS DISCOVERY: Advancing the Science of Drug Discovery</span><span> <strong>2021,</strong> <em>26 </em>
                                    (2)
                                     , 263-280. <a href="https://doi.org/10.1177/2472555220979589" title="DOI URL">https://doi.org/10.1177/2472555220979589</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2472555220979589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2472555220979589%26sid%3Dliteratum%253Aachs%26jtitle%3DSLAS%2520DISCOVERY%253A%2520Advancing%2520the%2520Science%2520of%2520Drug%2520Discovery%26atitle%3DSelecting%252BApproaches%252Bfor%252BHit%252BIdentification%252Band%252BIncreasing%252BOptions%252Bby%252BBuilding%252Bthe%252BEfficient%252BDiscovery%252Bof%252BActionable%252BChemical%252BMatter%252Bfrom%252BDNA-Encoded%252BLibraries%26aulast%3DFoley%26aufirst%3DTimothy%2BL.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D2%26spage%3D263%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Suzanna L.  Attia</span>, <span class="hlFld-ContribAuthor ">Samir  Softic</span>, <span class="hlFld-ContribAuthor ">Marialena  Mouzaki</span>. </span><span class="cited-content_cbyCitation_article-title">Evolving Role for Pharmacotherapy in NAFLD/NASH. </span><span class="cited-content_cbyCitation_journal-name">Clinical and Translational Science</span><span> <strong>2021,</strong> <em>14 </em>
                                    (1)
                                     , 11-19. <a href="https://doi.org/10.1111/cts.12839" title="DOI URL">https://doi.org/10.1111/cts.12839</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cts.12839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcts.12839%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520and%2520Translational%2520Science%26atitle%3DEvolving%252BRole%252Bfor%252BPharmacotherapy%252Bin%252BNAFLD%25252FNASH%26aulast%3DAttia%26aufirst%3DSuzanna%2BL.%26date%3D2021%26date%3D2020%26volume%3D14%26issue%3D1%26spage%3D11%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shea  Skenderian</span>, <span class="hlFld-ContribAuthor ">Grace  Park</span>, <span class="hlFld-ContribAuthor ">Cholsoon  Jang</span>. </span><span class="cited-content_cbyCitation_article-title">Organismal Fructose Metabolism in Health and Non-Alcoholic Fatty Liver Disease. </span><span class="cited-content_cbyCitation_journal-name">Biology</span><span> <strong>2020,</strong> <em>9 </em>
                                    (11)
                                     , 405. <a href="https://doi.org/10.3390/biology9110405" title="DOI URL">https://doi.org/10.3390/biology9110405</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biology9110405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiology9110405%26sid%3Dliteratum%253Aachs%26jtitle%3DBiology%26atitle%3DOrganismal%252BFructose%252BMetabolism%252Bin%252BHealth%252Band%252BNon-Alcoholic%252BFatty%252BLiver%252BDisease%26aulast%3DSkenderian%26aufirst%3DShea%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D11%26spage%3D405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Reto  Horst</span>, <span class="hlFld-ContribAuthor ">Kathleen A.  Farley</span>, <span class="hlFld-ContribAuthor ">Bethany L.  Kormos</span>, <span class="hlFld-ContribAuthor ">Jane M.  Withka</span>. </span><span class="cited-content_cbyCitation_article-title">NMR spectroscopy: the swiss army knife of drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular NMR</span><span> <strong>2020,</strong> <em>74 </em>
                                    (10-11)
                                     , 509-519. <a href="https://doi.org/10.1007/s10858-020-00330-0" title="DOI URL">https://doi.org/10.1007/s10858-020-00330-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10858-020-00330-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10858-020-00330-0%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520NMR%26atitle%3DNMR%252Bspectroscopy%25253A%252Bthe%252Bswiss%252Barmy%252Bknife%252Bof%252Bdrug%252Bdiscovery%26aulast%3DHorst%26aufirst%3DReto%26date%3D2020%26date%3D2020%26volume%3D74%26issue%3D10-11%26spage%3D509%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cholsoon  Jang</span>, <span class="hlFld-ContribAuthor ">Shogo  Wada</span>, <span class="hlFld-ContribAuthor ">Steven  Yang</span>, <span class="hlFld-ContribAuthor ">Bridget  Gosis</span>, <span class="hlFld-ContribAuthor ">Xianfeng  Zeng</span>, <span class="hlFld-ContribAuthor ">Zhaoyue  Zhang</span>, <span class="hlFld-ContribAuthor ">Yihui  Shen</span>, <span class="hlFld-ContribAuthor ">Gina  Lee</span>, <span class="hlFld-ContribAuthor ">Zoltan  Arany</span>, <span class="hlFld-ContribAuthor ">Joshua D.  Rabinowitz</span>. </span><span class="cited-content_cbyCitation_article-title">The small intestine shields the liver from fructose-induced steatosis. </span><span class="cited-content_cbyCitation_journal-name">Nature Metabolism</span><span> <strong>2020,</strong> <em>2 </em>
                                    (7)
                                     , 586-593. <a href="https://doi.org/10.1038/s42255-020-0222-9" title="DOI URL">https://doi.org/10.1038/s42255-020-0222-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s42255-020-0222-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs42255-020-0222-9%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Metabolism%26atitle%3DThe%252Bsmall%252Bintestine%252Bshields%252Bthe%252Bliver%252Bfrom%252Bfructose-induced%252Bsteatosis%26aulast%3DJang%26aufirst%3DCholsoon%26date%3D2020%26date%3D2020%26volume%3D2%26issue%3D7%26spage%3D586%26epage%3D593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anastasia I.  Ershova</span>, <span class="hlFld-ContribAuthor ">Mikhail Yu.  Ievlev</span>, <span class="hlFld-ContribAuthor ">Veronika N.  Maksimova</span>, <span class="hlFld-ContribAuthor ">Mikhail Yu.  Belikov</span>, <span class="hlFld-ContribAuthor ">Oleg V.  Ershov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Solution and Solid‐State Fluorescence of 2‐(
              N
              ‐cycloamino)cinchomeronic Dinitrile Derivatives. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (24)
                                     , 7243-7248. <a href="https://doi.org/10.1002/slct.202001710" title="DOI URL">https://doi.org/10.1002/slct.202001710</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202001710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202001710%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%25252C%252BSolution%252Band%252BSolid%2525E2%252580%252590State%252BFluorescence%252Bof%252B2%2525E2%252580%252590%252528%252BN%252B%2525E2%252580%252590cycloamino%252529cinchomeronic%252BDinitrile%252BDerivatives%26aulast%3DErshova%26aufirst%3DAnastasia%2BI.%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D24%26spage%3D7243%26epage%3D7248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amée M.  Buziau</span>, <span class="hlFld-ContribAuthor ">Casper G.  Schalkwijk</span>, <span class="hlFld-ContribAuthor ">Coen D.A.  Stehouwer</span>, <span class="hlFld-ContribAuthor ">Dean R.  Tolan</span>, <span class="hlFld-ContribAuthor ">Martijn C.G.J.  Brouwers</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the pathogenesis of hereditary fructose intolerance: implications for its treatment and the understanding of fructose-induced non-alcoholic fatty liver disease. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Life Sciences</span><span> <strong>2020,</strong> <em>77 </em>
                                    (9)
                                     , 1709-1719. <a href="https://doi.org/10.1007/s00018-019-03348-2" title="DOI URL">https://doi.org/10.1007/s00018-019-03348-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00018-019-03348-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00018-019-03348-2%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Life%2520Sciences%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bpathogenesis%252Bof%252Bhereditary%252Bfructose%252Bintolerance%25253A%252Bimplications%252Bfor%252Bits%252Btreatment%252Band%252Bthe%252Bunderstanding%252Bof%252Bfructose-induced%252Bnon-alcoholic%252Bfatty%252Bliver%252Bdisease%26aulast%3DBuziau%26aufirst%3DAm%25C3%25A9e%2BM.%26date%3D2020%26date%3D2019%26volume%3D77%26issue%3D9%26spage%3D1709%26epage%3D1719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashley  Jarvis</span>, <span class="hlFld-ContribAuthor ">Gilles  Ouvry</span>. </span><span class="cited-content_cbyCitation_article-title">Essential ingredients for rational drug design. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (20)
                                     , 126674. <a href="https://doi.org/10.1016/j.bmcl.2019.126674" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126674</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126674%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DEssential%252Bingredients%252Bfor%252Brational%252Bdrug%252Bdesign%26aulast%3DJarvis%26aufirst%3DAshley%26date%3D2019%26volume%3D29%26issue%3D20%26spage%3D126674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuan-Xuan  Du</span>, <span class="hlFld-ContribAuthor ">Quan-Xing  Zi</span>, <span class="hlFld-ContribAuthor ">Yu-Meng  Wu</span>, <span class="hlFld-ContribAuthor ">Yi  Jin</span>, <span class="hlFld-ContribAuthor ">Jun  Lin</span>, <span class="hlFld-ContribAuthor ">Sheng-Jiao  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">An environmentally benign multi-component reaction: regioselective synthesis of fluorinated 2-aminopyridines using diverse properties of the nitro group. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2019,</strong> <em>21 </em>
                                    (6)
                                     , 1505-1516. <a href="https://doi.org/10.1039/C8GC03698E" title="DOI URL">https://doi.org/10.1039/C8GC03698E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8GC03698E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8GC03698E%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DAn%252Benvironmentally%252Bbenign%252Bmulti-component%252Breaction%25253A%252Bregioselective%252Bsynthesis%252Bof%252Bfluorinated%252B2-aminopyridines%252Busing%252Bdiverse%252Bproperties%252Bof%252Bthe%252Bnitro%252Bgroup%26aulast%3DDu%26aufirst%3DXuan-Xuan%26date%3D2019%26date%3D2019%26volume%3D21%26issue%3D6%26spage%3D1505%26epage%3D1516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William P.  Esler</span>, <span class="hlFld-ContribAuthor ">Kendra K.  Bence</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic Targets in Nonalcoholic Fatty Liver Disease. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Gastroenterology and Hepatology</span><span> <strong>2019,</strong> <em>8 </em>
                                    (2)
                                     , 247-267. <a href="https://doi.org/10.1016/j.jcmgh.2019.04.007" title="DOI URL">https://doi.org/10.1016/j.jcmgh.2019.04.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jcmgh.2019.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jcmgh.2019.04.007%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Gastroenterology%2520and%2520Hepatology%26atitle%3DMetabolic%252BTargets%252Bin%252BNonalcoholic%252BFatty%252BLiver%252BDisease%26aulast%3DEsler%26aufirst%3DWilliam%2BP.%26date%3D2019%26volume%3D8%26issue%3D2%26spage%3D247%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sally  Chiu</span>, <span class="hlFld-ContribAuthor ">Kathleen  Mulligan</span>, <span class="hlFld-ContribAuthor ">Jean-Marc  Schwarz</span>. </span><span class="cited-content_cbyCitation_article-title">Dietary carbohydrates and fatty liver disease. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Clinical Nutrition & Metabolic Care</span><span> <strong>2018,</strong> <em>21 </em>
                                    (4)
                                     , 277-282. <a href="https://doi.org/10.1097/MCO.0000000000000469" title="DOI URL">https://doi.org/10.1097/MCO.0000000000000469</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/MCO.0000000000000469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FMCO.0000000000000469%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Clinical%2520Nutrition%2520%2526%2520Metabolic%2520Care%26atitle%3DDietary%252Bcarbohydrates%252Band%252Bfatty%252Bliver%252Bdisease%26aulast%3DChiu%26aufirst%3DSally%26date%3D2018%26volume%3D21%26issue%3D4%26spage%3D277%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) hKHK-C complexed with AMP-PNP (PBD code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NBV">3NBV</a>), showing the two molecules in the crystallographic asymmetric unit. Molecule A (colored by secondary structure) is in a closed conformation, and molecule B (yellow) is in an open conformation. Each molecule is bound to AMP-PNP, and the binding site in the closed conformation is shown in a close-up view in (B). (B) A close-up view of the AMP-PNP binding site is shown in two approximately orthogonal views. Three key interactions described in the text are identified with numbers. A semitransparent surface is drawn around the atoms constituting the binding site, colored according to the hydrophobicity of the underlying atoms, with brown being more hydrophobic than green. Hydrogen bonds are indicated with dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Representative structures of KHK inhibitors from the pyrimidinopyrimidine and indazole series reported in the literature.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding modes of fragment hits <b>3</b>–<b>5</b>, illustrating the three key interactions in the binding site highlighted in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>. (A) Compound <b>3</b> contains a saturated ring with a polar substitution in the ribose pocket, making a hydrogen bond with the backbone carbonyl oxygen of Gly229 (PBD code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBM">5WBM</a>). (B) The nitrile group of <b>4</b> interacts with a conserved molecule of water deep in the binding pocket (PBD code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBO">5WBO</a>). (C) The trifluoromethyl group of <b>5</b> makes favorable hydrophobic interactions with the proline wall (PBD code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBP">5WBP</a>). A sulfate ion (drawn as a ball-and-stick model) from the crystallization buffer is seen in all three structures to be bound at the site previously occupied by the γ phosphate group of AMP-PNP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>7</b> (blue in the crystal structure, PBD code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBQ">5WBQ</a>) and compound <b>8</b> (pink in the crystal structure, PBD code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBR">5WBR</a>) with improved potency against hKHK. The functional groups identified in blue, purple, and pink reproduce the key interactions described for the fragments hits in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> and <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>. In this figure, which shows the binding site in exactly the same view as the right-hand panel of <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, all protein atoms have been hidden for clarity. The nitrile group in both compounds interacts with a conserved water molecule, shown as a gold sphere. A second water molecule, shown as a red sphere, is seen in the crystal structure of <b>7</b>, which occupies the same space as that filled by the hydroxyl group in <b>8</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) In vitro profile of pyrrolopyridine <b>9</b>. <sup><i>a</i></sup>IC<sub>50</sub> values for hKHK and rKHK are reported as the mean of three replicates (pIC<sub>50</sub> = 6.17 ± 0.08 and 6.19 ± 0.01, respectively). <sup><i>b</i></sup>Permeability (<i>P</i><sub>app</sub>) was assessed in Ralph Russ canine kidney cells.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a><sup><i>c</i></sup>Thermodynamic solubility was measured at pH 7.4. <sup><i>d</i></sup>Fu = fraction unbound in plasma as assessed by equilibrium dialysis.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (B) Free plasma level of <b>9</b> in rat PK studies. 300 mg/kg dose was administered orally using 0.25% HPC-SL/0.05% DOSS as vehicle. Data are presented as mean values (±standard deviation) with <i>n</i> = 3 per data point. Solid line = exposure. Dashed line = in vitro rKHK IC<sub>50</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Merging pharmacophores led to the identification of pyridine <b>11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Structure and profile of pyridine <b>12</b> in in vitro assays. <sup><i>a</i></sup>IC<sub>50</sub> values for rat and human KHK-C inhibition are reported as the mean of 19 replicates (pIC<sub>50</sub> = 6.3 ± 0.2 and 6.5 ± 0.2 respectively). <sup><i>b</i></sup>IC<sub>50</sub> value for hKHK-A inhibition is reported as the mean of four replicates (pIC<sub>50</sub> = 6.41 ± 0.09). RLM = rat liver microsomes. (B) The binding mode of <b>12</b> in the crystal structure (PBD code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBZ">5WBZ</a>) is reported with a view of the binding site that is identical to the right panel of <a class="ref internalNav" href="#fig3" aria-label="Figures 3">Figures 3</a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. All protein atoms have been hidden for clarity. (C) Free plasma level of <b>12</b> in rat PK studies. A 150 mg/kg dose was administered orally using 1% polyvinylpyrrolidone/0.025% sodium lauryl sulfate/1% Pluronic (nanocrystal suspension) as vehicle. Data are presented as mean values (±standard deviation) with <i>n</i> = 4 per data point. Solid line = exposure. Dashed line = in vitro rKHK IC<sub>50</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0008.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Concentrations of hepatic and renal fructose 1-phosphate (F1P) following an iv bolus of fructose and increasing doses of compound <b>12</b> in Sprague Dawley rats. A nonlinear dose–response curve was fitted to a variable slope (four parameter) using GraphPad Prism, and the calculated ED<sub>50</sub> values for kidney and liver F1P reduction are reported. Data are presented as mean values (±standard error) with <i>n</i> = 7–8 per data point.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0009.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Plasma fructose levels in Sprague Dawley rats following an oral fructose bolus and treatment with the indicated dose of compound <b>12</b>. Animals were administered compound <b>12</b> orally 1 h prior to an oral bolus of fructose (2 g/kg). Data are presented as mean values (±standard error) with <i>n</i> = 6–8 per data point.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pyrrolopyridines <b>7</b>, <b>9</b>, and <b>10</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Pyridine <b>11</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/medium/jm-2017-00947a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Pyridine <b>12</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.7b00947/20170922/images/large/jm-2017-00947a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00947&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51667" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51667" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Bonthron, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donaldson, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, B.</span><span> </span><span class="NLM_article-title">Molecular basis of essential fructosuria: molecular cloning and mutational analysis of human ketohexokinase (fructokinase)</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1627</span><span class="NLM_x">–</span> <span class="NLM_lpage">1631</span><span class="refDoi"> DOI: 10.1093/hmg/3.9.1627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1093%2Fhmg%2F3.9.1627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=7833921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADyaK2MXhtVGnt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1994&pages=1627-1631&author=D.+T.+Bonthronauthor=N.+Bradyauthor=I.+A.+Donaldsonauthor=B.+Steinmann&title=Molecular+basis+of+essential+fructosuria%3A+molecular+cloning+and+mutational+analysis+of+human+ketohexokinase+%28fructokinase%29&doi=10.1093%2Fhmg%2F3.9.1627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of essential fructosuria: molecular cloning and mutational analysis of human ketohexokinase (fructokinase)</span></div><div class="casAuthors">Bonthron, David T.; Brady, Nicola; Donaldson, Iain A.; Steinmann, Beat</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1627-31</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    </div><div class="casAbstract">Essential fructosuria is one of the oldest known inborn errors of metab.  It is a benign condition which is believed to result from deficiency of hepatic fructokinase (ketohexokinase, KHK, E.C.2.7.1.3.).  This enzyme catalyzes the first step of metab. of dietary fructose, conversion of fructose to fructose-1-phosphate.  Despite the early recognition of this disorder, the primary structure of human KHK and the mol. basis of essential fructosuria have not been previously defined.  In this report, the isolation and sequencing of full-length cDNA clones encoding human ketohexokinase are described.  Alternative mRNA species and alternative KHK isoenzymes are produced by alternative polyadenylation and splicing of the KHK gene.  The KHK proteins show a high level of sequence conservation relative to rat KHK.  Direct evidence that mutation of the KHK structural gene is the cause of essential fructosuria was also obtained.  In a well-characterized family, in which 3 of 8 siblings have fructosuria, all affected individuals are compd. heterozygotes for 2 mutations Gly40Arg and Ala43Thr.  Both mutations result from G→A transitions, and each alters the same conserved region of the KHK protein.  Neither mutation was seen in a sample of 52 unrelated control individuals.  An addnl. conservative amino acid change (Val49IIe) was present on the KHK allele bearing Ala43Thr.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnhKZtroZ3uLVg90H21EOLACvtfcHk0lhFS0-40w4HpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhtVGnt78%253D&md5=1e3f908a2d87d3a49c4897aa84ac3345</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F3.9.1627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F3.9.1627%26sid%3Dliteratum%253Aachs%26aulast%3DBonthron%26aufirst%3DD.%2BT.%26aulast%3DBrady%26aufirst%3DN.%26aulast%3DDonaldson%26aufirst%3DI.%2BA.%26aulast%3DSteinmann%26aufirst%3DB.%26atitle%3DMolecular%2520basis%2520of%2520essential%2520fructosuria%253A%2520molecular%2520cloning%2520and%2520mutational%2520analysis%2520of%2520human%2520ketohexokinase%2520%2528fructokinase%2529%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D1994%26volume%3D3%26spage%3D1627%26epage%3D1631%26doi%3D10.1093%2Fhmg%2F3.9.1627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Asipu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayward, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonthron, D. T.</span><span> </span><span class="NLM_article-title">Properties of normal and mutant recombinant human ketohexokinases and implications for the pathogenesis of essential fructosuria</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2426</span><span class="NLM_x">–</span> <span class="NLM_lpage">2432</span><span class="refDoi"> DOI: 10.2337/diabetes.52.9.2426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.2337%2Fdiabetes.52.9.2426" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2003&pages=2426-2432&author=A.+Asipuauthor=B.+E.+Haywardauthor=J.+O%E2%80%99Reillyauthor=D.+T.+Bonthron&title=Properties+of+normal+and+mutant+recombinant+human+ketohexokinases+and+implications+for+the+pathogenesis+of+essential+fructosuria&doi=10.2337%2Fdiabetes.52.9.2426"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.52.9.2426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.52.9.2426%26sid%3Dliteratum%253Aachs%26aulast%3DAsipu%26aufirst%3DA.%26aulast%3DHayward%26aufirst%3DB.%2BE.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DJ.%26aulast%3DBonthron%26aufirst%3DD.%2BT.%26atitle%3DProperties%2520of%2520normal%2520and%2520mutant%2520recombinant%2520human%2520ketohexokinases%2520and%2520implications%2520for%2520the%2520pathogenesis%2520of%2520essential%2520fructosuria%26jtitle%3DDiabetes%26date%3D2003%26volume%3D52%26spage%3D2426%26epage%3D2432%26doi%3D10.2337%2Fdiabetes.52.9.2426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Ishimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanaspa, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diggle, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclean, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackman, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asipu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncal-Jimenez, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosugi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivard, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Iturbe, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Lozada, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonthron, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sautin, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. J.</span><span> </span><span class="NLM_article-title">Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">4320</span><span class="NLM_x">–</span> <span class="NLM_lpage">4325</span><span class="refDoi"> DOI: 10.1073/pnas.1119908109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1073%2Fpnas.1119908109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=22371574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC38XkslGltbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=4320-4325&author=T.+Ishimotoauthor=M.+A.+Lanaspaauthor=M.+T.+Leauthor=G.+E.+Garciaauthor=C.+P.+Diggleauthor=P.+S.+Macleanauthor=M.+R.+Jackmanauthor=A.+Asipuauthor=C.+A.+Roncal-Jimenezauthor=T.+Kosugiauthor=C.+J.+Rivardauthor=S.+Maruyamaauthor=B.+Rodriguez-Iturbeauthor=L.+G.+Sanchez-Lozadaauthor=D.+T.+Bonthronauthor=Y.+Y.+Sautinauthor=R.+J.+Johnson&title=Opposing+effects+of+fructokinase+C+and+A+isoforms+on+fructose-induced+metabolic+syndrome+in+mice&doi=10.1073%2Fpnas.1119908109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice</span></div><div class="casAuthors">Ishimoto, Takuji; Lanaspa, Miguel A.; Le, My Phuong T.; Garcia, Gabriela E.; Diggle, Christine P.; MacLean, Paul S.; Jackman, Matthew R.; Asipu, Aruna; Roncal-Jimenez, Carlos A.; Kosugi, Tomoki; Rivard, Christopher J.; Maruyama, Shoichi; Rodriguez-Iturbe, Bernardo; Snchez-Lozada, Laura G.; Bonthron, David T.; Sautin, Yuri Y.; Johnson, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4320-4325, S4320/1-S4320/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Fructose intake from added sugars correlates with the epidemic rise in obesity, metabolic syndrome, and nonalcoholic fatty liver disease.  Fructose intake also causes features of metabolic syndrome in lab. animals and humans.  The first enzyme in fructose metab. is fructokinase, which exists as two isoforms, A and C.  Here we show that fructose-induced metabolic syndrome is prevented in mice lacking both isoforms but is exacerbated in mice lacking fructokinase A.  Fructokinase C is expressed primarily in liver, intestine, and kidney and has high affinity for fructose, resulting in rapid metab. and marked ATP depletion.  In contrast, fructokinase A is widely distributed, has low affinity for fructose, and has less dramatic effects on ATP levels.  By reducing the amt. of fructose for metab. in the liver, fructokinase A protects against fructokinase C-mediated metabolic syndrome.  These studies provide insights into the mechanisms by which fructose causes obesity and metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobK1Ob9TEhNbVg90H21EOLACvtfcHk0lip-FEqFodfZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkslGltbc%253D&md5=fd8c85c10a00df73910e0937a4220b47</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1119908109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1119908109%26sid%3Dliteratum%253Aachs%26aulast%3DIshimoto%26aufirst%3DT.%26aulast%3DLanaspa%26aufirst%3DM.%2BA.%26aulast%3DLe%26aufirst%3DM.%2BT.%26aulast%3DGarcia%26aufirst%3DG.%2BE.%26aulast%3DDiggle%26aufirst%3DC.%2BP.%26aulast%3DMaclean%26aufirst%3DP.%2BS.%26aulast%3DJackman%26aufirst%3DM.%2BR.%26aulast%3DAsipu%26aufirst%3DA.%26aulast%3DRoncal-Jimenez%26aufirst%3DC.%2BA.%26aulast%3DKosugi%26aufirst%3DT.%26aulast%3DRivard%26aufirst%3DC.%2BJ.%26aulast%3DMaruyama%26aufirst%3DS.%26aulast%3DRodriguez-Iturbe%26aufirst%3DB.%26aulast%3DSanchez-Lozada%26aufirst%3DL.%2BG.%26aulast%3DBonthron%26aufirst%3DD.%2BT.%26aulast%3DSautin%26aufirst%3DY.%2BY.%26aulast%3DJohnson%26aufirst%3DR.%2BJ.%26atitle%3DOpposing%2520effects%2520of%2520fructokinase%2520C%2520and%2520A%2520isoforms%2520on%2520fructose-induced%2520metabolic%2520syndrome%2520in%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D4320%26epage%3D4325%26doi%3D10.1073%2Fpnas.1119908109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vos, M. B.</span><span> </span><span class="NLM_article-title">Fructose and liver function--is this behind nonalcoholic liver disease?</span> <span class="citation_source-journal">Curr. Opin. Clin. Nutr. Metab. Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">495</span><span class="refDoi"> DOI: 10.1097/MCO.0000000000000203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1097%2FMCO.0000000000000203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=26203597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlWiu73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2015&pages=490-495&author=R.+Jinauthor=M.+B.+Vos&title=Fructose+and+liver+function%2D%2Dis+this+behind+nonalcoholic+liver+disease%3F&doi=10.1097%2FMCO.0000000000000203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Fructose and liver function - is this behind nonalcoholic liver disease?</span></div><div class="casAuthors">Jin, Ran; Vos, Miriam B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Clinical Nutrition and Metabolic Care</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">490-495</span>CODEN:
                <span class="NLM_cas:coden">COCMF3</span>;
        ISSN:<span class="NLM_cas:issn">1363-1950</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: The purpose was to summarize recent advances in the understanding of nonalcoholic fatty liver disease (NAFLD) pathophysiol. and the role of fructose in NAFLD.  Recent findings: Epidemiol. studies continue to point to a strong assocn. between high fructose intake and NAFLD and its severity.  New studies of NAFLD reveal the importance of upregulated de novo lipogenesis as a key feature in its pathophysiol. along with increased visceral adiposity and alteration of gut microbiome.  Studies of fructose in NAFLD show how this nutrient may uniquely exacerbate the phenotype of NAFLD.  The timing of exposure to fructose may be important with early (in utero) exposure being particularly harmful.  Summary: Fructose is a potentially modifiable environmental exposure that appears to exacerbate NAFLD through multiple mechanisms.  Although larger, longer clin. studies are still needed, it appears that limitation of fructose sources in the diet is beneficial in NAFLD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2sBxW3w-0brVg90H21EOLACvtfcHk0lip-FEqFodfZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlWiu73K&md5=3fa2f3c01e39749ce02a616fe5388632</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1097%2FMCO.0000000000000203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMCO.0000000000000203%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DR.%26aulast%3DVos%26aufirst%3DM.%2BB.%26atitle%3DFructose%2520and%2520liver%2520function--is%2520this%2520behind%2520nonalcoholic%2520liver%2520disease%253F%26jtitle%3DCurr.%2520Opin.%2520Clin.%2520Nutr.%2520Metab.%2520Care%26date%3D2015%26volume%3D18%26spage%3D490%26epage%3D495%26doi%3D10.1097%2FMCO.0000000000000203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schultz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguila, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandarim-de-Lacerda, C. A.</span><span> </span><span class="NLM_article-title">Hepatic adverse effects of fructose consumption independent of overweight/obesity</span> <span class="citation_source-journal">Int. J. Mol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">21873</span><span class="NLM_x">–</span> <span class="NLM_lpage">21886</span><span class="refDoi"> DOI: 10.3390/ijms141121873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.3390%2Fijms141121873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=24196354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltlOnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=21873-21886&author=A.+Schultzauthor=D.+Neilauthor=M.+B.+Aguilaauthor=C.+A.+Mandarim-de-Lacerda&title=Hepatic+adverse+effects+of+fructose+consumption+independent+of+overweight%2Fobesity&doi=10.3390%2Fijms141121873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic adverse effects of fructose consumption independent of overweight/obesity</span></div><div class="casAuthors">Schultz, Alini; Neil, Debora; Aguila, Marcia B.; Mandarim-de-Lacerda, Carlos A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">21873-21886, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The chronic intake of fructose has been linked to insulin resistance, obesity, dyslipidemia and nonalcoholic fatty liver disease (NAFLD), which in turn, may progress to nonalcoholic steatohepatitis (NASH).  We aimed to evaluate the magnitude of the effects of the chronic consumption of high-fructose (HFr) and high fat (HF) alone or combined.  Four groups of male mice were fed different diets for 16 wk: std. chow (9% fat: SC), HF diet (42% fat), HFr diet (34% fructose) and HF/HFr diet (42% fat, 34% fructose).  The food intake was not different among the groups, and the body mass was not greater in the HFr group than in the SC group.  The homeostasis model assessment for insulin resistance (HOMA-IR), as well as plasmatic total cholesterol and triglycerides were greater in the groups HF, HFr and HF/HFr group than in the SC group.  We obsd. in the groups HF, HFr and HF/HFr, compared to the group SC, nonalcoholic fatty liver disease (NAFLD) with a predominance of lipogenesis mediated by SREBP-1c and PPAR-γ, and a redn. of the oxidn. mediated by PPAR-α.  We also obsd. an increase in gluconeogenesis mediated by the GLUT-2 and the PEPCK.  Importantly, we identified areas of necroinflammation indicating a transition from NAFLD to nonalcoholic steatohepatitis in the HFr and HF/HFr groups.  This study is relevant in demonstrating that fructose consumption, even in the absence of obesity, causes serious and deleterious changes in the liver with the presence of the dyslipidemia, insulin resistance (IR) and NAFLD with areas of necroinflammation.  These conditions are assocd. with a poor prognosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0l1MojOHkD7Vg90H21EOLACvtfcHk0lip-FEqFodfZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltlOnsLw%253D&md5=72e7b26099845396727bb9c4e5f75ab5</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.3390%2Fijms141121873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms141121873%26sid%3Dliteratum%253Aachs%26aulast%3DSchultz%26aufirst%3DA.%26aulast%3DNeil%26aufirst%3DD.%26aulast%3DAguila%26aufirst%3DM.%2BB.%26aulast%3DMandarim-de-Lacerda%26aufirst%3DC.%2BA.%26atitle%3DHepatic%2520adverse%2520effects%2520of%2520fructose%2520consumption%2520independent%2520of%2520overweight%252Fobesity%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2013%26volume%3D14%26spage%3D21873%26epage%3D21886%26doi%3D10.3390%2Fijms141121873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sun, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Empie, M. W.</span><span> </span><span class="NLM_article-title">Fructose metabolism in humans - what isotopic tracer studies tell us</span> <span class="citation_source-journal">Nutr. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="refDoi"> DOI: 10.1186/1743-7075-9-89</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1186%2F1743-7075-9-89" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVOrtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=89&author=S.+Z.+Sunauthor=M.+W.+Empie&title=Fructose+metabolism+in+humans+-+what+isotopic+tracer+studies+tell+us&doi=10.1186%2F1743-7075-9-89"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Fructose metabolism in humans - what isotopic tracer studies tell us</span></div><div class="casAuthors">Sun, Sam Z.; Empie, Mark W.</div><div class="citationInfo"><span class="NLM_cas:title">Nutrition & Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89</span>CODEN:
                <span class="NLM_cas:coden">NMUEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1743-7075</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Fructose consumption and its implications on public health are currently under study.  This work reviewed the metabolic fate of dietary fructose based on isotope tracer studies in humans.  The mean oxidn. rate of dietary fructose was 45.0% ± 10.7 (mean ± SD) in non-exercising subjects within 3-6 h and 45.8% ± 7.3 in exercising subjects within 2-3 h.  When fructose was ingested together with glucose, the mean oxidn. rate of the mixed sugars increased to 66.0% ± 8.2 in exercising subjects.  The mean conversion rate from fructose to glucose was 41% ± 10.5 (mean ± SD) in 3-6 h after ingestion.  The conversion amt. from fructose to glycogen remains to be further clarified.  A small percentage of ingested fructose (<1%) appears to be directly converted to plasma TG.  However, hyperlipidemic effects of larger amts. of fructose consumption are obsd. in studies using infused labeled acetate to quantify longer term de novo lipogenesis.  While the mechanisms for the hyperlipidemic effect remain controversial, energy source shifting and lipid sparing may play a role in the effect, in addn. to de novo lipogenesis.  Finally, approx. a quarter of ingested fructose can be converted into lactate within a few of hours.  The reviewed data provides a profile of how dietary fructose is utilized in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKxogOzIq04rVg90H21EOLACvtfcHk0liHSY0he4gLRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVOrtrs%253D&md5=061bfbe4e8f8039444d472da4893e169</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1186%2F1743-7075-9-89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1743-7075-9-89%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%2BZ.%26aulast%3DEmpie%26aufirst%3DM.%2BW.%26atitle%3DFructose%2520metabolism%2520in%2520humans%2520-%2520what%2520isotopic%2520tracer%2520studies%2520tell%2520us%26jtitle%3DNutr.%2520Metab.%26date%3D2012%26volume%3D9%26spage%3D89%26doi%3D10.1186%2F1743-7075-9-89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Abdelmalek, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unalp-Arida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colvin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonalcoholic Steatohepatitis Clinical Research Network.</span><span> </span><span class="NLM_article-title">Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1961</span><span class="NLM_x">–</span> <span class="NLM_lpage">1971</span><span class="refDoi"> DOI: 10.1002/hep.23535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1002%2Fhep.23535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=20301112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnslyqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=1961-1971&author=M.+F.+Abdelmalekauthor=A.+Suzukiauthor=C.+Guyauthor=A.+Unalp-Aridaauthor=R.+Colvinauthor=R.+J.+Johnsonauthor=A.+M.+Diehlauthor=Nonalcoholic+Steatohepatitis+Clinical+Research+Network.&title=Increased+fructose+consumption+is+associated+with+fibrosis+severity+in+patients+with+nonalcoholic+fatty+liver+disease&doi=10.1002%2Fhep.23535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4dR"><div class="casContent"><span class="casTitleNuber">4d</span><div class="casTitle"><span class="NLM_cas:atitle">Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease</span></div><div class="casAuthors">Abdelmalek, Manal F.; Suzuki, Ayako; Guy, Cynthia; Unalp-Arida, Aynur; Colvin, Ryan; Johnson, Richard J.; Diehl, Anna Mae</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1961-1971</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The rising incidence of obesity and diabetes coincides with a marked increase in fructose consumption.  Fructose consumption is higher in individuals with nonalcoholic fatty liver disease (NAFLD) than in age-matched and body mass index (BMI)-matched controls.  Because fructose elicits metabolic perturbations that may be hepatotoxic, we investigated the relationship between fructose consumption and disease severity in NAFLD.  We studied 427 adults enrolled in the NASH Clin. Research Network for whom Block food questionnaire data were collected within 3 mo of a liver biopsy.  Fructose consumption was estd. based on reporting (frequency × amt.) of Kool-aid, fruit juices, and nondietary soda intake, expressed as servings per wk, and classified into none, min. to moderate (<7 servings/wk), and daily (≥7 servings/wk).  The assocn. of fructose intake with metabolic and histol. features of NAFLD was analyzed using multiple linear and ordinal logistic regression analyses with and without controlling for other confounding factors.  Increased fructose consumption was univariately assocd. with decreased age (P < 0.0001), male sex (P < 0.0001), hypertriglyceridemia (P < 0.04), low high-d. lipoprotein (HDL) cholesterol (<0.0001), decreased serum glucose (P < 0.001), increased calorie intake (P < 0.0001), and hyperuricemia (P < 0.0001).  After controlling for age, sex, BMI, and total calorie intake, daily fructose consumption was assocd. with lower steatosis grade and higher fibrosis stage (P < 0.05 for each).  In older adults (age ≥ 48 years), daily fructose consumption was assocd. with increased hepatic inflammation (P < 0.05) and hepatocyte ballooning (P = 0.05).  Conclusion: In patients with NAFLD, daily fructose ingestion is assocd. with reduced hepatic steatosis but increased fibrosis.  These results identify a readily modifiable environmental risk factor that may ameliorate disease progression in patients with NAFLD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoelIWrtgd0ZrVg90H21EOLACvtfcHk0liHSY0he4gLRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnslyqsbg%253D&md5=7b9b16653f15980048b9bc3148262989</span></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1002%2Fhep.23535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.23535%26sid%3Dliteratum%253Aachs%26aulast%3DAbdelmalek%26aufirst%3DM.%2BF.%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DGuy%26aufirst%3DC.%26aulast%3DUnalp-Arida%26aufirst%3DA.%26aulast%3DColvin%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DR.%2BJ.%26aulast%3DDiehl%26aufirst%3DA.%2BM.%26aulast%3D%26atitle%3DIncreased%2520fructose%2520consumption%2520is%2520associated%2520with%2520fibrosis%2520severity%2520in%2520patients%2520with%2520nonalcoholic%2520fatty%2520liver%2520disease%26jtitle%3DHepatology%26date%3D2010%26volume%3D51%26spage%3D1961%26epage%3D1971%26doi%3D10.1002%2Fhep.23535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Ouyang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sautin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruchette, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdelmalek, M. F.</span><span> </span><span class="NLM_article-title">Fructose consumption as a risk factor for non-alcoholic fatty liver disease</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">999</span><span class="refDoi"> DOI: 10.1016/j.jhep.2008.02.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1016%2Fj.jhep.2008.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=18395287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvVSksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=993-999&author=X.+Ouyangauthor=P.+Cirilloauthor=Y.+Sautinauthor=S.+McCallauthor=J.+L.+Bruchetteauthor=A.+M.+Diehlauthor=R.+J.+Johnsonauthor=M.+F.+Abdelmalek&title=Fructose+consumption+as+a+risk+factor+for+non-alcoholic+fatty+liver+disease&doi=10.1016%2Fj.jhep.2008.02.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4eR"><div class="casContent"><span class="casTitleNuber">4e</span><div class="casTitle"><span class="NLM_cas:atitle">Fructose consumption as a risk factor for non-alcoholic fatty liver disease</span></div><div class="casAuthors">Ouyang, Xiaosen; Cirillo, Pietro; Sautin, Yuri; McCall, Shannon; Bruchette, James L.; Diehl, Anna Mae; Johnson, Richard J.; Abdelmalek, Manal F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">993-999</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">While the rise in non-alc. fatty liver disease (NAFLD) parallels the increase in obesity and diabetes, a significant increase in dietary fructose consumption in industrialized countries has also occurred.  The increased consumption of high fructose corn syrup, primarily in the form of soft drinks, is linked with complications of the insulin resistance syndrome.  Furthermore, the hepatic metab. of fructose favors de novo lipogenesis and ATP depletion.  We hypothesize that increased fructose consumption contributes to the development of NAFLD.  A dietary history and paired serum and liver tissue were obtained from patients with evidence of biopsy-proven NAFLD (n = 49) without cirrhosis and controls (n = 24) matched for gender, age (±5 years), and body mass index (±3 points).  Consumption of fructose in patients with NAFLD was nearly 2- to 3-fold higher than controls [365 kcal vs 170 kcal (p < 0.05)].  In patients with NAFLD (n = 6), hepatic mRNA expression of fructokinase (KHK), an important enzyme for fructose metab., and fatty acid synthase, an important enzyme for lipogenesis were increased (p = 0.04 and p = 0.02, resp.).  In an AML hepatocyte cell line, fructose resulted in dose-dependent increase in KHK protein and activity.  The pathogenic mechanism underlying the development of NAFLD may be assocd. with excessive dietary fructose consumption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-_vja7yTvALVg90H21EOLACvtfcHk0liHSY0he4gLRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvVSksLk%253D&md5=f18d8203b7ff8d756359ca120296a6da</span></div><a href="/servlet/linkout?suffix=cit4e&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2008.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2008.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DOuyang%26aufirst%3DX.%26aulast%3DCirillo%26aufirst%3DP.%26aulast%3DSautin%26aufirst%3DY.%26aulast%3DMcCall%26aufirst%3DS.%26aulast%3DBruchette%26aufirst%3DJ.%2BL.%26aulast%3DDiehl%26aufirst%3DA.%2BM.%26aulast%3DJohnson%26aufirst%3DR.%2BJ.%26aulast%3DAbdelmalek%26aufirst%3DM.%2BF.%26atitle%3DFructose%2520consumption%2520as%2520a%2520risk%2520factor%2520for%2520non-alcoholic%2520fatty%2520liver%2520disease%26jtitle%3DJ.%2520Hepatol.%26date%3D2008%26volume%3D48%26spage%3D993%26epage%3D999%26doi%3D10.1016%2Fj.jhep.2008.02.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Softic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, C. R.</span><span> </span><span class="NLM_article-title">Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease</span> <span class="citation_source-journal">Dig. Dis. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1282</span><span class="NLM_x">–</span> <span class="NLM_lpage">1293</span><span class="refDoi"> DOI: 10.1007/s10620-016-4054-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1007%2Fs10620-016-4054-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=26856717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC28Xis1aksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2016&pages=1282-1293&author=S.+Softicauthor=D.+E.+Cohenauthor=C.+R.+Kahn&title=Role+of+dietary+fructose+and+hepatic+de+novo+lipogenesis+in+fatty+liver+disease&doi=10.1007%2Fs10620-016-4054-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease</span></div><div class="casAuthors">Softic, Samir; Cohen, David E.; Kahn, C. Ronald</div><div class="citationInfo"><span class="NLM_cas:title">Digestive Diseases and Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1282-1293</span>CODEN:
                <span class="NLM_cas:coden">DDSCDJ</span>;
        ISSN:<span class="NLM_cas:issn">0163-2116</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Nonalcoholic fatty liver disease (NAFLD) is a liver manifestation of metabolic syndrome.  Overconsumption of high-fat diet (HFD) and increased intake of sugar-sweetened beverages are major risk factors for development of NAFLD.  Today the most commonly consumed sugar is high fructose corn syrup.  Hepatic lipids may be derived from dietary intake, esterification of plasma free fatty acids (FFA) or hepatic de novo lipogenesis (DNL).  A central abnormality in NAFLD is enhanced DNL.  Hepatic DNL is increased in individuals with NAFLD, while the contribution of dietary fat and plasma FFA to hepatic lipids is not significantly altered.  The importance of DNL in NAFLD is further established in mouse studies with knockout of genes involved in this process.  Dietary fructose increases levels of enzymes involved in DNL even more strongly than HFD.  Several properties of fructose metab. make it particularly lipogenic.  Fructose is absorbed via portal vein and delivered to the liver in much higher concns. as compared to other tissues.  Fructose increases protein levels of all DNL enzymes during its conversion into triglycerides.  Addnl., fructose supports lipogenesis in the setting of insulin resistance as fructose does not require insulin for its metab., and it directly stimulates SREBP1c, a major transcriptional regulator of DNL.  Fructose also leads to ATP depletion and suppression of mitochondrial fatty acid oxidn., resulting in increased prodn. of reactive oxygen species.  Furthermore, fructose promotes ER stress and uric acid formation, addnl. insulin independent pathways leading to DNL.  In summary, fructose metab. supports DNL more strongly than HFD and hepatic DNL is a central abnormality in NAFLD.  Disrupting fructose metab. in the liver may provide a new therapeutic option for the treatment of NAFLD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrovDr4GnQvCrVg90H21EOLACvtfcHk0lgV-K8JMAGK5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xis1aksrc%253D&md5=02f8d6d99e6f494749dc06f8a96d7eba</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1007%2Fs10620-016-4054-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10620-016-4054-0%26sid%3Dliteratum%253Aachs%26aulast%3DSoftic%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DD.%2BE.%26aulast%3DKahn%26aufirst%3DC.%2BR.%26atitle%3DRole%2520of%2520dietary%2520fructose%2520and%2520hepatic%2520de%2520novo%2520lipogenesis%2520in%2520fatty%2520liver%2520disease%26jtitle%3DDig.%2520Dis.%2520Sci.%26date%3D2016%26volume%3D61%26spage%3D1282%26epage%3D1293%26doi%3D10.1007%2Fs10620-016-4054-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Herman, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuel, V. T.</span><span> </span><span class="NLM_article-title">The sweet path to metabolic demise: fructose and lipid synthesis</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">719</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span><span class="refDoi"> DOI: 10.1016/j.tem.2016.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1016%2Fj.tem.2016.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=27387598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKnsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=719-730&author=M.+A.+Hermanauthor=V.+T.+Samuel&title=The+sweet+path+to+metabolic+demise%3A+fructose+and+lipid+synthesis&doi=10.1016%2Fj.tem.2016.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis</span></div><div class="casAuthors">Herman, Mark A.; Samuel, Varman T.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">719-730</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Epidemiol. studies link fructose consumption with metabolic disease, an assocn. attributable in part to fructose-mediated lipogenesis.  The mechanisms governing fructose-induced lipogenesis and disease remain debated.  Acutely, fructose increases de novo lipogenesis through the efficient and uninhibited action of ketohexokinase and aldolase B which yields substrates for fatty-acid synthesis.  Chronic fructose consumption further enhances the capacity for hepatic fructose metab. by activating several key transcription factors (i.e., SREBP1c and ChREBP) which augment the expression of lipogenic enzymes, increasing lipogenesis and further compounding hypertriglyceridemia and hepatic steatosis.  Hepatic insulin resistance develops from diacylglycerol-PKCε-mediated impairment of insulin signaling and possibly addnl. mechanisms.  Initiatives that decrease fructose consumption and therapies that block fructose-mediated lipogenesis will be necessary to avert future metabolic pandemics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlgluy07wBArVg90H21EOLACvtfcHk0lgV-K8JMAGK5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKnsbnN&md5=2ae1fabbad2bfb2b1674e1b799b54717</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2016.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2016.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DHerman%26aufirst%3DM.%2BA.%26aulast%3DSamuel%26aufirst%3DV.%2BT.%26atitle%3DThe%2520sweet%2520path%2520to%2520metabolic%2520demise%253A%2520fructose%2520and%2520lipid%2520synthesis%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2016%26volume%3D27%26spage%3D719%26epage%3D730%26doi%3D10.1016%2Fj.tem.2016.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kim, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krawczyk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doridot, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trauger, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noh, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meissen, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatnik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, M. A.</span><span> </span><span class="NLM_article-title">ChREBP regulates fructose-induced glucose production independently of insulin signaling</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">4372</span><span class="NLM_x">–</span> <span class="NLM_lpage">4386</span><span class="refDoi"> DOI: 10.1172/JCI81993</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1172%2FJCI81993" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2016&pages=4372-4386&author=M.+S.+Kimauthor=S.+A.+Krawczykauthor=L.+Doridotauthor=A.+J.+Fowlerauthor=J.+X.+Wangauthor=S.+A.+Traugerauthor=H.+L.+Nohauthor=H.+J.+Kangauthor=J.+K.+Meissenauthor=M.+Blatnikauthor=J.+K.+Kimauthor=M.+Laiauthor=M.+A.+Herman&title=ChREBP+regulates+fructose-induced+glucose+production+independently+of+insulin+signaling&doi=10.1172%2FJCI81993"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1172%2FJCI81993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI81993%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.%2BS.%26aulast%3DKrawczyk%26aufirst%3DS.%2BA.%26aulast%3DDoridot%26aufirst%3DL.%26aulast%3DFowler%26aufirst%3DA.%2BJ.%26aulast%3DWang%26aufirst%3DJ.%2BX.%26aulast%3DTrauger%26aufirst%3DS.%2BA.%26aulast%3DNoh%26aufirst%3DH.%2BL.%26aulast%3DKang%26aufirst%3DH.%2BJ.%26aulast%3DMeissen%26aufirst%3DJ.%2BK.%26aulast%3DBlatnik%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DJ.%2BK.%26aulast%3DLai%26aufirst%3DM.%26aulast%3DHerman%26aufirst%3DM.%2BA.%26atitle%3DChREBP%2520regulates%2520fructose-induced%2520glucose%2520production%2520independently%2520of%2520insulin%2520signaling%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2016%26volume%3D126%26spage%3D4372%26epage%3D4386%26doi%3D10.1172%2FJCI81993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Erion, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vatner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonemitsu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillum, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manchem, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhanot, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cline, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shulman, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuel, V. T.</span><span> </span><span class="NLM_article-title">The role of the carbohydrate response element-binding protein in male fructose-fed rats</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span><span class="refDoi"> DOI: 10.1210/en.2012-1725</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1210%2Fen.2012-1725" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=36-44&author=D.+M.+Erionauthor=V.+Popovauthor=J.+J.+Hsiaoauthor=D.+Vatnerauthor=K.+Mitchellauthor=S.+Yonemitsuauthor=Y.+Nagaiauthor=M.+Kahnauthor=M.+P.+Gillumauthor=J.+Dongauthor=S.+F.+Murrayauthor=V.+P.+Manchemauthor=S.+Bhanotauthor=G.+W.+Clineauthor=G.+I.+Shulmanauthor=V.+T.+Samuel&title=The+role+of+the+carbohydrate+response+element-binding+protein+in+male+fructose-fed+rats&doi=10.1210%2Fen.2012-1725"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1210%2Fen.2012-1725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2012-1725%26sid%3Dliteratum%253Aachs%26aulast%3DErion%26aufirst%3DD.%2BM.%26aulast%3DPopov%26aufirst%3DV.%26aulast%3DHsiao%26aufirst%3DJ.%2BJ.%26aulast%3DVatner%26aufirst%3DD.%26aulast%3DMitchell%26aufirst%3DK.%26aulast%3DYonemitsu%26aufirst%3DS.%26aulast%3DNagai%26aufirst%3DY.%26aulast%3DKahn%26aufirst%3DM.%26aulast%3DGillum%26aufirst%3DM.%2BP.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DMurray%26aufirst%3DS.%2BF.%26aulast%3DManchem%26aufirst%3DV.%2BP.%26aulast%3DBhanot%26aufirst%3DS.%26aulast%3DCline%26aufirst%3DG.%2BW.%26aulast%3DShulman%26aufirst%3DG.%2BI.%26aulast%3DSamuel%26aufirst%3DV.%2BT.%26atitle%3DThe%2520role%2520of%2520the%2520carbohydrate%2520response%2520element-binding%2520protein%2520in%2520male%2520fructose-fed%2520rats%26jtitle%3DEndocrinology%26date%3D2013%26volume%3D154%26spage%3D36%26epage%3D44%26doi%3D10.1210%2Fen.2012-1725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Stanhope, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medici, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bremer, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunez, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keim, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havel, P. J.</span><span> </span><span class="NLM_article-title">A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults</span> <span class="citation_source-journal">Am. J. Clin. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">1144</span><span class="NLM_x">–</span> <span class="NLM_lpage">1154</span><span class="refDoi"> DOI: 10.3945/ajcn.114.100461</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.3945%2Fajcn.114.100461" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=25904601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOgtrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2015&pages=1144-1154&author=K.+L.+Stanhopeauthor=V.+Mediciauthor=A.+A.+Bremerauthor=V.+Leeauthor=H.+D.+Lamauthor=M.+V.+Nunezauthor=G.+X.+Chenauthor=N.+L.+Keimauthor=P.+J.+Havel&title=A+dose-response+study+of+consuming+high-fructose+corn+syrup-sweetened+beverages+on+lipid%2Flipoprotein+risk+factors+for+cardiovascular+disease+in+young+adults&doi=10.3945%2Fajcn.114.100461"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults</span></div><div class="casAuthors">Stanhope, Kimber L.; Medici, Valentina; Bremer, Andrew A.; Lee, Vivien; Lam, Hazel D.; Nunez, Marinelle V.; Chen, Guoxia X.; Keim, Nancy L.; Havel, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Clinical Nutrition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1144-1454</span>CODEN:
                <span class="NLM_cas:coden">AJCNAC</span>;
        ISSN:<span class="NLM_cas:issn">0002-9165</span>.
    
            (<span class="NLM_cas:orgname">American Society for Nutrition</span>)
        </div><div class="casAbstract">Background: National Health and Nutrition Examn. Survey data show an increased risk of cardiovascular disease (CVD) mortality with an increased intake of added sugar.  Objective: We detd. the dose-response effects of consuming beverages sweetened with high-fructose corn syrup (HFCS) at zero, low, medium, and high proportions of energy requirements (Ereq) on circulating lipid/lipoprotein risk factors for CVD and uric acid in adults [age: 18-40 y; body mass index (in kg/m2): 18-35].  Design: We conducted a parallel-arm, nonrandomized, double-blinded intervention study in which adults participated in 3.5 inpatient days of baseline testing at the University of California Davis Clin. and Translational Science Center's Clin. Research Center.  Participants then consumed beverages sweetened with HFCS at 0% (aspartame sweetened, n = 23), 10% (n = 18), 17.5% (n = 16), or 25% (n = 28) of Ereq during 13 outpatient days and during 3.5 inpatient days of intervention testing at the research center.  We conducted 24-h serial blood collections during the baseline and intervention testing periods.  Results: Consuming beverages contg. 10%, 17.5%, or 25% Ereq from HFCS produced significant linear dose-response increases of lipid/lipoprotein risk factors for CVD and uric acid: postprandial triglyceride (0%: 0 ± 4; 10%: 22 ± 8; 17.5%: 25 ± 5: 25%: 37 ± 5 mg/dL, mean of Δ ± SE, P < 0.0001 effect of HFCS-dose), fasting LDL cholesterol (0%: -1.0 ± 3.1; 10%: 7.4 ± 3.2; 17.5%: 8.2 ± 3.1; 25%: 15.9 ± 3.1 mg/dL, P < 0.0001), and 24-h mean uric acid concns. (0%: -0.13 ± 0.07; 10%: 0.15 ± 0.06; 17.5%: 0.30 ± 0.07; 25%: 0.59 ± 0.09 mg/dL, P < 0.0001).  Compared with beverages contg. 0% HFCS, all 3 doses of HFCS-contg. beverages increased concns. of postprandial triglyceride, and the 2 higher doses increased fasting and/or postprandial concns. of non-HDL cholesterol, LDL cholesterol, apolipoprotein B, apolipoprotein CIII, and uric acid.  Conclusions: Consuming beverages contg. 10%, 17.5%, or 25% Ereq from HFCS produced dose-dependent increases in circulating lipid/lipoprotein risk factors for CVD and uric acid within 2 wk.  These results provide mechanistic support for the epidemiol. evidence that the risk of cardiovascular mortality is pos. assocd. with consumption of increasing amts. of added sugars.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb3V0OYkg-Q7Vg90H21EOLACvtfcHk0lhs9-7T7giDpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOgtrfP&md5=86ffd09c1984920985eb5a5c735be761</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.3945%2Fajcn.114.100461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3945%252Fajcn.114.100461%26sid%3Dliteratum%253Aachs%26aulast%3DStanhope%26aufirst%3DK.%2BL.%26aulast%3DMedici%26aufirst%3DV.%26aulast%3DBremer%26aufirst%3DA.%2BA.%26aulast%3DLee%26aufirst%3DV.%26aulast%3DLam%26aufirst%3DH.%2BD.%26aulast%3DNunez%26aufirst%3DM.%2BV.%26aulast%3DChen%26aufirst%3DG.%2BX.%26aulast%3DKeim%26aufirst%3DN.%2BL.%26aulast%3DHavel%26aufirst%3DP.%2BJ.%26atitle%3DA%2520dose-response%2520study%2520of%2520consuming%2520high-fructose%2520corn%2520syrup-sweetened%2520beverages%2520on%2520lipid%252Flipoprotein%2520risk%2520factors%2520for%2520cardiovascular%2520disease%2520in%2520young%2520adults%26jtitle%3DAm.%2520J.%2520Clin.%2520Nutr.%26date%3D2015%26volume%3D101%26spage%3D1144%26epage%3D1154%26doi%3D10.3945%2Fajcn.114.100461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Stanhope, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keim, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffen, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bremer, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatcher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyachenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGahan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauss, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otokozawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beysen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellerstein, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berglund, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havel, P. J.</span><span> </span><span class="NLM_article-title">Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">1322</span><span class="NLM_x">–</span> <span class="NLM_lpage">1334</span><span class="refDoi"> DOI: 10.1172/JCI37385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1172%2FJCI37385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=19381015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFyrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=1322-1334&author=K.+L.+Stanhopeauthor=J.+M.+Schwarzauthor=N.+L.+Keimauthor=S.+C.+Griffenauthor=A.+A.+Bremerauthor=J.+L.+Grahamauthor=B.+Hatcherauthor=C.+L.+Coxauthor=A.+Dyachenkoauthor=W.+Zhangauthor=J.+P.+McGahanauthor=A.+Seibertauthor=R.+M.+Kraussauthor=S.+Chiuauthor=E.+J.+Schaeferauthor=M.+Aiauthor=S.+Otokozawaauthor=K.+Nakajimaauthor=T.+Nakanoauthor=C.+Beysenauthor=M.+K.+Hellersteinauthor=L.+Berglundauthor=P.+J.+Havel&title=Consuming+fructose-sweetened%2C+not+glucose-sweetened%2C+beverages+increases+visceral+adiposity+and+lipids+and+decreases+insulin+sensitivity+in+overweight%2Fobese+humans&doi=10.1172%2FJCI37385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans</span></div><div class="casAuthors">Stanhope, Kimber L.; Schwarz, Jean Marc; Keim, Nancy L.; Griffen, Steven C.; Bremer, Andrew A.; Graham, James L.; Hatcher, Bonnie; Cox, Chad L.; Dyachenko, Artem; Zhang, Wei; McGahan, John P.; Seibert, Anthony; Krauss, Ronald M.; Chiu, Sally; Schaefer, Ernst J.; Ai, Masumi; Otokozawa, Seiko; Nakajima, Katsuyuki; Nakano, Takamitsu; Beysen, Carine; Hellerstein, Marc K.; Berglund, Lars; Havel, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1322-1334</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Studies in animals have documented that, compared with glucose, dietary fructose induces dyslipidemia and insulin resistance.  To assess the relative effects of these dietary sugars during sustained consumption in humans, overweight and obese subjects consumed glucose- or fructose-sweetened beverages providing 25% of energy requirements for 10 wk.  Although both groups exhibited similar wt. gain during the intervention, visceral adipose vol. was significantly increased only in subjects consuming fructose.  Fasting plasma triglyceride concns. increased by approx. 10% during 10 wk of glucose consumption but not after fructose consumption.  In contrast, hepatic de novo lipogenesis (DNL) and the 23-h postprandial triglyceride AUC were increased specifically during fructose consumption.  Similarly, markers of altered lipid metab. and lipoprotein remodeling, including fasting apoB, LDL, small dense LDL, oxidized LDL, and postprandial concns. of remnant-like particle-triglyceride and -cholesterol significantly increased during fructose but not glucose consumption.  In addn., fasting plasma glucose and insulin levels increased and insulin sensitivity decreased in subjects consuming fructose but not in those consuming glucose.  These data suggest that dietary fructose specifically increases DNL, promotes dyslipidemia, decreases insulin sensitivity, and increases visceral adiposity in overweight/obese adults.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGNXGbG-wmzLVg90H21EOLACvtfcHk0lhs9-7T7giDpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFyrtrg%253D&md5=aeac5902da6dc4d0ae1a023f3b22d536</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1172%2FJCI37385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI37385%26sid%3Dliteratum%253Aachs%26aulast%3DStanhope%26aufirst%3DK.%2BL.%26aulast%3DSchwarz%26aufirst%3DJ.%2BM.%26aulast%3DKeim%26aufirst%3DN.%2BL.%26aulast%3DGriffen%26aufirst%3DS.%2BC.%26aulast%3DBremer%26aufirst%3DA.%2BA.%26aulast%3DGraham%26aufirst%3DJ.%2BL.%26aulast%3DHatcher%26aufirst%3DB.%26aulast%3DCox%26aufirst%3DC.%2BL.%26aulast%3DDyachenko%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DMcGahan%26aufirst%3DJ.%2BP.%26aulast%3DSeibert%26aufirst%3DA.%26aulast%3DKrauss%26aufirst%3DR.%2BM.%26aulast%3DChiu%26aufirst%3DS.%26aulast%3DSchaefer%26aufirst%3DE.%2BJ.%26aulast%3DAi%26aufirst%3DM.%26aulast%3DOtokozawa%26aufirst%3DS.%26aulast%3DNakajima%26aufirst%3DK.%26aulast%3DNakano%26aufirst%3DT.%26aulast%3DBeysen%26aufirst%3DC.%26aulast%3DHellerstein%26aufirst%3DM.%2BK.%26aulast%3DBerglund%26aufirst%3DL.%26aulast%3DHavel%26aufirst%3DP.%2BJ.%26atitle%3DConsuming%2520fructose-sweetened%252C%2520not%2520glucose-sweetened%252C%2520beverages%2520increases%2520visceral%2520adiposity%2520and%2520lipids%2520and%2520decreases%2520insulin%2520sensitivity%2520in%2520overweight%252Fobese%2520humans%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2009%26volume%3D119%26spage%3D1322%26epage%3D1334%26doi%3D10.1172%2FJCI37385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lustig, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noworolski, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erkin-Cakmak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gugliucci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, J. M.</span><span> </span><span class="NLM_article-title">Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome</span> <span class="citation_source-journal">Obesity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span><span class="refDoi"> DOI: 10.1002/oby.21371</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1002%2Foby.21371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=26499447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvV2lsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=453-460&author=R.+H.+Lustigauthor=K.+Mulliganauthor=S.+M.+Noworolskiauthor=V.+W.+Taiauthor=M.+J.+Wenauthor=A.+Erkin-Cakmakauthor=A.+Gugliucciauthor=J.+M.+Schwarz&title=Isocaloric+fructose+restriction+and+metabolic+improvement+in+children+with+obesity+and+metabolic+syndrome&doi=10.1002%2Foby.21371"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome</span></div><div class="casAuthors">Lustig, Robert H.; Mulligan, Kathleen; Noworolski, Susan M.; Tai, Viva W.; Wen, Michael J.; Erkin-Cakmak, Ayca; Gugliucci, Alejandro; Schwarz, Jean-Marc</div><div class="citationInfo"><span class="NLM_cas:title">Obesity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">453-460</span>CODEN:
                <span class="NLM_cas:coden">OBESAX</span>;
        ISSN:<span class="NLM_cas:issn">1930-7381</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : Dietary fructose is implicated in metabolic syndrome, but intervention studies are confounded by pos. caloric balance, changes in adiposity, or artifactually high amts.  This study detd. whether isocaloric substitution of starch for sugar would improve metabolic parameters in Latino (n = 27) and African-American (n = 16) children with obesity and metabolic syndrome.  Methods : Participants consumed a diet for 9 days to deliver comparable percentages of protein, fat, and carbohydrate as their self-reported diet; however, dietary sugar was reduced from 28% to 10% and substituted with starch.  Participants recorded daily wts., with calories adjusted for wt. maintenance.  Participants underwent dual-energy X-ray absorptiometry and oral glucose tolerance testing on Days 0 and 10.  Biochem. analyses were controlled for wt. change by repeated measures ANCOVA.  Results : Redns. in diastolic blood pressure (-5 mmHg; P = 0.002), lactate (-0.3 mmol/L; P < 0.001), triglyceride, and LDL-cholesterol (-46% and -0.3 mmol/L; P < 0.001) were noted.  Glucose tolerance and hyperinsulinemia improved (P < 0.001).  Wt. reduced by 0.9 ± 0.2 kg (P < 0.001) and fat-free mass by 0.6 kg (P = 0.04).  Post hoc sensitivity anal. demonstrates that results in the subcohort that did not lose wt. (n = 10) were directionally consistent.  Conclusions : Isocaloric fructose restriction improved surrogate metabolic parameters in children with obesity and metabolic syndrome irresp. of wt. change.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK8UFgsIj787Vg90H21EOLACvtfcHk0lhs9-7T7giDpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvV2lsbs%253D&md5=4486cd76573a96339298ecb5b7694da8</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1002%2Foby.21371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Foby.21371%26sid%3Dliteratum%253Aachs%26aulast%3DLustig%26aufirst%3DR.%2BH.%26aulast%3DMulligan%26aufirst%3DK.%26aulast%3DNoworolski%26aufirst%3DS.%2BM.%26aulast%3DTai%26aufirst%3DV.%2BW.%26aulast%3DWen%26aufirst%3DM.%2BJ.%26aulast%3DErkin-Cakmak%26aufirst%3DA.%26aulast%3DGugliucci%26aufirst%3DA.%26aulast%3DSchwarz%26aufirst%3DJ.%2BM.%26atitle%3DIsocaloric%2520fructose%2520restriction%2520and%2520metabolic%2520improvement%2520in%2520children%2520with%2520obesity%2520and%2520metabolic%2520syndrome%26jtitle%3DObesity%26date%3D2016%26volume%3D24%26spage%3D453%26epage%3D460%26doi%3D10.1002%2Foby.21371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schwarz, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noworolski, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyachenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herraiz, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bersot, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schambelan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, K.</span><span> </span><span class="NLM_article-title">Effect of a high-fructose weight-maintaining diet on lipogenesis and liver fat</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">2434</span><span class="NLM_x">–</span> <span class="NLM_lpage">2442</span><span class="refDoi"> DOI: 10.1210/jc.2014-3678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1210%2Fjc.2014-3678" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=25825943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOru7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=2434-2442&author=J.+M.+Schwarzauthor=S.+M.+Noworolskiauthor=M.+J.+Wenauthor=A.+Dyachenkoauthor=J.+L.+Priorauthor=M.+E.+Weinbergauthor=L.+A.+Herraizauthor=V.+W.+Taiauthor=N.+Bergeronauthor=T.+P.+Bersotauthor=M.+N.+Raoauthor=M.+Schambelanauthor=K.+Mulligan&title=Effect+of+a+high-fructose+weight-maintaining+diet+on+lipogenesis+and+liver+fat&doi=10.1210%2Fjc.2014-3678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of a high-fructose weight-maintaining diet on lipogenesis and liver fat</span></div><div class="casAuthors">Schwarz, Jean-Marc; Noworolski, Susan M.; Wen, Michael J.; Dyachenko, Artem; Prior, Jessica L.; Weinberg, Melissa E.; Herraiz, Laurie A.; Tai, Viva W.; Bergeron, Nathalie; Bersot, Thomas P.; Rao, Madhu N.; Schambelan, Morris; Mulligan, Kathleen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2434-2442</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Context: Consumption of high-fructose diets promotes hepatic fatty acid synthesis (de novo lipogenesis [DNL]) and an atherogenic lipid profile.  It is unclear whether these effects occur independent of pos. energy balance and wt. gain.  Objectives: We compared the effects of a high-fructose, (25% of energy content) wt.-maintaining diet to those of an isocaloric diet with the same macronutrient distribution but in which complex carbohydrate (CCHO) was substituted for fructose.  Design, Setting, and Participants: Eight healthy men were studied as inpatients for consecutive 9-day periods.  Stable isotope tracers were used to measure fractional hepatic DNL and endogenous glucose prodn. (EGP) and its suppression during a euglycemic-hyperinsulinemic clamp.  Liver fat was measured by magnetic resonance spectroscopy.  Results: Wt. remained stable.  Regardless of the order in which the diets were fed, the high-fructose diet was assocd. with both higher DNL (av., 18.6 ± 1.4% vs 11.0 ± 1.4% for CCHO; P = .001) and higher liver fat (median, +137% of CCHO; P = .016) in all participants.  Fasting EGP and insulin-mediated glucose disposal did not differ significantly, but EGP during hyperinsulinemia was greater (0.60 ± 0.07 vs 0.46 ± 0.06 mg/kg/min; P = .013) with the high-fructose diet, suggesting blunted suppression of EGP.  Conclusion: Short-term high-fructose intake was assocd. with increased DNL and liver fat in healthy men fed wt.-maintaining diets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS65RvfxkRA7Vg90H21EOLACvtfcHk0lirTCy7rhCbcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOru7fO&md5=ce05c14d39d8b6e743eaeff71b3c18ed</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1210%2Fjc.2014-3678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2014-3678%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarz%26aufirst%3DJ.%2BM.%26aulast%3DNoworolski%26aufirst%3DS.%2BM.%26aulast%3DWen%26aufirst%3DM.%2BJ.%26aulast%3DDyachenko%26aufirst%3DA.%26aulast%3DPrior%26aufirst%3DJ.%2BL.%26aulast%3DWeinberg%26aufirst%3DM.%2BE.%26aulast%3DHerraiz%26aufirst%3DL.%2BA.%26aulast%3DTai%26aufirst%3DV.%2BW.%26aulast%3DBergeron%26aufirst%3DN.%26aulast%3DBersot%26aufirst%3DT.%2BP.%26aulast%3DRao%26aufirst%3DM.%2BN.%26aulast%3DSchambelan%26aufirst%3DM.%26aulast%3DMulligan%26aufirst%3DK.%26atitle%3DEffect%2520of%2520a%2520high-fructose%2520weight-maintaining%2520diet%2520on%2520lipogenesis%2520and%2520liver%2520fat%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2015%26volume%3D100%26spage%3D2434%26epage%3D2442%26doi%3D10.1210%2Fjc.2014-3678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Abid, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taha, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nseir, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosovski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assy, N.</span><span> </span><span class="NLM_article-title">Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">918</span><span class="NLM_x">–</span> <span class="NLM_lpage">924</span><span class="refDoi"> DOI: 10.1016/j.jhep.2009.05.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1016%2Fj.jhep.2009.05.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=19765850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1CqurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2009&pages=918-924&author=A.+Abidauthor=O.+Tahaauthor=W.+Nseirauthor=R.+Farahauthor=M.+Grosovskiauthor=N.+Assy&title=Soft+drink+consumption+is+associated+with+fatty+liver+disease+independent+of+metabolic+syndrome&doi=10.1016%2Fj.jhep.2009.05.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome</span></div><div class="casAuthors">Abid, Ali; Taha, Ola; Nseir, William; Farah, Raymond; Grosovski, Maria; Assy, Nimer</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">918-924</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Background/Aims: The independent role of soft drink consumption in non-alc. fatty liver disease (NAFLD) patients remains unclear.  We aimed to assess the assocn. between consumption of soft drinks and fatty liver in patients with or without metabolic syndrome.  Methods: We recruited 31 patients (age: 43 ± 12 years) with NAFLD and risk factors for metabolic syndrome, 29 patients with NAFLD and without risk factors for metabolic syndrome, and 30 gender- and age-matched individuals without NAFLD.  The degree of fatty infiltration was measured by ultrasound.  Data on phys. activity and intake of food and soft drinks were collected during two 7-day periods over 6 mo using a food questionnaire.  Insulin resistance, inflammation, and oxidant-antioxidant markers were measured.  Results: We found that 80% of patients with NAFLD had excessive intake of soft drink beverages (>500 cm3/day) compared to 17% of healthy controls (p < 0.001).  The NAFLD group consumed five times more carbohydrates from soft drinks compared to healthy controls (40% vs. 8%, p < 0.001).  Seven percent of patients consumed one soft drink per day, 55% consumed two or three soft drinks per day, and 38% consumed more than four soft drinks per day for most days and for the 6-mo period.  The most common soft drinks were Coca-Cola (regular: 32%; diet: 21%) followed by fruit juices (47%).  Patients with NAFLD with metabolic syndrome had similar malonyldialdehyde, paraoxonase, and C-reactive protein (CRP) levels but higher homeostasis model assessment (HOMA) and higher ferritin than NAFLD patients without metabolic syndrome (HOMA: 8.3 ± 8 vs. 3.7 ± 3.7 mg/dL, p < 0.001; ferritin: 186 ± 192 vs. 87 ± 84 mg/dL, p < 0.01).  Logistic regression anal. showed that soft drink consumption is a strong predictor of fatty liver (odds ratio: 2.0; p < 0.04) independent of metabolic syndrome and CRP level.  Conclusions: NAFLD patients display higher soft drink consumption independent of metabolic syndrome diagnosis.  These findings might optimize NAFLD risk stratification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMa47NLmenfrVg90H21EOLACvtfcHk0lirTCy7rhCbcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1CqurvM&md5=3d004438b6f78fc3a33d11c058d2ebd4</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2009.05.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2009.05.033%26sid%3Dliteratum%253Aachs%26aulast%3DAbid%26aufirst%3DA.%26aulast%3DTaha%26aufirst%3DO.%26aulast%3DNseir%26aufirst%3DW.%26aulast%3DFarah%26aufirst%3DR.%26aulast%3DGrosovski%26aufirst%3DM.%26aulast%3DAssy%26aufirst%3DN.%26atitle%3DSoft%2520drink%2520consumption%2520is%2520associated%2520with%2520fatty%2520liver%2520disease%2520independent%2520of%2520metabolic%2520syndrome%26jtitle%3DJ.%2520Hepatol.%26date%3D2009%26volume%3D51%26spage%3D918%26epage%3D924%26doi%3D10.1016%2Fj.jhep.2009.05.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Assy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasser, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamayse, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nseir, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beniashvili, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djibre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosovski, M.</span><span> </span><span class="NLM_article-title">Soft drink consumption linked with fatty liver in the absence of traditional risk factors</span> <span class="citation_source-journal">Can. J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">811</span><span class="NLM_x">–</span> <span class="NLM_lpage">816</span><span class="refDoi"> DOI: 10.1155/2008/810961</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1155%2F2008%2F810961" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=18925303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A280%3ADC%252BD1cnms1Wqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=811-816&author=N.+Assyauthor=G.+Nasserauthor=I.+Kamayseauthor=W.+Nseirauthor=Z.+Beniashviliauthor=A.+Djibreauthor=M.+Grosovski&title=Soft+drink+consumption+linked+with+fatty+liver+in+the+absence+of+traditional+risk+factors&doi=10.1155%2F2008%2F810961"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Soft drink consumption linked with fatty liver in the absence of traditional risk factors</span></div><div class="casAuthors">Assy Nimer; Nasser Gattas; Kamayse Iad; Nseir William; Beniashvili Zaza; Djibre Agness; Grosovski Maria</div><div class="citationInfo"><span class="NLM_cas:title">Canadian journal of gastroenterology = Journal canadien de gastroenterologie</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">811-6</span>
        ISSN:<span class="NLM_cas:issn">0835-7900</span>.
    </div><div class="casAbstract">BACKGROUND:  Little is known about dietary habits and their relationships with liver disease in nonalcoholic fatty liver disease (NAFLD) patients, particularly in the absence of obesity, diabetes or hyperlipidemia.  OBJECTIVE:  To assess the association between soft drink consumption and the presence of fatty liver in NAFLD patients who do not have classic risk factors.  METHODS:  Three hundred ten patients with NAFLD diagnosed by ultrasound were assessed for 36 months in a cross-sectional manner.  Thirty-one patients (10%) who had NAFLD without classic risk factors were compared with 30 healthy controls.  Physical activity was assessed during the preceding week and year, and every six months for 36 months.  Data on daily dietary intake of food and soft drink, and the source of added sugar were collected during two seven-day periods, at the beginning of the study, and within two weeks after the metabolic tests by using a validated food questionnaire given by a trained dietician.  Insulin resistance and lipid peroxidation were assessed by homeostasis model assessment-insulin resistance index (HOMA-IRI) and malondialdehyde (MDA) levels, respectively.  RESULTS:  Eighty per cent of patients (25 of 31) consumed an excessive amount of soft drink beverages (more than 50 g/day of added sugar) for 36 months, compared with 20% in healthy controls (P<0.001).  Twenty per cent of patients consumed one drink per day, 40% consumed two to three drinks per day, and 40% consumed more than four drinks per day for most days during 36 months.  The most common soft drinks consumed were regular Coca-Cola (40% of patients), Diet Coke (40%) and flavoured fruit juices (20%).  Ultrasound findings revealed mild fatty liver in 44% of cases (n=14), moderate fatty liver in 38% (n=12), and severe fatty liver in 18% (n=5).  HOMA-IRI and MDA levels were significantly higher in patients with NAFLD than in healthy controls (HOMA-IRI, 3.7 versus 1.7, P<0.001; and MDA, 420+/-300 micromol/mL versus 200+/-100 micromol/mL; P<0.001).  When controlled for other factors, including dietary composition and physical activity, soft drink beverage consumption was the only independent variable that was able to predict the presence of fatty liver in 82.5% of cases with a sensitivity of 100%, a specificity of 76%, a positive predictive value of 57% and a negative predictive value of 100%.  CONCLUSION:  The present study may add important insight into the role of sugar-sweetened beverage consumption as a cause of fatty liver in patients without risk factors.  Patients are encouraged to change their long-standing drinking behaviour.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRRjkNsMhLchnp3bfzSLaX5fW6udTcc2eY3-pJfXM_mGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cnms1Wqsw%253D%253D&md5=64201069a40bf629800a1c96179fb12c</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1155%2F2008%2F810961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2008%252F810961%26sid%3Dliteratum%253Aachs%26aulast%3DAssy%26aufirst%3DN.%26aulast%3DNasser%26aufirst%3DG.%26aulast%3DKamayse%26aufirst%3DI.%26aulast%3DNseir%26aufirst%3DW.%26aulast%3DBeniashvili%26aufirst%3DZ.%26aulast%3DDjibre%26aufirst%3DA.%26aulast%3DGrosovski%26aufirst%3DM.%26atitle%3DSoft%2520drink%2520consumption%2520linked%2520with%2520fatty%2520liver%2520in%2520the%2520absence%2520of%2520traditional%2520risk%2520factors%26jtitle%3DCan.%2520J.%2520Gastroenterol.%26date%3D2008%26volume%3D22%26spage%3D811%26epage%3D816%26doi%3D10.1155%2F2008%2F810961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Ishimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanaspa, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivard, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncal-Jimenez, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlicky, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicerchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahan, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdelmalek, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackman, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLean, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diggle, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asipu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inaba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosugi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Lozada, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sautin, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonthron, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. J.</span><span> </span><span class="NLM_article-title">High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1632</span><span class="NLM_x">–</span> <span class="NLM_lpage">1643</span><span class="refDoi"> DOI: 10.1002/hep.26594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1002%2Fhep.26594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=23813872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWqsLvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2013&pages=1632-1643&author=T.+Ishimotoauthor=M.+A.+Lanaspaauthor=C.+J.+Rivardauthor=C.+A.+Roncal-Jimenezauthor=D.+J.+Orlickyauthor=C.+Cicerchiauthor=R.+H.+McMahanauthor=M.+F.+Abdelmalekauthor=H.+R.+Rosenauthor=M.+R.+Jackmanauthor=P.+S.+MacLeanauthor=C.+P.+Diggleauthor=A.+Asipuauthor=S.+Inabaauthor=T.+Kosugiauthor=W.+Satoauthor=S.+Maruyamaauthor=L.+G.+Sanchez-Lozadaauthor=Y.+Y.+Sautinauthor=J.+O.+Hillauthor=D.+T.+Bonthronauthor=R.+J.+Johnson&title=High-fat+and+high-sucrose+%28western%29+diet+induces+steatohepatitis+that+is+dependent+on+fructokinase&doi=10.1002%2Fhep.26594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase</span></div><div class="casAuthors">Ishimoto, Takuji; Lanaspa, Miguel A.; Rivard, Christopher J.; Roncal-Jimenez, Carlos A.; Orlicky, David J.; Cicerchi, Christina; McMahan, Rachel H.; Abdelmalek, Manal F.; Rosen, Hugo R.; Jackman, Matthew R.; MacLean, Paul S.; Diggle, Christine P.; Asipu, Aruna; Inaba, Shinichiro; Kosugi, Tomoki; Sato, Waichi; Maruyama, Shoichi; Sanchez-Lozada, Laura G.; Sautin, Yuri Y.; Hill, James O.; Bonthron, David T.; Johnson, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1632-1643</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Fructose intake from added sugars has been implicated as a cause of nonalcoholic fatty liver disease.  Here we tested the hypothesis that fructose may interact with a high-fat diet to induce fatty liver, and to det. if this was dependent on a key enzyme in fructose metab., fructokinase.  Wild-type or fructokinase knockout mice were fed a low-fat (11%), high-fat (36%), or high-fat (36%) and high-sucrose (30%) diet for 15 wk.  Both wild-type and fructokinase knockout mice developed obesity with mild hepatic steatosis and no evidence of hepatic inflammation on a high-fat diet compared to a low-fat diet.  In contrast, wild-type mice fed a high-fat and high-sucrose diet developed more severe hepatic steatosis with low-grade inflammation and fibrosis, as noted by increased CD68, tumor necrosis factor alpha, monocyte chemoattractant protein-1, alpha-smooth muscle actin, and collagen I and TIMP1 expression.  These changes were prevented in the fructokinase knockout mice.  Conclusion: An additive effect of high-fat and high-sucrose diet on the development of hepatic steatosis exists.  Further, the combination of sucrose with high-fat diet may induce steatohepatitis.  The protection in fructokinase knockout mice suggests a key role for fructose (from sucrose) in this development of steatohepatitis.  These studies emphasize the important role of fructose in the development of fatty liver and nonalcoholic steatohepatitis. (Hepatol. 2013;58:1632-1643).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4FrhsSKjOl7Vg90H21EOLACvtfcHk0liDuPlZYaBNSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWqsLvE&md5=d4544aba25dd28f735c4e0b76e02cc48</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fhep.26594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.26594%26sid%3Dliteratum%253Aachs%26aulast%3DIshimoto%26aufirst%3DT.%26aulast%3DLanaspa%26aufirst%3DM.%2BA.%26aulast%3DRivard%26aufirst%3DC.%2BJ.%26aulast%3DRoncal-Jimenez%26aufirst%3DC.%2BA.%26aulast%3DOrlicky%26aufirst%3DD.%2BJ.%26aulast%3DCicerchi%26aufirst%3DC.%26aulast%3DMcMahan%26aufirst%3DR.%2BH.%26aulast%3DAbdelmalek%26aufirst%3DM.%2BF.%26aulast%3DRosen%26aufirst%3DH.%2BR.%26aulast%3DJackman%26aufirst%3DM.%2BR.%26aulast%3DMacLean%26aufirst%3DP.%2BS.%26aulast%3DDiggle%26aufirst%3DC.%2BP.%26aulast%3DAsipu%26aufirst%3DA.%26aulast%3DInaba%26aufirst%3DS.%26aulast%3DKosugi%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DW.%26aulast%3DMaruyama%26aufirst%3DS.%26aulast%3DSanchez-Lozada%26aufirst%3DL.%2BG.%26aulast%3DSautin%26aufirst%3DY.%2BY.%26aulast%3DHill%26aufirst%3DJ.%2BO.%26aulast%3DBonthron%26aufirst%3DD.%2BT.%26aulast%3DJohnson%26aufirst%3DR.%2BJ.%26atitle%3DHigh-fat%2520and%2520high-sucrose%2520%2528western%2529%2520diet%2520induces%2520steatohepatitis%2520that%2520is%2520dependent%2520on%2520fructokinase%26jtitle%3DHepatology%26date%3D2013%26volume%3D58%26spage%3D1632%26epage%3D1643%26doi%3D10.1002%2Fhep.26594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Lanaspa, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicerchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlicky, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzycki, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inaba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncal-Jimenez, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diggle, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asipu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrash, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosugi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Lozada, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McManaman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonthron, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sautin, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. J.</span><span> </span><span class="NLM_article-title">Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2434</span><span class="refDoi"> DOI: 10.1038/ncomms3434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1038%2Fncomms3434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=24022321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A280%3ADC%252BC3sbntValtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=2434&author=M.+A.+Lanaspaauthor=T.+Ishimotoauthor=N.+Liauthor=C.+Cicerchiauthor=D.+J.+Orlickyauthor=P.+Ruzyckiauthor=C.+Rivardauthor=S.+Inabaauthor=C.+A.+Roncal-Jimenezauthor=E.+S.+Balesauthor=C.+P.+Diggleauthor=A.+Asipuauthor=J.+M.+Petrashauthor=T.+Kosugiauthor=S.+Maruyamaauthor=L.+G.+Sanchez-Lozadaauthor=J.+L.+McManamanauthor=D.+T.+Bonthronauthor=Y.+Y.+Sautinauthor=R.+J.+Johnson&title=Endogenous+fructose+production+and+metabolism+in+the+liver+contributes+to+the+development+of+metabolic+syndrome&doi=10.1038%2Fncomms3434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome</span></div><div class="casAuthors">Lanaspa Miguel A; Ishimoto Takuji; Li Nanxing; Cicerchi Christina; Orlicky David J; Ruzycki Philip; Ruzicky Philip; Rivard Christopher; Inaba Shinichiro; Roncal-Jimenez Carlos A; Bales Elise S; Diggle Christine P; Asipu Aruna; Petrash J Mark; Kosugi Tomoki; Maruyama Shoichi; Sanchez-Lozada Laura G; McManaman James L; Bonthron David T; Sautin Yuri Y; Johnson Richard J</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2434</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Carbohydrates with high glycaemic index are proposed to promote the development of obesity, insulin resistance and fatty liver, but the mechanism by which this occurs remains unknown.  High serum glucose concentrations are known to induce the polyol pathway and increase fructose generation in the liver.  Here we show that this hepatic, endogenously produced fructose causes systemic metabolic changes.  We demonstrate that mice unable to metabolize fructose are protected from an increase in energy intake and body weight, visceral obesity, fatty liver, elevated insulin levels and hyperleptinaemia after exposure to 10% glucose for 14 weeks.  In normal mice, glucose consumption is accompanied by aldose reductase and polyol pathway activation in steatotic areas.  In this regard, we show that aldose reductase-deficient mice are protected against glucose-induced fatty liver.  We conclude that endogenous fructose generation and metabolism in the liver represents an important mechanism by which glucose promotes the development of metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSyyD60uMeGg_69nzq6467DfW6udTcc2eb2xz5yUR-MD7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbntValtA%253D%253D&md5=dabbcf5d4c20a391b47ceafe21cd6413</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fncomms3434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms3434%26sid%3Dliteratum%253Aachs%26aulast%3DLanaspa%26aufirst%3DM.%2BA.%26aulast%3DIshimoto%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DCicerchi%26aufirst%3DC.%26aulast%3DOrlicky%26aufirst%3DD.%2BJ.%26aulast%3DRuzycki%26aufirst%3DP.%26aulast%3DRivard%26aufirst%3DC.%26aulast%3DInaba%26aufirst%3DS.%26aulast%3DRoncal-Jimenez%26aufirst%3DC.%2BA.%26aulast%3DBales%26aufirst%3DE.%2BS.%26aulast%3DDiggle%26aufirst%3DC.%2BP.%26aulast%3DAsipu%26aufirst%3DA.%26aulast%3DPetrash%26aufirst%3DJ.%2BM.%26aulast%3DKosugi%26aufirst%3DT.%26aulast%3DMaruyama%26aufirst%3DS.%26aulast%3DSanchez-Lozada%26aufirst%3DL.%2BG.%26aulast%3DMcManaman%26aufirst%3DJ.%2BL.%26aulast%3DBonthron%26aufirst%3DD.%2BT.%26aulast%3DSautin%26aufirst%3DY.%2BY.%26aulast%3DJohnson%26aufirst%3DR.%2BJ.%26atitle%3DEndogenous%2520fructose%2520production%2520and%2520metabolism%2520in%2520the%2520liver%2520contributes%2520to%2520the%2520development%2520of%2520metabolic%2520syndrome%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D2434%26doi%3D10.1038%2Fncomms3434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Sachs, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sternfeld, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, G.</span><span> </span><span class="NLM_article-title">Essential fructosuria: Its pathophysiology</span> <span class="citation_source-journal">AMA Am. J. Dis. Child.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1942</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span><span class="refDoi"> DOI: 10.1001/archpedi.1942.02010020037004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1001%2Farchpedi.1942.02010020037004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADyaH38XitlSktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1942&pages=252-269&author=B.+Sachsauthor=L.+Sternfeldauthor=G.+Kraus&title=Essential+fructosuria%3A+Its+pathophysiology&doi=10.1001%2Farchpedi.1942.02010020037004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Essential fructosuria. Its pathophysiology</span></div><div class="casAuthors">Sachs, Benjamin; Sternfeld, Leon; Kraus, George</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Diseases of Children</span>
        (<span class="NLM_cas:date">1942</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">252-69</span>CODEN:
                <span class="NLM_cas:coden">AJDCAI</span>;
        ISSN:<span class="NLM_cas:issn">0002-922X</span>.
    </div><div class="casAbstract">Tests of kidney and liver function were normal in the 2 cases of essential fructosuria studied.  After ingestion of fructose there was little rise in the lactic acid content of the blood of the patients while that of normal individuals rose appreciably.  The mechanism for fructosuria appears to lie in the failure of part of the ingested fructose to be broken down to lactic acid.  A tabular review of 55 cases reported in the literature is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIP5k-IUS0N7Vg90H21EOLACvtfcHk0lhy5l28nMdtbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaH38XitlSktg%253D%253D&md5=3178112bf02c60846edee1ba6a27c201</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1001%2Farchpedi.1942.02010020037004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpedi.1942.02010020037004%26sid%3Dliteratum%253Aachs%26aulast%3DSachs%26aufirst%3DB.%26aulast%3DSternfeld%26aufirst%3DL.%26aulast%3DKraus%26aufirst%3DG.%26atitle%3DEssential%2520fructosuria%253A%2520Its%2520pathophysiology%26jtitle%3DAMA%2520Am.%2520J.%2520Dis.%2520Child.%26date%3D1942%26volume%3D63%26spage%3D252%26epage%3D269%26doi%3D10.1001%2Farchpedi.1942.02010020037004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Bais, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rofe, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conyers, R. A.</span><span> </span><span class="NLM_article-title">The purification and properties of human liver ketohexokinase. A role for ketohexokinase and fructose-bisphosphate aldolase in the metabolic production of oxalate from xylitol</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">230</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span><span class="refDoi"> DOI: 10.1042/bj2300053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1042%2Fbj2300053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=230&publication_year=1985&pages=53-60&author=R.+Baisauthor=H.+M.+Jamesauthor=A.+M.+Rofeauthor=R.+A.+Conyers&title=The+purification+and+properties+of+human+liver+ketohexokinase.+A+role+for+ketohexokinase+and+fructose-bisphosphate+aldolase+in+the+metabolic+production+of+oxalate+from+xylitol&doi=10.1042%2Fbj2300053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1042%2Fbj2300053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2300053%26sid%3Dliteratum%253Aachs%26aulast%3DBais%26aufirst%3DR.%26aulast%3DJames%26aufirst%3DH.%2BM.%26aulast%3DRofe%26aufirst%3DA.%2BM.%26aulast%3DConyers%26aufirst%3DR.%2BA.%26atitle%3DThe%2520purification%2520and%2520properties%2520of%2520human%2520liver%2520ketohexokinase.%2520A%2520role%2520for%2520ketohexokinase%2520and%2520fructose-bisphosphate%2520aldolase%2520in%2520the%2520metabolic%2520production%2520of%2520oxalate%2520from%2520xylitol%26jtitle%3DBiochem.%2520J.%26date%3D1985%26volume%3D230%26spage%3D53%26epage%3D60%26doi%3D10.1042%2Fbj2300053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Trinh, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asipu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonthron, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, S. E. V.</span><span> </span><span class="NLM_article-title">Structures of alternatively spliced isoforms of human ketohexokinase</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span><span class="refDoi"> DOI: 10.1107/S0907444908041115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1107%2FS0907444908041115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=19237742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Chs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=201-211&author=C.+H.+Trinhauthor=A.+Asipuauthor=D.+T.+Bonthronauthor=S.+E.+V.+Phillips&title=Structures+of+alternatively+spliced+isoforms+of+human+ketohexokinase&doi=10.1107%2FS0907444908041115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of alternatively spliced isoforms of human ketohexokinase</span></div><div class="casAuthors">Trinh, Chi H.; Asipu, Aruna; Bonthron, David T.; Phillips, Simon E. V.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">201-211, S201/1</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A mol. understanding of the unique aspects of dietary fructose metab. may be the key to understanding and controlling the current epidemic of fructose-related obesity, diabetes and related adverse metabolic states in Western populations.  Fructose catabolism is initiated by its phosphorylation to fructose 1-phosphate, which is performed by ketohexokinase (KHK).  Here, the crystal structures of the two alternatively spliced isoforms of human ketohexokinase, hepatic KHK-C and the peripheral isoform KHK-A, and of the ternary complex of KHK-A with the substrate fructose and AMP-PNP are reported.  The structure of the KHK-A ternary complex revealed an active site with both the substrate fructose and the ATP analog in positions ready for phosphorylation following a reaction mechanism similar to that of the pfkB family of carbohydrate kinases.  Hepatic KHK deficiency causes the benign disorder essential fructosuria.  The effects of the disease-causing mutations (Gly40Arg and Ala43Thr) have been modeled in the context of the KHK structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLVyR1D5ZQrbVg90H21EOLACvtfcHk0lgYxzVKGIMWSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Chs7o%253D&md5=0a54cabf6e404115beb59b7e0feed670</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1107%2FS0907444908041115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444908041115%26sid%3Dliteratum%253Aachs%26aulast%3DTrinh%26aufirst%3DC.%2BH.%26aulast%3DAsipu%26aufirst%3DA.%26aulast%3DBonthron%26aufirst%3DD.%2BT.%26aulast%3DPhillips%26aufirst%3DS.%2BE.%2BV.%26atitle%3DStructures%2520of%2520alternatively%2520spliced%2520isoforms%2520of%2520human%2520ketohexokinase%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2009%26volume%3D65%26spage%3D201%26epage%3D211%26doi%3D10.1107%2FS0907444908041115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Maryanoff, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McComsey, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabut, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luci, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masucci, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abad, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrounia, I.</span><span> </span><span class="NLM_article-title">Inhibitors of ketohexokinase: discovery of pyrimidinopyrimidines with specific substitution that complements the ATP-binding site</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">–</span> <span class="NLM_lpage">543</span><span class="refDoi"> DOI: 10.1021/ml200070g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200070g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltlGhsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=538-543&author=B.+E.+Maryanoffauthor=J.+C.+O%E2%80%99Neillauthor=D.+F.+McComseyauthor=S.+C.+Yabutauthor=D.+K.+Luciauthor=A.+D.+Jordanauthor=J.+A.+Masucciauthor=W.+J.+Jonesauthor=M.+C.+Abadauthor=A.+C.+Gibbsauthor=I.+Petrounia&title=Inhibitors+of+ketohexokinase%3A+discovery+of+pyrimidinopyrimidines+with+specific+substitution+that+complements+the+ATP-binding+site&doi=10.1021%2Fml200070g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Ketohexokinase: Discovery of Pyrimidinopyrimidines with Specific Substitution that Complements the ATP-Binding Site</span></div><div class="casAuthors">Maryanoff, Bruce E.; O'Neill, John C.; McComsey, David F.; Yabut, Stephen C.; Luci, Diane K.; Jordan, Alfonzo D.; Masucci, John A.; Jones, William J.; Abad, Marta C.; Gibbs, Alan C.; Petrounia, Ioanna</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">538-543</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Attenuation of fructose metab. by the inhibition of ketohexokinase (KHK; fructokinase) should reduce body wt., free fatty acids, and triglycerides, thereby offering a novel approach to treat diabetes and obesity in response to modern diets.  We have identified potent, selective inhibitors of human hepatic KHK within a series of pyrimidinopyrimidines (1).  For example, 8, 38, and 47 exhibited KHK IC50 values of 12, 7, and 8 nM, resp., and also showed potent cellular KHK inhibition (IC50 < 500 nM), which relates to their intrinsic potency vs KHK and their ability to penetrate cells.  X-ray cocrystal structures of KHK complexes of 3, 8, and 47 revealed the important interactions within the enzyme's ATP-binding pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoenT0KLTIMX7Vg90H21EOLACvtfcHk0lgYxzVKGIMWSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltlGhsr8%253D&md5=8ed0465ad9571e67ac226935994fa5fb</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1021%2Fml200070g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200070g%26sid%3Dliteratum%253Aachs%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%2BC.%26aulast%3DMcComsey%26aufirst%3DD.%2BF.%26aulast%3DYabut%26aufirst%3DS.%2BC.%26aulast%3DLuci%26aufirst%3DD.%2BK.%26aulast%3DJordan%26aufirst%3DA.%2BD.%26aulast%3DMasucci%26aufirst%3DJ.%2BA.%26aulast%3DJones%26aufirst%3DW.%2BJ.%26aulast%3DAbad%26aufirst%3DM.%2BC.%26aulast%3DGibbs%26aufirst%3DA.%2BC.%26aulast%3DPetrounia%26aufirst%3DI.%26atitle%3DInhibitors%2520of%2520ketohexokinase%253A%2520discovery%2520of%2520pyrimidinopyrimidines%2520with%2520specific%2520substitution%2520that%2520complements%2520the%2520ATP-binding%2520site%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D538%26epage%3D543%26doi%3D10.1021%2Fml200070g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Maryanoff, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McComsey, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabut, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luci, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connelly, M. A.</span><span> </span><span class="NLM_article-title">Pyrimidinopyrimidine inhibitors of ketohexokinase: Exploring the ring C2 group that interacts with Asp-27B in the ligand binding pocket</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5326</span><span class="NLM_x">–</span> <span class="NLM_lpage">5329</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1016%2Fj.bmcl.2012.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=22795331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVCjtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5326-5329&author=B.+E.+Maryanoffauthor=J.+C.+O%E2%80%99Neillauthor=D.+F.+McComseyauthor=S.+C.+Yabutauthor=D.+K.+Luciauthor=A.+C.+Gibbsauthor=M.+A.+Connelly&title=Pyrimidinopyrimidine+inhibitors+of+ketohexokinase%3A+Exploring+the+ring+C2+group+that+interacts+with+Asp-27B+in+the+ligand+binding+pocket&doi=10.1016%2Fj.bmcl.2012.06.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14cR"><div class="casContent"><span class="casTitleNuber">14c</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrimidinopyrimidine inhibitors of ketohexokinase: Exploring the ring C2 group that interacts with Asp-27B in the ligand binding pocket</span></div><div class="casAuthors">Maryanoff, Bruce E.; O'Neill, John C.; McComsey, David F.; Yabut, Stephen C.; Luci, Diane K.; Gibbs, Alan C.; Connelly, Margery A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5326-5329</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inhibitors of ketohexokinase (KHK) have potential for the treatment of diabetes and obesity.  We have continued studies on a pyrimidinopyrimidine series of potent KHK inhibitors by exploring the 2-position substituent (R3) that interacts with Asp-27B in the ATP-binding region of KHK (viz. 1, 2; Table 1).  We found that increased spacing between the terminal ammonium group and the heterocyclic scaffold (viz. 16-20), such that interaction with Asp-27B is not possible, still results in potent KHK inhibition (IC50 = 15-50 nM).  We propose a new interaction with Asp-194, which serves to expand the pyrimidinopyrimidine pharmacophore.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGradcYZ9M9bdLVg90H21EOLACvtfcHk0lhwjsWMPfLFrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVCjtLzK&md5=0da67e40de493f46030c88682482270e</span></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%2BC.%26aulast%3DMcComsey%26aufirst%3DD.%2BF.%26aulast%3DYabut%26aufirst%3DS.%2BC.%26aulast%3DLuci%26aufirst%3DD.%2BK.%26aulast%3DGibbs%26aufirst%3DA.%2BC.%26aulast%3DConnelly%26aufirst%3DM.%2BA.%26atitle%3DPyrimidinopyrimidine%2520inhibitors%2520of%2520ketohexokinase%253A%2520Exploring%2520the%2520ring%2520C2%2520group%2520that%2520interacts%2520with%2520Asp-27B%2520in%2520the%2520ligand%2520binding%2520pocket%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5326%26epage%3D5329%26doi%3D10.1016%2Fj.bmcl.2012.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Gibbs, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abad, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tounge, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewandowski, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Struble, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sui, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L. C.</span><span> </span><span class="NLM_article-title">Electron density guided fragment-based lead discovery of ketohexokinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7979</span><span class="NLM_x">–</span> <span class="NLM_lpage">7991</span><span class="refDoi"> DOI: 10.1021/jm100677s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100677s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGntr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7979-7991&author=A.+C.+Gibbsauthor=M.+C.+Abadauthor=X.+Zhangauthor=B.+A.+Toungeauthor=F.+A.+Lewandowskiauthor=G.+T.+Strubleauthor=W.+Sunauthor=Z.+Suiauthor=L.+C.+Kuo&title=Electron+density+guided+fragment-based+lead+discovery+of+ketohexokinase+inhibitors&doi=10.1021%2Fjm100677s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14dR"><div class="casContent"><span class="casTitleNuber">14d</span><div class="casTitle"><span class="NLM_cas:atitle">Electron Density Guided Fragment-Based Lead Discovery of Ketohexokinase Inhibitors</span></div><div class="casAuthors">Gibbs, Alan C.; Abad, Marta C.; Zhang, Xuqing; Tounge, Brett A.; Lewandowski, Francis A.; Struble, Geoffrey T.; Sun, Weimei; Sui, Zhihua; Kuo, Lawrence C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7979-7991</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A fragment-based drug design paradigm has been successfully applied in the discovery of lead series of ketohexokinase inhibitors.  The paradigm consists of three iterations of design, synthesis, and x-ray crystallog. screening to progress low mol. wt. fragments to leadlike compds.  Applying electron d. of fragments within the protein binding site as defined by x-ray crystallog., one can generate target specific leads without the use of affinity data.  Our approach contrasts with most fragment-based drug design methodol. where soln. activity is a main design guide.  Herein we describe the discovery of submicromolar ketohexokinase inhibitors with promising druglike properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOp4ro7Ui4WrVg90H21EOLACvtfcHk0lhwjsWMPfLFrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGntr%252FF&md5=3abdf4ac63d4afcf6a4db484d0d87259</span></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=10.1021%2Fjm100677s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100677s%26sid%3Dliteratum%253Aachs%26aulast%3DGibbs%26aufirst%3DA.%2BC.%26aulast%3DAbad%26aufirst%3DM.%2BC.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DTounge%26aufirst%3DB.%2BA.%26aulast%3DLewandowski%26aufirst%3DF.%2BA.%26aulast%3DStruble%26aufirst%3DG.%2BT.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DSui%26aufirst%3DZ.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26atitle%3DElectron%2520density%2520guided%2520fragment-based%2520lead%2520discovery%2520of%2520ketohexokinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7979%26epage%3D7991%26doi%3D10.1021%2Fjm100677s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Abad, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span> </span><span class="NLM_article-title">Electron density guided fragment-based drug design-a lead generation example</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">493</span><span class="NLM_x">, </span> <span class="NLM_fpage">487</span><span class="NLM_x">–</span> <span class="NLM_lpage">508</span><span class="refDoi"> DOI: 10.1016/B978-0-12-381274-2.00019-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1016%2FB978-0-12-381274-2.00019-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=493&publication_year=2011&pages=487-508&author=M.+C.+Abadauthor=A.+C.+Gibbsauthor=X.+Zhang&title=Electron+density+guided+fragment-based+drug+design-a+lead+generation+example&doi=10.1016%2FB978-0-12-381274-2.00019-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14e&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-381274-2.00019-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-381274-2.00019-4%26sid%3Dliteratum%253Aachs%26aulast%3DAbad%26aufirst%3DM.%2BC.%26aulast%3DGibbs%26aufirst%3DA.%2BC.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DElectron%2520density%2520guided%2520fragment-based%2520drug%2520design-a%2520lead%2520generation%2520example%26jtitle%3DMethods%2520Enzymol.%26date%3D2011%26volume%3D493%26spage%3D487%26epage%3D508%26doi%3D10.1016%2FB978-0-12-381274-2.00019-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, G.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abad, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sui, Z.</span><span> </span><span class="NLM_article-title">Optimization of a pyrazole hit from FBDD into a novel series of indazoles as ketohexokinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4762</span><span class="NLM_x">–</span> <span class="NLM_lpage">4767</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.06.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1016%2Fj.bmcl.2011.06.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=21767952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC3MXps1Snu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4762-4767&author=X.+Zhangauthor=F.+Songauthor=G.-H.+Kuoauthor=A.+Xiangauthor=A.+C.+Gibbsauthor=M.+C.+Abadauthor=W.+Sunauthor=L.+C.+Kuoauthor=Z.+Sui&title=Optimization+of+a+pyrazole+hit+from+FBDD+into+a+novel+series+of+indazoles+as+ketohexokinase+inhibitors&doi=10.1016%2Fj.bmcl.2011.06.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14fR"><div class="casContent"><span class="casTitleNuber">14f</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of a pyrazole hit from FBDD into a novel series of indazoles as ketohexokinase inhibitors</span></div><div class="casAuthors">Zhang, Xuqing; Song, Fengbing; Kuo, Gee-Hong; Xiang, Amy; Gibbs, Alan C.; Abad, Marta C.; Sun, Weimei; Kuo, Lawrence C.; Sui, Zhihua</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4762-4767</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of indazoles, e.g. I-III, have been discovered as KHK inhibitors from a pyrazole hit identified through fragment-based drug discovery (FBDD).  The optimization process guided by both X-ray crystallog. and soln. activity resulted in lead-like compds. with good pharmaceutical properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzfA7mcimTDLVg90H21EOLACvtfcHk0liARPZxBXXMLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXps1Snu74%253D&md5=80b3561f1d3ef419c2ec3a4d7dc3154d</span></div><a href="/servlet/linkout?suffix=cit14f&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.06.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.06.067%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DSong%26aufirst%3DF.%26aulast%3DKuo%26aufirst%3DG.-H.%26aulast%3DXiang%26aufirst%3DA.%26aulast%3DGibbs%26aufirst%3DA.%2BC.%26aulast%3DAbad%26aufirst%3DM.%2BC.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DSui%26aufirst%3DZ.%26atitle%3DOptimization%2520of%2520a%2520pyrazole%2520hit%2520from%2520FBDD%2520into%2520a%2520novel%2520series%2520of%2520indazoles%2520as%2520ketohexokinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4762%26epage%3D4767%26doi%3D10.1016%2Fj.bmcl.2011.06.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lanter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sui, Z.</span><span> </span><span class="NLM_article-title">Medicinal chemistry inspired fragment-based drug discovery</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">493</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span><span class="refDoi"> DOI: 10.1016/B978-0-12-381274-2.00016-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1016%2FB978-0-12-381274-2.00016-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=493&publication_year=2011&pages=421-445&author=J.+Lanterauthor=X.+Zhangauthor=Z.+Sui&title=Medicinal+chemistry+inspired+fragment-based+drug+discovery&doi=10.1016%2FB978-0-12-381274-2.00016-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-381274-2.00016-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-381274-2.00016-9%26sid%3Dliteratum%253Aachs%26aulast%3DLanter%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DSui%26aufirst%3DZ.%26atitle%3DMedicinal%2520chemistry%2520inspired%2520fragment-based%2520drug%2520discovery%26jtitle%3DMethods%2520Enzymol.%26date%3D2011%26volume%3D493%26spage%3D421%26epage%3D445%26doi%3D10.1016%2FB978-0-12-381274-2.00016-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Johnson, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlanson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, D. C.</span><span> </span><span class="NLM_article-title">Fragment-to-Lead Medicinal Chemistry Publications in 2015</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01123</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01123" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1KlsbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=89-99&author=C.+N.+Johnsonauthor=D.+A.+Erlansonauthor=C.+W.+Murrayauthor=D.+C.+Rees&title=Fragment-to-Lead+Medicinal+Chemistry+Publications+in+2015&doi=10.1021%2Facs.jmedchem.6b01123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-to-Lead Medicinal Chemistry Publications in 2015</span></div><div class="casAuthors">Johnson, Christopher N.; Erlanson, Daniel A.; Murray, Christopher W.; Rees, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-99</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Fragment-based drug discovery (FBDD) is now well-established as a technol. for generating new chem. leads and drugs.  This Miniperspective provides a tabulated overview of the fragment-to-lead literature published in the year 2015, together with a commentary on trends obsd. across the FBDD field during this time.  It is hoped that this tabulated summary will provide a useful point of ref. for both FBDD practitioners and the wider medicinal chem. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojX6ZlmVXQrLVg90H21EOLACvtfcHk0lhZpiXu4NsZbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1KlsbnP&md5=da9d027787d70d4276378cb01f8e0ce2</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01123%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DRees%26aufirst%3DD.%2BC.%26atitle%3DFragment-to-Lead%2520Medicinal%2520Chemistry%2520Publications%2520in%25202015%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D89%26epage%3D99%26doi%3D10.1021%2Facs.jmedchem.6b01123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Lau, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Withka, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hepworth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magee, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakken, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendsch, Z. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thanabal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolodziej, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narasimhan, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Hoorn, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. E.</span><span> </span><span class="NLM_article-title">Design of a multi-purpose fragment screening library using molecular complexity and orthogonal diversity metrics</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">636</span><span class="refDoi"> DOI: 10.1007/s10822-011-9434-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1007%2Fs10822-011-9434-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=621-636&author=W.+F.+Lauauthor=J.+M.+Withkaauthor=D.+Hepworthauthor=T.+V.+Mageeauthor=Y.+J.+Duauthor=G.+A.+Bakkenauthor=M.+D.+Millerauthor=Z.+S.+Hendschauthor=V.+Thanabalauthor=S.+A.+Kolodziejauthor=L.+Xingauthor=Q.+Huauthor=L.+S.+Narasimhanauthor=R.+Loveauthor=M.+E.+Charltonauthor=S.+Hughesauthor=W.+P.+van+Hoornauthor=J.+E.+Mills&title=Design+of+a+multi-purpose+fragment+screening+library+using+molecular+complexity+and+orthogonal+diversity+metrics&doi=10.1007%2Fs10822-011-9434-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs10822-011-9434-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-011-9434-0%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DW.%2BF.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DMagee%26aufirst%3DT.%2BV.%26aulast%3DDu%26aufirst%3DY.%2BJ.%26aulast%3DBakken%26aufirst%3DG.%2BA.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DHendsch%26aufirst%3DZ.%2BS.%26aulast%3DThanabal%26aufirst%3DV.%26aulast%3DKolodziej%26aufirst%3DS.%2BA.%26aulast%3DXing%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DNarasimhan%26aufirst%3DL.%2BS.%26aulast%3DLove%26aufirst%3DR.%26aulast%3DCharlton%26aufirst%3DM.%2BE.%26aulast%3DHughes%26aufirst%3DS.%26aulast%3Dvan%2BHoorn%26aufirst%3DW.%2BP.%26aulast%3DMills%26aufirst%3DJ.%2BE.%26atitle%3DDesign%2520of%2520a%2520multi-purpose%2520fragment%2520screening%2520library%2520using%2520molecular%2520complexity%2520and%2520orthogonal%2520diversity%2520metrics%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2011%26volume%3D25%26spage%3D621%26epage%3D636%26doi%3D10.1007%2Fs10822-011-9434-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Lee, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambler, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boscoe, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bree, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodfuehrer, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehnhardt, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dower, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drozda, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frisbie, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavrin, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hepworth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hope, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamtekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilty, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovering, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathias, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papaioannou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiah, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samardjiev, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samas, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, M. W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soutter, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strohbach, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symanowicz, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomason, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trzupek, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zapf, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S. W.</span><span> </span><span class="NLM_article-title">Discovery of clinical candidate 1-{[(2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a potent, selective inhibitor of interleukin-1 receptor associated kinase 4 (IRAK4), by fragment-based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">5521</span><span class="NLM_x">–</span> <span class="NLM_lpage">5542</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00231</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00231" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnslGqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5521-5542&author=K.+L.+Leeauthor=C.+M.+Amblerauthor=D.+R.+Andersonauthor=B.+P.+Boscoeauthor=A.+G.+Breeauthor=J.+I.+Brodfuehrerauthor=J.+S.+Changauthor=C.+Choiauthor=S.+Chungauthor=K.+J.+Curranauthor=J.+E.+Dayauthor=C.+M.+Dehnhardtauthor=K.+Dowerauthor=S.+E.+Drozdaauthor=R.+K.+Frisbieauthor=L.+K.+Gavrinauthor=J.+A.+Goldbergauthor=S.+Hanauthor=M.+Hegenauthor=D.+Hepworthauthor=H.+R.+Hopeauthor=S.+Kamtekarauthor=I.+C.+Kiltyauthor=A.+Leeauthor=L.-L.+Linauthor=F.+E.+Loveringauthor=M.+D.+Loweauthor=J.+P.+Mathiasauthor=H.+M.+Morganauthor=E.+A.+Murphyauthor=N.+Papaioannouauthor=A.+Patnyauthor=B.+S.+Pierceauthor=V.+R.+Raoauthor=E.+Saiahauthor=I.+J.+Samardjievauthor=B.+M.+Samasauthor=M.+W.+H.+Shenauthor=J.+H.+Shinauthor=H.+H.+Soutterauthor=J.+W.+Strohbachauthor=P.+T.+Symanowiczauthor=J.+R.+Thomasonauthor=J.+D.+Trzupekauthor=R.+Vargasauthor=F.+Vincentauthor=J.+Yanauthor=C.+W.+Zapfauthor=S.+W.+Wright&title=Discovery+of+clinical+candidate+1-%7B%5B%282S%2C3S%2C4S%29-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl%5Dmethoxy%7D-7-methoxyisoquinoline-6-carboxamide+%28PF-06650833%29%2C+a+potent%2C+selective+inhibitor+of+interleukin-1+receptor+associated+kinase+4+%28IRAK4%29%2C+by+fragment-based+drug+design&doi=10.1021%2Facs.jmedchem.7b00231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design</span></div><div class="casAuthors">Lee, Katherine L.; Ambler, Catherine M.; Anderson, David R.; Boscoe, Brian P.; Bree, Andrea G.; Brodfuehrer, Joanne I.; Chang, Jeanne S.; Choi, Chulho; Chung, Seungwon; Curran, Kevin J.; Day, Jacqueline E.; Dehnhardt, Christoph M.; Dower, Ken; Drozda, Susan E.; Frisbie, Richard K.; Gavrin, Lori K.; Goldberg, Joel A.; Han, Seungil; Hegen, Martin; Hepworth, David; Hope, Heidi R.; Kamtekar, Satwik; Kilty, Iain C.; Lee, Arthur; Lin, Lih-Ling; Lovering, Frank E.; Lowe, Michael D.; Mathias, John P.; Morgan, Heidi M.; Murphy, Elizabeth A.; Papaioannou, Nikolaos; Patny, Akshay; Pierce, Betsy S.; Rao, Vikram R.; Saiah, Eddine; Samardjiev, Ivan J.; Samas, Brian M.; Shen, Marina W. H.; Shin, Julia H.; Soutter, Holly H.; Strohbach, Joseph W.; Symanowicz, Peter T.; Thomason, Jennifer R.; Trzupek, John D.; Vargas, Richard; Vincent, Fabien; Yan, Jiangli; Zapf, Christoph W.; Wright, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5521-5542</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Through fragment-based drug design focused on engaging the active site of IRAK4 and leveraging three-dimensional topol. in a ligand-efficient manner, a micromolar hit identified from a screen of a Pfizer fragment library was optimized to afford IRAK4 inhibitors with nanomolar potency in cellular assays.  The medicinal chem. effort featured the judicious placement of lipophilicity, informed by cocrystal structures with IRAK4 and optimization of ADME properties to deliver clin. candidate I.  This compd. benefitted from a 5-unit increase in lipophilic efficiency from the fragment hit, excellent kinase selectivity, and pharmacokinetic properties suitable for oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrCep64bhMbVg90H21EOLACvtfcHk0lgG6JNXpL_ulw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnslGqu7c%253D&md5=9771ad2d33089f6ef3dba3556536ff1a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00231%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BL.%26aulast%3DAmbler%26aufirst%3DC.%2BM.%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DBoscoe%26aufirst%3DB.%2BP.%26aulast%3DBree%26aufirst%3DA.%2BG.%26aulast%3DBrodfuehrer%26aufirst%3DJ.%2BI.%26aulast%3DChang%26aufirst%3DJ.%2BS.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DChung%26aufirst%3DS.%26aulast%3DCurran%26aufirst%3DK.%2BJ.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DDower%26aufirst%3DK.%26aulast%3DDrozda%26aufirst%3DS.%2BE.%26aulast%3DFrisbie%26aufirst%3DR.%2BK.%26aulast%3DGavrin%26aufirst%3DL.%2BK.%26aulast%3DGoldberg%26aufirst%3DJ.%2BA.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DHope%26aufirst%3DH.%2BR.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DKilty%26aufirst%3DI.%2BC.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DL.-L.%26aulast%3DLovering%26aufirst%3DF.%2BE.%26aulast%3DLowe%26aufirst%3DM.%2BD.%26aulast%3DMathias%26aufirst%3DJ.%2BP.%26aulast%3DMorgan%26aufirst%3DH.%2BM.%26aulast%3DMurphy%26aufirst%3DE.%2BA.%26aulast%3DPapaioannou%26aufirst%3DN.%26aulast%3DPatny%26aufirst%3DA.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DRao%26aufirst%3DV.%2BR.%26aulast%3DSaiah%26aufirst%3DE.%26aulast%3DSamardjiev%26aufirst%3DI.%2BJ.%26aulast%3DSamas%26aufirst%3DB.%2BM.%26aulast%3DShen%26aufirst%3DM.%2BW.%2BH.%26aulast%3DShin%26aufirst%3DJ.%2BH.%26aulast%3DSoutter%26aufirst%3DH.%2BH.%26aulast%3DStrohbach%26aufirst%3DJ.%2BW.%26aulast%3DSymanowicz%26aufirst%3DP.%2BT.%26aulast%3DThomason%26aufirst%3DJ.%2BR.%26aulast%3DTrzupek%26aufirst%3DJ.%2BD.%26aulast%3DVargas%26aufirst%3DR.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DZapf%26aufirst%3DC.%2BW.%26aulast%3DWright%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%25201-%257B%255B%25282S%252C3S%252C4S%2529-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl%255Dmethoxy%257D-7-methoxyisoquinoline-6-carboxamide%2520%2528PF-06650833%2529%252C%2520a%2520potent%252C%2520selective%2520inhibitor%2520of%2520interleukin-1%2520receptor%2520associated%2520kinase%25204%2520%2528IRAK4%2529%252C%2520by%2520fragment-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5521%26epage%3D5542%26doi%3D10.1021%2Facs.jmedchem.7b00231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Mayer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, B.</span><span> </span><span class="NLM_article-title">Characterization of ligand binding by saturation transfer difference NMR spectroscopy</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1784</span><span class="NLM_x">–</span> <span class="NLM_lpage">1788</span><span class="refDoi"> DOI: 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADyaK1MXktVCntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=1784-1788&author=M.+Mayerauthor=B.+Meyer&title=Characterization+of+ligand+binding+by+saturation+transfer+difference+NMR+spectroscopy&doi=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of ligand binding by saturation transfer difference NMR spectroscopy</span></div><div class="casAuthors">Mayer, Moriz; Meyer, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1784-1788</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">The difference between a satn. transfer spectrum and a normal NMR spectrum provides a new and fast method (satn. transfer difference (STD) NMR spectroscopy) to screen compd. libraries for binding activity to proteins.  STD NMR spectroscopy of mixts. of potential ligands with as little as 1 nmol of protein yields 1D and 2D NMR spectra that exclusively show signals from mols. with binding affinity.  In addn., the ligand's binding epitope is easily identified because ligand residues in direct contact to the protein show much stronger STD signals.  For example, the binding specificity of Lewisb-hexasaccharide to Aleulria aurantia agglutinin (AAA) can be mapped to the two fucosyl residues.  The efficiency of the STD NMR technique is shown by the binding of N-acetylglucosamine (GlcNAc) to wheat germ agglutinin (WGA).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf8j8HiAqDArVg90H21EOLACvtfcHk0lgG6JNXpL_ulw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVCntb0%253D&md5=03f825af40d22911062112dc6074cf46</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819990614%252938%253A12%253C1784%253A%253AAID-ANIE1784%253E3.0.CO%253B2-Q%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DB.%26atitle%3DCharacterization%2520of%2520ligand%2520binding%2520by%2520saturation%2520transfer%2520difference%2520NMR%2520spectroscopy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1999%26volume%3D38%26spage%3D1784%26epage%3D1788%26doi%3D10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Reynolds, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tounge, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bembenek, S. D.</span><span> </span><span class="NLM_article-title">Ligand binding efficiency: trends, physical basis, and implications</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2432</span><span class="NLM_x">–</span> <span class="NLM_lpage">2438</span><span class="refDoi"> DOI: 10.1021/jm701255b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701255b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktFSgsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2432-2438&author=C.+H.+Reynoldsauthor=B.+A.+Toungeauthor=S.+D.+Bembenek&title=Ligand+binding+efficiency%3A+trends%2C+physical+basis%2C+and+implications&doi=10.1021%2Fjm701255b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand binding efficiency: trends, physical basis, and implications</span></div><div class="casAuthors">Reynolds, Charles H.; Tounge, Brett A.; Bembenek, Scott D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2432-2438</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ligand efficiency (i.e., potency/size) has emerged as an important metric in drug discovery.  In general, smaller, more efficient ligands are believed to have improved prospects for good drug properties (e.g., bioavailability).  Our anal. of thousands of ligands across a variety of targets shows that ligand efficiency is dependent on ligand size with smaller ligands having greater efficiencies, on av., than larger ligands.  We propose two primary causes for this size dependence: the inevitable redn. in the quality of fit between ligand and receptor as the ligand becomes larger and more complex and the redn. in accessible ligand surface area on a per atom basis as size increases.  These results have far-ranging implications for anal. of high-throughput screening hits, fragment-based approaches to drug discovery, and even computational models of potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkrPWFEZZEMrVg90H21EOLACvtfcHk0lhGqngtIrrcHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktFSgsbw%253D&md5=a9a41b44dbca7f34562c40b56c7ae683</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm701255b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701255b%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DTounge%26aufirst%3DB.%2BA.%26aulast%3DBembenek%26aufirst%3DS.%2BD.%26atitle%3DLigand%2520binding%2520efficiency%253A%2520trends%252C%2520physical%2520basis%252C%2520and%2520implications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2432%26epage%3D2438%26doi%3D10.1021%2Fjm701255b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">The prediction of human clearance from hepatic microsomal metabolism data</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=11727321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFOlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=36-44&author=R.+S.+Obach&title=The+prediction+of+human+clearance+from+hepatic+microsomal+metabolism+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human clearance from hepatic microsomal metabolism data</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-44</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">PharmaPress Ltd.</span>)
        </div><div class="casAbstract">A review with 42 refs.  Human liver microsomal intrinsic clearance has become a commonly measured parameter during drug discovery, and such data are used to design compds. predicted to possess optimal drug disposition characteristics.  Liver microsomal intrinsic clearance values can be scaled and used to predict hepatic clearance in humans.  Clearance, when combined with the vol. of distribution, dets. the half-life of a drug.  Hepatic clearance, when combined with absorption, dets. the oral bioavailability of a drug.  Half-life and oral bioavailability are key determinants of the dosing regimen, ie, size of dose and frequency of administration.  Thus, the accurate prediction of human clearance is important in the selection of new compds. for progression into development, as new drugs on the market must not only be efficacious and safe, but must also be convenient to use for patients and physicians.  Over the past decade, exploring methods whereby human clearance can be predicted from in vitro data has been an area of active research in drug metab. science.  Human liver microsomes have been a key tool in this research.  This in vitro system possesses many of the major drug metabolizing enzymes and is thus applicable to a wide variety of compds.  This review describes the theor. and practical aspects of predicting clearance from human liver microsomal intrinsic clearance data, a summary of advantages and shortcomings of this in vitro system, a synopsis of recent applications of human liver microsomal intrinsic clearance data in clearance predictions, and a discussion of potential future directions for this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsU3SBmySKm7Vg90H21EOLACvtfcHk0lhGqngtIrrcHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFOlsQ%253D%253D&md5=421bc7764c3d7f501b69aa97996d1db9</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DThe%2520prediction%2520of%2520human%2520clearance%2520from%2520hepatic%2520microsomal%2520metabolism%2520data%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2001%26volume%3D4%26spage%3D36%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Hay, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaumont, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, M.</span><span> </span><span class="NLM_article-title">Modulation of the partition coefficient between octanol and buffer at pH 7.4 and pKa to achieve the optimum balance of blood clearance and volume of distribution for a series of tetrahydropyran histamine type 3 receptor antagonists</span> <span class="citation_source-journal">Drug. Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1864</span><span class="NLM_x">–</span> <span class="NLM_lpage">1870</span><span class="refDoi"> DOI: 10.1124/dmd.109.027888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1124%2Fdmd.109.027888" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1864-1870&author=T.+Hayauthor=R.+Jonesauthor=K.+Beaumontauthor=M.+Kemp&title=Modulation+of+the+partition+coefficient+between+octanol+and+buffer+at+pH+7.4+and+pKa+to+achieve+the+optimum+balance+of+blood+clearance+and+volume+of+distribution+for+a+series+of+tetrahydropyran+histamine+type+3+receptor+antagonists&doi=10.1124%2Fdmd.109.027888"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.027888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.027888%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DT.%26aulast%3DJones%26aufirst%3DR.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DKemp%26aufirst%3DM.%26atitle%3DModulation%2520of%2520the%2520partition%2520coefficient%2520between%2520octanol%2520and%2520buffer%2520at%2520pH%25207.4%2520and%2520pKa%2520to%2520achieve%2520the%2520optimum%2520balance%2520of%2520blood%2520clearance%2520and%2520volume%2520of%2520distribution%2520for%2520a%2520series%2520of%2520tetrahydropyran%2520histamine%2520type%25203%2520receptor%2520antagonists%26jtitle%3DDrug.%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1864%26epage%3D1870%26doi%3D10.1124%2Fdmd.109.027888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitney-Pickett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gebhard, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federico, J. J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varma, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempshall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kattan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span> </span><span class="NLM_article-title">Development of a new permeability assay using low-efflux MDCKII cells</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">4974</span><span class="NLM_x">–</span> <span class="NLM_lpage">4985</span><span class="refDoi"> DOI: 10.1002/jps.22674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1002%2Fjps.22674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=21766308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4974-4985&author=L.+Diauthor=C.+Whitney-Pickettauthor=J.+P.+Umlandauthor=H.+Zhangauthor=X.+Zhangauthor=D.+F.+Gebhardauthor=Y.+Laiauthor=J.+J.+Federicoauthor=R.+E.+Davidsonauthor=R.+Smithauthor=E.+L.+Reynerauthor=C.+Leeauthor=B.+Fengauthor=C.+Rotterauthor=M.+V.+Varmaauthor=S.+Kempshallauthor=K.+Fennerauthor=A.+F.+El-Kattanauthor=T.+E.+Listonauthor=M.+D.+Troutman&title=Development+of+a+new+permeability+assay+using+low-efflux+MDCKII+cells&doi=10.1002%2Fjps.22674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new permeability assay using low-efflux MDCKII cells</span></div><div class="casAuthors">Di, Li; Whitney-Pickett, Carrie; Umland, John P.; Zhang, Hui; Zhang, Xun; Gebhard, David F.; Lai, Yurong; Federico, James J.; Davidson, Ralph E.; Smith, Russ; Reyner, Eric L.; Lee, Caroline; Feng, Bo; Rotter, Charles; Varma, Manthena V.; Kempshall, Sarah; Fenner, Katherine; El-kattan, Ayman F.; Liston, Theodore E.; Troutman, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4974-4985</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Permeability is an important property of drug candidates.  The Madin-Darby canine kidney cell line (MDCK) permeability assay is widely used and the primary concern of using MDCK cells is the presence of endogenous transporters of nonhuman origin.  The canine P-glycoprotein (Pgp) can interfere with permeability and transporter studies, leading to less reliable data.  A new cell line, MDCKII-LE (low efflux), has been developed by selecting a subpopulation of low-efflux cells from MDCKII-WT using an iterative fluorescence-activated cell sorting technique with calcein-AM as a Pgp and efflux substrate.  MDCKII-LE cells are a subpopulation of MDCKII cells with over 200-fold lower canine Pgp mRNA level and fivefold lower protein level than MDCKII-WT.  MDCKII-LE cells showed less functional efflux activity than MDCKII-WT based on efflux ratios.  Notably, MDCKII-MDR1 showed about 1.5-fold decreased expression of endogenous canine Pgp, suggesting that using the net flux ratio might not completely cancel out the background endogenous transporter activities.  MDCKII-LE cells offer clear advantages over the MDCKII-WT by providing less efflux transporter background signals and minimizing interference from canine Pgp.  The MDCKII-LE apparent permeability values well differentiates compds. from high to medium/low human intestinal absorption and can be used for Biopharmaceutical Classification System.  The MDCKII-LE permeability assay (4-in-1 cassette dosing) is high throughput with good precision, reproducibility, robustness, and cost-effective. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTVtRmYnbF17Vg90H21EOLACvtfcHk0lhGqngtIrrcHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D&md5=97f647fc215ea6d04882351ffc912a1e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fjps.22674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22674%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGebhard%26aufirst%3DD.%2BF.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DFederico%26aufirst%3DJ.%2BJ.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DReyner%26aufirst%3DE.%2BL.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DRotter%26aufirst%3DC.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DFenner%26aufirst%3DK.%26aulast%3DEl-Kattan%26aufirst%3DA.%2BF.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520new%2520permeability%2520assay%2520using%2520low-efflux%2520MDCKII%2520cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4974%26epage%3D4985%26doi%3D10.1002%2Fjps.22674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Banker, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. A.</span><span> </span><span class="NLM_article-title">Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">974</span><span class="refDoi"> DOI: 10.1002/jps.10332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1002%2Fjps.10332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=12712416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1ehsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=967-974&author=M.+J.+Bankerauthor=T.+H.+Clarkauthor=J.+A.+Williams&title=Development+and+validation+of+a+96-well+equilibrium+dialysis+apparatus+for+measuring+plasma+protein+binding&doi=10.1002%2Fjps.10332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding</span></div><div class="casAuthors">Banker, Michael J.; Clark, Tracey H.; Williams, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">967-974</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A 96-well equil. dialysis block was designed and constructed that is compatible with most std. 96-well format lab. supplies and instruments.  The unique design of the dialysis app. allows one to dispense and aspirate from either or both the sample and dialyzate sides from the top of the app., which is not possible with systems currently on the market.  This feature permits the investigator to analyze a large no. of samples, time points, or replicates in the same expt.  The novel alignment of the dialysis membrane vertically in the well maximizes the surface-to-vol. ratio, eliminates problems assocd. with trapped air pockets, and allows one to add or remove samples independently or all at once.  Furthermore, the design of the app. allows both the sample and dialyzate sides of the dialysis well to be accessible by robotic systems, so assays can be readily automated.  Teflon construction is used to minimize nonspecific binding of test samples to the app.  The device is reusable, easily assembled, and can be shaken in controlled temp. environments to decrease the time required to reach equil. as well as facilitate dissoln. of test compds.  Plasma protein binding values obtained for 10 diverse compds. using std. dialysis equipment and the 96-well dialysis block validates this method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp9qyX_9tHHrVg90H21EOLACvtfcHk0libL94n45bEAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1ehsrs%253D&md5=0948f0a11373c57be06be9e0d604ad40</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fjps.10332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.10332%26sid%3Dliteratum%253Aachs%26aulast%3DBanker%26aufirst%3DM.%2BJ.%26aulast%3DClark%26aufirst%3DT.%2BH.%26aulast%3DWilliams%26aufirst%3DJ.%2BA.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%252096-well%2520equilibrium%2520dialysis%2520apparatus%2520for%2520measuring%2520plasma%2520protein%2520binding%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2003%26volume%3D92%26spage%3D967%26epage%3D974%26doi%3D10.1002%2Fjps.10332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Zonouzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izakian, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S. W.</span><span> </span><span class="NLM_article-title">Novel synthesis of some new fluorescent 2-amino-3-cyanopyridines</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">2713</span><span class="NLM_x">–</span> <span class="NLM_lpage">2721</span><span class="refDoi"> DOI: 10.3987/COM-12-12566</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.3987%2FCOM-12-12566" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2012&pages=2713-2721&author=A.+Zonouziauthor=Z.+Izakianauthor=S.+W.+Ng&title=Novel+synthesis+of+some+new+fluorescent+2-amino-3-cyanopyridines&doi=10.3987%2FCOM-12-12566"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3987%2FCOM-12-12566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FCOM-12-12566%26sid%3Dliteratum%253Aachs%26aulast%3DZonouzi%26aufirst%3DA.%26aulast%3DIzakian%26aufirst%3DZ.%26aulast%3DNg%26aufirst%3DS.%2BW.%26atitle%3DNovel%2520synthesis%2520of%2520some%2520new%2520fluorescent%25202-amino-3-cyanopyridines%26jtitle%3DHeterocycles%26date%3D2012%26volume%3D85%26spage%3D2713%26epage%3D2721%26doi%3D10.3987%2FCOM-12-12566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Ishikawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, S.</span><span> </span><span class="NLM_article-title">Preparation of perfluoroalkylated benzoheterocyclic compounds using hexafluoro-1,2-epoxypropane</span> <span class="citation_source-journal">Bull. Chem. Soc. Jpn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2164</span><span class="NLM_x">–</span> <span class="NLM_lpage">2167</span><span class="refDoi"> DOI: 10.1246/bcsj.50.2164</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1246%2Fbcsj.50.2164" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1977&pages=2164-2167&author=N.+Ishikawaauthor=S.+Sasaki&title=Preparation+of+perfluoroalkylated+benzoheterocyclic+compounds+using+hexafluoro-1%2C2-epoxypropane&doi=10.1246%2Fbcsj.50.2164"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1246%2Fbcsj.50.2164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fbcsj.50.2164%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DN.%26aulast%3DSasaki%26aufirst%3DS.%26atitle%3DPreparation%2520of%2520perfluoroalkylated%2520benzoheterocyclic%2520compounds%2520using%2520hexafluoro-1%252C2-epoxypropane%26jtitle%3DBull.%2520Chem.%2520Soc.%2520Jpn.%26date%3D1977%26volume%3D50%26spage%3D2164%26epage%3D2167%26doi%3D10.1246%2Fbcsj.50.2164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Bagal, S. K.; Cui, J. J.; Greasley, S. E.; Lunney, E. A.; McAlpine, I. J.; Nagata, A.; Ninkovic, S.; Omoto, K.; Skerratt, S. E.; Storer, R. I.; Warmus, J. S.</span><span> </span><span class="NLM_article-title">N-Pyrazolyl Pyridinylbenzamides as Tropomyosin-Related Kinase Inhibitors and Their Preparation</span>. WO2015170218 A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+K.+Bagal&author=J.+J.+Cui&author=S.+E.+Greasley&author=E.+A.+Lunney&author=I.+J.+McAlpine&author=A.+Nagata&author=S.+Ninkovic&author=K.+Omoto&author=S.+E.+Skerratt&author=R.+I.+Storer&author=J.+S.+Warmus&title=N-Pyrazolyl+Pyridinylbenzamides+as+Tropomyosin-Related+Kinase+Inhibitors+and+Their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBagal%26aufirst%3DS.%2BK.%26atitle%3DN-Pyrazolyl%2520Pyridinylbenzamides%2520as%2520Tropomyosin-Related%2520Kinase%2520Inhibitors%2520and%2520Their%2520Preparation%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Gangjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisliuk, R. L.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of classical and nonclassical 2-amino-4-oxo-5-substituted-6-methylpyrrolo[3,2-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span><span class="refDoi"> DOI: 10.1021/jm701052u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701052u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=68-76&author=A.+Gangjeeauthor=W.+Liauthor=J.+Yangauthor=R.+L.+Kisliuk&title=Design%2C+synthesis%2C+and+biological+evaluation+of+classical+and+nonclassical+2-amino-4-oxo-5-substituted-6-methylpyrrolo%5B3%2C2-d%5Dpyrimidines+as+dual+thymidylate+synthase+and+dihydrofolate+reductase+inhibitors&doi=10.1021%2Fjm701052u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm701052u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701052u%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DKisliuk%26aufirst%3DR.%2BL.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520classical%2520and%2520nonclassical%25202-amino-4-oxo-5-substituted-6-methylpyrrolo%255B3%252C2-d%255Dpyrimidines%2520as%2520dual%2520thymidylate%2520synthase%2520and%2520dihydrofolate%2520reductase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D68%26epage%3D76%26doi%3D10.1021%2Fjm701052u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Vonrhein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flensburg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smart, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paciorek, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Womack, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bricogne, G.</span><span> </span><span class="NLM_article-title">Data processing and analysis with the autoPROC toolbox</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span><span class="refDoi"> DOI: 10.1107/S0907444911007773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1107%2FS0907444911007773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=21460447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=293-302&author=C.+Vonrheinauthor=C.+Flensburgauthor=P.+Kellerauthor=A.+Sharffauthor=O.+Smartauthor=W.+Paciorekauthor=T.+Womackauthor=G.+Bricogne&title=Data+processing+and+analysis+with+the+autoPROC+toolbox&doi=10.1107%2FS0907444911007773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Data processing and analysis with the autoPROC toolbox</span></div><div class="casAuthors">Vonrhein, Clemens; Flensburg, Claus; Keller, Peter; Sharff, Andrew; Smart, Oliver; Paciorek, Wlodek; Womack, Thomas; Bricogne, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-302</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A typical diffraction expt. will generate many images and data sets from different crystals in a very short time.  This creates a challenge for the high-throughput operation of modern synchrotron beamlines as well as for the subsequent data processing.  Novice users in particular may feel overwhelmed by the tables, plots and nos. that the different data-processing programs and software packages present to them.  Here, some of the more common problems that a user has to deal with when processing a set of images that will finally make up a processed data set are shown, concg. on difficulties that may often show up during the first steps along the path of turning the expt. (i.e. data collection) into a model (i.e. interpreted electron d.).  Difficulties such as unexpected crystal forms, issues in crystal handling and suboptimal choices of data-collection strategies can often be dealt with, or at least diagnosed, by analyzing specific data characteristics during processing.  In the end, one wants to distinguish problems over which one has no immediate control once the expt. is finished from problems that can be remedied a posteriori.  A new software package, autoPROC, is also presented that combines third-party processing programs with new tools and an automated workflow script that is intended to provide users with both guidance and insight into the offline processing of data affected by the difficulties mentioned above, with particular emphasis on the automated treatment of multi-sweep data sets collected on multi-axis goniostats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmah7iUrMLXLVg90H21EOLACvtfcHk0liB4-JRvZQlVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D&md5=a0a3579f6b371b6312819883864aa80d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1107%2FS0907444911007773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911007773%26sid%3Dliteratum%253Aachs%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DFlensburg%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DP.%26aulast%3DSharff%26aufirst%3DA.%26aulast%3DSmart%26aufirst%3DO.%26aulast%3DPaciorek%26aufirst%3DW.%26aulast%3DWomack%26aufirst%3DT.%26aulast%3DBricogne%26aufirst%3DG.%26atitle%3DData%2520processing%2520and%2520analysis%2520with%2520the%2520autoPROC%2520toolbox%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D293%26epage%3D302%26doi%3D10.1107%2FS0907444911007773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">Xds</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=Xds&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0liB4-JRvZQlVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXds%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krissinel, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. S.</span><span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+W.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0liB4-JRvZQlVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, W.; Roversi, P.; Sharff, A.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span>BUSTER; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=A.+Sharff&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0liwKDwoa0_-wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NBV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NBV','PDB','3NBV'); return false;">PDB: 3NBV</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBM','PDB','5WBM'); return false;">PDB: 5WBM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBO','PDB','5WBO'); return false;">PDB: 5WBO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBP','PDB','5WBP'); return false;">PDB: 5WBP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBQ','PDB','5WBQ'); return false;">PDB: 5WBQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBR','PDB','5WBR'); return false;">PDB: 5WBR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBZ','PDB','5WBZ'); return false;">PDB: 5WBZ</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i36"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00947">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_44002"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00947">10.1021/acs.jmedchem.7b00947</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Crystal structure describing the environment of Asp27(B) at the interface of the two KHK monomers, distribution of properties for fragment selection among confirmed hits, map of interactions for crystal structure of compound <b>12</b>, in vitro selectivity data for compound <b>12</b>, data collection and refinement statistics for crystal structures of compounds <b>3</b>, <b>4</b>, <b>5</b>, <b>7</b>, <b>8</b>, and <b>12</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00947/suppl_file/jm7b00947_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00947/suppl_file/jm7b00947_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00947/suppl_file/jm7b00947_si_001.pdf">jm7b00947_si_001.pdf (791.79 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00947/suppl_file/jm7b00947_si_002.csv">jm7b00947_si_002.csv (0.67 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates and structure factors for hKHK bound to compounds <b>3</b>, <b>4</b>, <b>5</b>, <b>7</b>, <b>8</b>, and <b>12</b> have been deposited to the RCSB with PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBM">5WBM</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBO">5WBO</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBP">5WBP</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBQ">5WBQ</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBR">5WBR</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBZ">5WBZ</a>, respectively. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00947%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-18%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00947" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679996417eff3ce8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
